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1
General introduction and outline of the thesis
“To him medicine owes the art of clinical inspection and observation.” 
Hippocrates (460 BC – 370 BC).1
The practice of physical examination, diagnosis and prognosis is introduced by the 
Egyptians and the Babylonians. The Diagnostic Handbook written by the ummânū (chief 
scholar) Esagil-kin-apli is known as one of the earliest and most extensive Babylonian 
medical texts (1069-1046 BC). In this handbook it was suggested that the patient’s 
disease could be determined by use of clinical inspection and physical examination.2 
Later it was Hippocrates (460-370 BC) “father of Western medicine” who in, a structured 
fashion, described many diseases and medical conditions. He is well known as a major 
contributor of descriptions of the symptomatology and physical findings of many different 
diseases.1,3 Despite this ancient knowledge, how many physicians today would have the 
courage to write, unaided, a text on the physical examination, diagnosis, and treatment 
of different diseases at the bedside? It was the Dutch physician Isidore Snapper (1889-
1973), who first shared his knowledge regarding the use of Bedside Medicine.4 Before 
that, Jordan Furneaux, a British surgeon, gave one of the first elaborated descriptions 
of alterations in peripheral perfusion during ‘shock’ conditions (1827). 
Although I feel fortunate to live in the 21th century, with incredible innovations in medical 
technology and progress in patient-centered care, the emphasis and dependence on 
technology in modern medicine has generated an unquestioned faith in this technology, 
which in turn may undermine the clinician’s confidence in their own clinical skills. This may 
result in a decline of traditional bedside patient assessment at the expense of an increased 
use of technical diagnostic procedures. The danger of such unwavering confidence in 
technology (even in the absence of a solid evidence base for its benefits) may eventually 
reduce the status of traditional clinical bedside assessment to that of a “medical folklore”.5
Circulatory shock
Nowadays ‘shock’ is best defined as a life-threatening, generalized form of acute 
circulatory failure associated with inadequate oxygen utilization by the cells. It is a state 
in which the circulation is unable to deliver sufficient oxygen to meet the demands of 
the tissues, resulting in cellular dysfunction. The result is cellular dysoxia, i.e. the loss of 
the physiological independence between oxygen delivery and oxygen consumption, 
associated with increased lactate levels.6 Circulatory shock frequently consists of 
inadequate tissue blood flow and if untreated, proceeds from organ dysfunction to 
organ failure and eventually death. It is therefore one of the most common reasons to 
admit patients to the Intensive Care Unit.7
According to Weil and Shubin,8 founders of the understanding and management 
of circulatory (dys)function, shock can be classified into four main categories: 1. 
Hypovolemic (decreased circulating volume), 2. Cardiogenic (cardiac pump failure), 
3. Obstructive (cardiovascular circuit obstruction), and 4. Distributive (vascular 
dysfunction) causes (Figure 1)9.
Of these four types, the first three are characterized by decreased cardiac output 
(i.e. low flow state) and as such can be regarded typical ‘shock’ conditions. The last 
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type, distributive shock (of which septic shock is the most common example), is typically 
associated with high cardiac output (hyperdynamic flow) and as such provides a huge 
challenge in terms of understanding the underlying biologic features and identifying 
the ‘ideal’ endpoints for hemodynamic therapy. It is the result of several mediators, 
such as pathogen factors (i.e. microbial load and virulence) leading to a host–pathogen 
interaction and an exaggerated inflammation resulting in loss of autoregulation and a 
severe disbalance between vasodilation and vasoconstriction. Sepsis, severe sepsis, and 
septic shock are all used to describe the increasing severity of a systemic inflammatory 
response to infection accompanied by systemic symptoms (i.e. fever, leucocytosis, 
hyperventilation, tachycardia).10 These alterations finally cause inadequate regional 
oxygen delivery, tissue injury and/or refractory hypotension and acute organ dysfunction, 
accompanied by a normal or even of a supranormal cardiac output.11,12
Hemodynamic monitoring is essential for diagnosis and management of shock. 
In time, many techniques have been developed: invasive or noninvasive, continuous 
or intermittent, and  looking at different physiologic variables, directly or indirectly 
(through signal processing).13 
Hemodynamic monitoring
“Hemodynamic monitoring plays an important role in the management of today’s 
acutely ill patient.” 13
Hemodynamic monitoring emerged as a distinct scientific discipline late in the 
19th century when Scipione Riva-Rocci developed an easy-to-use version of the 
sphygmomanometer to measure arterial blood pressure. Almost 70 years later in 
1964, dr. Ronald Bradley introduced miniature diagnostic catheters for intravascular 
use.14 This inspired Jeremy Swan and William Ganz in 1968 to develop an intravascular 
flow-directed catheter, which could be percutaneously inserted and positioned in 
the pulmonary artery for the measurement of cardiac output with thermodilution.15 
With their landmark study detailing the human use of this catheter, the era of modern 
Figure 1. Schematic representation of the four types of shock. The classification of the different 
shock types, reproduced from Vincent et al.9, with permission of the NEJM.
Distributive shock Hypovolemic shock Cardiogenic shock Obstructive shock
Obstruction
Pericardial 
tamponade
Loss of 
plasma or 
blood 
volume
Vasodilatation
Ventricular
failure
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hemodynamic monitoring begun. 16 Pulmonary artery catheterization highlighted 
the importance of (semi)continuous monitoring of hemodynamic parameters at the 
bedside. Concurrently, the introduction of monitors attached to digital computers to 
monitor hemodynamic measurements was a defining moment in the development of 
critical care medicine.17 The combination of this latter technology and pulmonary artery 
catheters provided intensivists with a powerful platform to (semi)continuously monitor 
heart function and cardiac output. Despite the widespread use of this invasive catheter 
in critically ill patients in the 1980’s and 1990’s, its use has declined in the past years 
and frequent complications were highligted.17-20 Nowadays, there is a trend toward 
less invasive methods of hemodynamic monitoring. Current hemodynamic monitoring 
tools need to be “reliable, continuous, noninvasive, operator-independent, cost-
effective, and should have a fast response time (beat-to-beat).”21 Therefore alternative 
techniques have been developed, for instance: the transpulmonary thermodilution 
with integrated pulse contour analysis (PiCCO TM) monitoring system (PULSION 
Medical System, Munich, Germany).22 This device is less invasive than pulmonary artery 
catheterization because it allows the assessment of cardiopulmonary hemodynamics 
without contact between the catheter and different cardiopulmonary structures.
Despite these advanced state-of-the-art hemodynamic monitoring techniques, simply 
targeting parameters related to the systemic circulation does not resuscitate various 
organ system tissues and might lead to increased use of medical interventions and 
hospital mortality.23 Surprisingly, the quest towards advanced hemodynamic monitoring 
techniques (central venous, arterial and pulmonary artery catheters) left a great study 
in 1969 unattended. In this study it was demonstrated that circulatory shock patients 
admitted to the Intensive Care Unit with a toe temperature ≤ 27°C had more chance to die 
during their intensive care unit stay.24 The importance of peripheral perfusion assessment 
at the bedside was highlighted with this study already in the 20th century. 
The 21st century
Welcoming a new era of hemodynamic monitoring: Expanding from the macro to the 
microcirculation*.25
It is known that all shock states, including distributive shock, are characterized by 
inadequate tissue perfusion and consequent tissue ischemia. In this latter type of 
shock, a combination of hypovolemia, reduced ventricular function, and pronounced 
vasodilation can lead to inadequate tissue perfusion. Because each of these determinants 
can cause hypotension, monitoring of cardiac function and volume status is essential 
for selecting the proper therapy. However, regional tissue hypoperfusion may persist, 
despite the normalization of systemic hemodynamics. During circulatory shock, blood 
flow is diverted from less important tissues to vital organs (heart, brain, and kidneys) 
to maintain vital organ perfusion at the cost of peripheral circulation, resulting in poor 
outcome in various pathophysiologic conditions. 26,27 Sympathetic activity, which is 
induced by the baroreceptor reflex as a response to systemic hypotension, leads to 
increased vasomotor tone. As sympathetic neuroactivity predominates in the skin and 
18
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muscle, the sympathetic neurohumoural response-induced vasoconstriction manifests 
primarily as decreased peripheral perfusion.28 Therefore, the rationale of peripheral 
perfusion monitoring is based on the concept that peripheral tissues are the first to 
reflect hypoperfusion  during shock, and the last to reperfuse during resuscitation.29. 
Several studies demonstrated that inadequate systemic circulation in both 
hypodynamic and hyperdynamic shock states can be accompanied by impaired tissue and 
microcirculatory perfusion. The importance of monitoring the peripheral microcirculatory 
tissue perfusion in different types of shock was further expanded upon by the work of 
Creteur, DeBacker, and their coworkers,30,31 who used visualization of microvessels and 
sublingual capnometry. These abnormalities can be determined noninvasively at the 
bedside using several clinical assessments. Since we now have entered an era where 
modern medical practitioners seek improved diagnostic techniques, that are easy to 
apply at the bedside, have low-risk for complications, and are non-invasive; noninvasive 
clinical assessment of peripheral perfusion gained interest.32,33 To date, many issues, to 
the quest that already started in 1969, remain to be elucidated. For instance, the clinical 
significance of the various noninvasive peripheral perfusion methods in different patient 
populations as well as its role as resuscitation endpoint.
Aim of the thesis
The aim of this thesis was to investigate the value of noninvasive assessment of the 
peripheral perfusion at the bedside for the recognition and treatment of critically ill patients.
Outline of the thesis
First, we start this thesis with a recapitulation of the currently available methods 
that can be used at the bedside for the noninvasive monitoring of the peripheral 
circulation in critically ill patients. We also discuss the potential role of peripheral 
perfusion monitoring for outcome prediction and resuscitation strategies, Chapter 2A 
and Chapter 2B (Dutch version) respectively.
In the next part of this thesis we discuss how peripheral perfusion parameters 
act under different circulatory conditions. We first evaluated the effect of central 
hypovolemia on the pulse oximeter-derived peripheral perfusion index (PPI) in awake 
healthy volunteers (Chapter 3). Second (Chapter 4), as blood flow in different vascular 
beds is regulated by local vasomotor tone, we explored the effect of peripheral cooling 
on the different peripheral perfusion parameters in healthy volunteers. 
The third part of this thesis focuses on the clinical value of peripheral circulation 
assessment at the bedside in different patient populations. In Chapter 5 we evaluated 
the relative contribution of systemic blood flow and peripheral vasomotor tone (i.e., 
vasoconstriction) to sublingual and peripheral perfusion parameters before, during, 
and after therapeutic hypothermia in patients following out-of-hospital cardiac arrest, 
and the relation to outcome. We further explored the value of peripheral perfusion 
assessment for the prediction of complications following major abdominal surgery 
(Chapter 6). Finally in this part, we studied the association between the evolution of 
19
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different peripheral perfusion parameters with outcome in patients admitted to the 
intensive care unit, after undergoing initial septic shock resuscitation (Chapter 7).
In the fourth part of this thesis we aimed to answer the quintessential question: 
can we incorporate the different peripheral perfusion parameters into a resuscitation 
protocol that could benefit the patient. We therefore studied, in a prospective 
randomized controlled fashion, whether alterations in peripheral perfusion could be 
prevented in postoperative esophagectomy patients admitted to the Intensive Care 
Unit (Chapter 8). Next, we investigated in an experimental setting, whether changes 
in the perfusion of different regional vascular beds are dependent on the type of 
circulatory shock (obstructive vs. septic) and whether the different microvascular and 
peripheral perfusion parameters can be used to assess the adequacy of hemodynamic 
resuscitation during these different types of shock (Chapter 9). Finally, we conducted 
a single-center prospective randomized controlled pilot-study in septic shock patients 
admitted to the Intensive Care Unit. In this study our primary goal was to compare early 
goal directed fluid resuscitation based on clinical assessment of peripheral perfusion 
with standard fluid therapy, to investigate whether peripheral perfusion guided 
resuscitation is feasible and would lead to less fluid administration (Chapter 10).
In Chapter 11, 12, and 13 we respectively discuss the main results of each chapter, 
provide recommendations for future work, and summarize the most important findings 
of this thesis.
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Abstract
Purpose of review
The holy grail of circulatory monitoring is the use of an accurate, continuous and noninvasive 
method that can easily assess tissue perfusion under clinical conditions. As peripheral 
tissues are sensitive to alterations in perfusion, the noninvasive monitoring of peripheral 
circulation could be used as an early marker of systemic haemodynamic derangement. We 
therefore aim to discuss the currently available methods that can be used at the bedside 
as well as the role of peripheral perfusion monitoring in critically ill patients.
Recent findings
The deterioration of peripheral circulation has frequently been observed in critically 
ill patients with the use of subjective assessment and several optical techniques. 
In various patient categories, more severe and persistent alterations have been 
associated with worse outcomes, and these associations were independent of 
systemic haemodynamic parameters. Interventions aimed at systemic parameters 
have an unpredictable effect on peripheral circulation parameters, especially during 
hyperdynamic conditions. Thus, it appears that changes in peripheral perfusion reflect 
changes in regional vasomotor tone rather than systemic blood flow.
Summary
Subjective assessments and optical techniques provide important information 
regarding peripheral circulation. Moreover, these techniques are relatively easy to 
implement and interpret at the bedside and can be applied during acute conditions. 
Further research is warranted to investigate the effects of therapeutic interventions on 
peripheral perfusion parameters and patient outcome.
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Introduction
The conventional classification for the causes of haemodynamic instability discriminates 
between a lack of circulating volume, insufficient pump function, obstruction of blood 
flow and loss of blood flow regulation.1 Although corresponding treatment modalities 
have been established, selecting the correct method can be very difficult when a proper 
diagnosis cannot be made. Especially in patients with severe sepsis, a combination 
of hypovolaemia, reduced ventricular function, and pronounced vasodilation can 
lead to inadequate tissue perfusion. Because each of these determinants can cause 
hypotension, monitoring of cardiac function and volume status is essential for selecting 
the proper therapy. However, regional tissue hypoperfusion may persist, despite the 
normalization of systemic haemodynamics. 
During circulatory shock, blood flow is diverted from less important tissues 
to vital organs (heart, brain, and kidneys) to maintain vital organ  perfusion at the 
cost of peripheral circulation, resulting in poor outcome in various pathophysiologic 
conditions. Sympathetic activity, which is induced by the baroreceptor reflex as a 
response to systemic hypotension, leads to increased vasomotor tone. As sympathetic 
neuroactivity predominates in the skin and muscle, the sympathetic neurohumoural 
response-induced vasoconstriction manifests primarily as decreased peripheral 
perfusion.2 Therefore, the rationale of peripheral perfusion monitoring is based on the 
concept that peripheral tissues are the first to reflect hypoperfusion during shock, and 
the last to reperfuse during resuscitation.3
It is well known that inadequate systemic circulation in both hypodynamic and 
hyperdynamic shock states can be accompanied by impaired peripheral circulation.4 
These abnormalities can be determined noninvasively using simple clinical 
assessments,5 skin temperature measurements,5 and optical monitoring devices.6,7 
These ‘peripheral’ techniques each involve the use of ‘abnormal’ values, which are 
generally associated with worse outcome in critically ill patients, do not need an 
intravascular catheter, and can be used directly at the bedside without entry into the 
body through orifices or skin or mucosal tissue punctures (Table 1). In the following 
section, we will discuss the currently available and commonly used techniques for 
assessing peripheral circulation in clinical conditions.
Clinical assessment of peripheral perfusion
The cutaneous vascular bed plays an important role in the thermoregulation of the 
body, and this process can result in skin perfusion alterations that have direct effects 
on skin temperature and colour, that is, a cold, clammy, white, and mottled skin. 
Capillary refill time
Capillary refill time (CRT) is defined as the time required for a distal capillary bed (i.e., 
the nailbed) to regain its colour after pressure has been applied to cause blanching. 
This concept was first introduced by Champion et al.8 in 1981 as a component of the 
international trauma severity score for the rapid and structured cardiopulmonary 
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assessment of critically ill patients. Because CRT assessment is an easily applicable 
method in many circumstances, it is most useful for assessing peripheral perfusion and 
predicting unfavourable outcomes in both critically ill adult and paediatric patients. For 
instance, in paediatric patients, Bohnhorst et al.9 showed that among several clinical signs 
present at the very first instance of suspected infection, a prolonged CRT demonstrated 
the most sensitive correlation with proven infection. In a recent review of clinical features 
that are used to confirm or exclude the possibility of serious infection in paediatric patients 
presented to ambulatory care, a prolonged CRT was shown to be one of the strongest 
indications of serious infection.10 In these patients, there may be alterations in the balance 
of vasoconstrictor and vasodilator substances and in the cross-talk between endothelial 
cells, which could result in impaired microvascular tissue blood flow regulation that is 
related to significant dehydration, serious infection, and severe organ dysfunction.11
In a healthy adult population, Schriger and Baraff12 reported that the upper limit of a 
normal CRT is 4.5 s. After applying this cutoff in critically ill patients, we demonstrated 
that a delayed return of normal colour (>4.5 s) can be regarded as decreased peripheral 
perfusion. Moreover, we found that following initial haemodynamic optimization 
during the first 24 h of ICU admission, the CRT could be used to discriminate patients 
with more severe organ dysfunction. In addition, a prolonged CRT (>4.5 s) was related 
to tissue hypoperfusion and a greater likelihood of worsening organ failure in the 
following days, compared with patients with a normal CRT.5,13 Although interobserver 
variability remains a matter of debate, an upper normality limit of more than 4.5 s 
appears to be highly reproducible for critically ill patients admitted to the ICU.14
Skin temperature
Skin temperature is best estimated using the dorsal surface of the hands or fingers of 
the medical examiner, as these areas are most sensitive to temperature perception. 
Patients are considered to have cool extremities if all examined extremities are 
considered cool by the examiner or if only the lower extremities are cool despite warm 
upper extremities in the absence of peripheral vascular occlusive disease.15 It has been 
demonstrated that subjectively determined variations in skin temperature correspond 
to objective measures of peripheral skin perfusion.13,16 Similarly, fingertip temperature 
estimations correlated well with objective assessments of fingertip blood flow.13,17 
Accordingly, patients with a subjectively determined ‘abnormal’ peripheral perfusion 
following initial haemodynamic resuscitation have been associated with higher lactate 
levels and more severe organ dysfunction.5
Mottling
Mottling of the skin is easily recognized and is often encountered in critically ill patients. 
It is defined as a bluish skin discoloration that typically manifests near the elbows or 
knees and has a distinct patchy pattern. Mottling is the result of heterogenic small 
vessel vasoconstriction and is thought to reflect abnormal skin perfusion. To analyse 
mottling objectively, Ait-Oufella et al.18 recently developed a clinical scoring system 
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(from 0 to 5) based on the area of mottling from the knees to the periphery (Fig. 1). 
This group reported that a higher mottling score within 6h after initial resuscitation 
was a strong predictive factor of 14-day mortality during septic shock, and this was 
independent of systemic haemodynamics. This scoring system is very easy to learn, 
has good interobserver agreement, and can be used at the bedside.
From these studies, it is clear that the clinical assessment (Fig. 1) of peripheral 
perfusion is a valuable adjunct for the haemodynamic monitoring of critically ill 
patients and should be incorporated into future multimodal monitoring strategies to 
adequately monitor optimal circulatory shock resuscitation.
Body temperature gradient
Although skin temperature has been shown to be an easily accessible parameter for 
circulatory shock severity,19 later research demonstrated that body temperature gradients 
can better reflect changes in cutaneous blood flow than the absolute skin temperature 
itself in critically ill patients.20,21 Body temperature gradients are determined by the 
temperature difference between two measurement points, such as peripheral-to-ambient, 
central-to-toe, and forearm-to-fingertip (Tskin-diff). Increased vasoconstriction during 
circulatory shock leads to decreased skin temperature and a diminished ability of the core 
Peripheral Perfusion Index 
Capillary refill time
Pressure is applied to 
nailbed until it turns 
white
Blood returned to 
tissue
Score 2
Score 5
Mottle Score
Near-infrared spectroscopy
Body temperature gradient
Delta TEMPERATURE
Tforearm - Tfingertip 
= 
Tskindiff
Figure 1. Peripheral perfusion methods used in clinical practice. Different methods are used to 
measure peripheral perfusion, and these provide quantitative real-time information regarding 
peripheral circulation at the bedside. 
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to regulate its temperature before hypothermia occurs. Consequently, core temperature 
is maintained at the cost of the periphery to maintain vital organ perfusion, resulting 
in an increased central-to-peripheral temperature difference, when vasoconstriction 
decreases fingertip blood flow. This concept permits the establishment of central-to-toe 
temperature difference as an indicator of peripheral perfusion in critically ill patients, and 
a normal temperature gradient of 3–7°C occurs once the patient’s haemodynamics have 
been optimized.22 Because the effect of the operating room environment on skin and 
body temperature changes during surgery, especially with the use of cardiopulmonary 
bypass, Tskin-diff may be a more reliable measurement for critically ill patients.23 The 
use of Tskin-diff is based on assumption that the reference temperature is a skin site 
exposed to the same ambient temperature producing little change in the gradient 
(Fig. 1). Experimental studies have suggested Tskin-diff thresholds of 0°C for initiating 
vasoconstriction and 4°C for severe vasoconstriction.23,24 In critically ill adult patients, 
Tskin-diff measurements conducted simultaneously with clinical observation have helped 
to address the reliability of subjective peripheral perfusion assessment, and are able to 
indicate abnormal peripheral perfusion in the postresuscitation period.5 
Optical monitoring
Optical methods apply light with different wavelengths directly to the tissue to assess various 
tissue states. There are several research techniques (described elsewhere25) that apply 
optical methods to visualize the microcirculation, assess oxygen availability, measure Pco2, 
and assess microvascular function in different tissues. Commonly used optical methods in 
the clinical setting that are able to monitor peripheral perfusion at the bedside include 
finger photoplethysmography and near-infrared spectroscopy (NIRS). Although these 
techniques are particularly promising, as objective numerical information can be obtained 
within a couple of minutes, the interpretations should be considered in combination with 
the clinical examination and additional peripheral perfusion measurements.13
Peripheral perfusion index
The peripheral perfusion index (PPI) is derived from the photoelectric plethysmographic 
signal of the pulse oximeter. Pulse oximetry, a standard of care in the ICU, allows 
for the measurement of arterial haemoglobin oxygen saturation and pulse rate 
monitoring. This noninvasive tool uses two wavelengths of light (red and infrared) that 
are transmitted through the distal phalanx of the index finger, resulting in the display of 
a pulsatile photoplethysmographic waveform. Analogous to an arterial pulse contour 
analysis, several variables can be derived from the plethysmographic waveform, such 
as the PPI (Fig. 1). The PPI is the ratio of the pulsatile part to the nonpulsatile part 
of the curve, expressed as a percentage. Because the size of the pulsatile portion 
increases with vasodilation and decreases with vasoconstriction, changes in the 
PPI reflect changes in peripheral vasomotor tone. This was first demonstrated in a 
model of axillary plexus-induced vasodilatation, and the analgesic effect of this nerve 
block could be predicted within minutes using the increase in PPI as a measure of 
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concomitant peripheral vasodilatation in patients undergoing hand surgery.26 Similarly, 
the PPI was shown to be rapidly reduced following sympathetic response-induced 
vasoconstriction after the introduction of a nociceptive skin stimulus27 or an intravenous 
injection of epinephrine28 or norepinephrine.29 Furthermore, in a lower body negative 
pressure model, the PPI also rapidly decreased following sympathetic activation in 
healthy volunteers who underwent stepwise decreases in venous return.30
In a large population of healthy volunteers, the median PPI value was 1.4%.7 In 
critically ill patients, the same value was found to represent a very sensitive cutoff point 
for determining abnormal peripheral perfusion, as defined by a prolonged CRT and an 
increased skin temperature difference.5,7,31 Therefore, this easily obtainable and noninvasive 
method can be used for monitoring peripheral perfusion in critically ill patients.
Near-infrared spectroscopy
NIRS is a noninvasive technique that enables the determination of tissue 
oxygenation based on the spectrophotometric quantitation of oxyhaemoglobin and 
deoxyhaemoglobin within a tissue. Although this technique can be applied to any 
tissue, it is primarily used to monitor peripheral oxygenation of muscle tissue in critically 
ill patients. The variables that are analysed using NIRS can either be directly calculated 
or derived from physiological interventions, such as an arterial and venous vascular 
occlusion test (VOT). As a result, information regarding muscle oxygen saturation 
(StO2) and the absolute tissue haemoglobin index, an indicator of blood volume in 
the microvasculature tissue region, can be obtained.2 In addition, changes in StO2 
levels during a VOT have been used to represent microvascular reactivity.6,32-34 The 
utility of NIRS for managing critically ill patients remains a matter of debate. Increasing 
publications using NIRS have described profound alterations in microvascular function 
in patients suffering from different pathophysiological conditions, such as sepsis and 
traumatic shock.32-35 In a study by Shapiro et al.36, the dynamic NIRS variables collected 
during a VOT were strongly associated with the severity of organ dysfunction and 
mortality in patients with septic shock. In this study, the StO2 recovery slope was most 
sensitive for the prediction of mortality. This is of special interest because there is a 
lack of agreement on standardization for the appropriate method for performing a 
VOT37,38. When measured at the thenar eminence, NIRS-derived measurements are 
influenced by the peripheral circulation condition (Fig. 1).13 Nevertheless, when used 
in conjunction with other peripheral perfusion methods, repeated StO2 monitoring 
has the potential to assess the effect of therapeutic intervention on the peripheral 
microvascular circulation in various shock states. Similarly, Colin et al.39 investigated 
the dynamic response of StO2 at different sites during the first 6h of severe sepsis 
resuscitation, and argued that StO2 values measured at the masseter muscle may better 
relate to patient outcome and may be a more powerful indicator for monitoring the 
effect of resuscitation, compared with measurements taken at the thenar eminence.
Although NIRS can potentially be very useful for tissue oxygenation and perfusion 
assessments, additional studies are still being conducted to clarify its role in the clinical 
management of ICU patients.
31
2a
Monitoring peripheral perfusion in critically ill patients at the bedside
Potential therapeutic interventions to resuscitate 
peripheral perfusion 
Although the relationship between systemic and peripheral circulation is not always 
well defined, the assessment of peripheral perfusion during peripheral cooling-
induced vasoconstriction in healthy volunteers has shown that profound changes 
in the peripheral circulation can occur independently of systemic haemodynamic 
parameters, such as blood pressure and cardiac output.31 Similar observations have 
been made during therapeutic hypothermia following cardiac arrest.40 In patients 
with severe sepsis, this discrepancy between systemic and peripheral circulation can 
become even larger; regional vasoconstriction appears to be independent of systemic 
blood flow in these patients.41 Considering that peripheral vasoconstriction during 
septic shock is an effect of increased sympathetic activity, the origin of the latter is 
unclear; it is likely that baroreceptor reflex activity, systemic inflammatory response, 
and the loss of parasympathetic activity each may play a role.42,43
Although the mechanism involved in sepsis resuscitation is not yet fully understood, 
it is clear that the persistence of impaired peripheral perfusion is associated with worse 
patient outcomes.5,6 It can be hypothesized that interventions specifically aimed at 
the peripheral vascular bed could resuscitate these alterations. For instance, based 
on the central-to-toe temperature, Boerma et al.44 showed that the administration of 
nitroglycerine to septic patients following early resuscitation significantly improved 
peripheral perfusion, independently of systemic haemodynamics. Although there was 
a trend to increasing mortality, this was accompanied by reduced morbidity in the 
nitroglycerine-treated patient group compared with the placebo group; as a result, 
vasodilatory agents may be promising treatment modalities. 
Although fluid resuscitation is the first line therapy for sepsis-induced hypoperfusion, 
few studies have evaluated its effect on peripheral perfusion. Futier et al.45 recently 
showed that the administration of a fluid challenge had positive effects on peripheral 
tissue oxygenation in patients undergoing major abdominal surgery.
Whether these interventions are capable of resuscitating different peripheral 
perfusion parameters is, however, still unknown. Current studies to determine the effects 
of these interventions on peripheral circulation in critically ill patients are ongoing.
Conclusion
The rationale for monitoring peripheral perfusion is based on the concept that the 
peripheral circulation is the first to reflect a disturbance of the circulation that may 
lead to shock. Monitoring peripheral circulation not only provides a different point 
of reference for patient circulation but it also does not require invasive techniques 
and can be used directly at the bedside. Moreover, it is a simple approach that can 
be rapidly applied throughout the hospital, including the emergency department, 
operating room, wards, and ICU.
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Abstract 
Peripheral tissues, such as skin and muscles, are sensitive to alterations in perfusion. 
During circulatory shock, these tissues are the first to receive less blood and the last 
to recover after treatment. By monitoring peripheral circulation, disturbance of the 
systemic circulation can be detected at an early stage. Peripheral perfusion is often 
disturbed in critically ill patients. Peripheral perfusion may remain disturbed, even if 
conventional hemodynamic parameters such as blood pressure and heart frequency 
normalize after treatment. Persistent abnormal peripheral perfusion is related to a 
poorer clinical course. With current non-invasive methods, peripheral circulation in 
critically ill patients can easily be assessed at the bedside. Interventions that improve 
peripheral circulation may speed up recovery in critically ill patients.
Samenvatting
 • Perifere weefsels, zoals huid en spieren, zijn gevoelig voor veranderingen in 
de perfusie. Tijdens circulatoire shock worden deze weefsels als eerste minder 
doorbloed en na behandeling herstellen ze als laatste.
 • Door het monitoren van de perifere circulatie kan daarom al in een vroeg stadium 
een verstoring van de systemische circulatie worden opgespoord.
 • Bij ernstig zieke patiënten is de perifere perfusie vaak verstoord.
 • De perifere perfusie kan verstoord blijven, ook als de waarden van conventionele 
hemodynamische parameters, als bloeddruk en hartfrequentie, na behandeling 
normaliseren.
 • Een blijvend afwijkende perifere perfusie is gerelateerd aan een slechter klinisch 
beloop.
 • Met de huidige non-invasieve methoden kan de perifere circulatie bij ernstig zieke 
patiënten eenvoudig worden beoordeeld aan het bed.
 • Mogelijk kunnen interventies die de perifere circulatie verbeteren het klinisch 
herstel bespoedigen bij ernstig zieke patiënten.
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Introduction
Al sinds 1969 is bekend dat de temperatuur van de grote teen een maat is voor de ernst van 
circulatoire shock.1 De onderzoekers lieten zien dat patiënten met een teentemperatuur 
≤ 27°C bij opname op de IC een slechtere hartfunctie en een groter risico op overlijden 
hadden. Anno 2013 zijn er andere methoden om de doorbloeding van de perifere 
circulatie te bepalen aan het bed van de patiënt. Een slechtere perifere doorbloeding, 
zoals bepaald met deze nieuwere methoden, is geassocieerd met een verhoogd risico 
op orgaanfalen en op overlijden.2-5 Mogelijk wordt het verbeteren van de perifere 
doorbloeding een belangrijk doel bij de behandeling van ernstig zieke patiënten.6
In dit artikel presenteren we de huidige non-invasieve methoden om de doorbloeding 
van de perifere circulatie te bepalen en de implicaties hiervan voor de kliniek.
Waarom de perifere perfusie meten
Tijdens de initiële periode van circulatoire shock vindt een herverdeling van het 
hartminuutvolume plaats, van de perifere weefsels (huid en spier) naar de vitale organen 
(hersenen en hart). Dit is het gevolg van verschillende compensatiemechanismen en heeft 
als doel de doorbloeding van de vitale organen te garanderen. Door een daling van de 
arteriële bloeddruk worden de vasomotorische centra in het ruggenmerg gestimuleerd 
via de arteriële baroreceptoren en de hersenstam. Dit leidt achtereenvolgens tot een 
sterke sympathische reflex, stimulatie van perifere chemoreceptoren, vasoconstrictie 
in arteriolen en venen in de niet-vitale organen en een verminderde doorbloeding 
van de huid en het spierweefsel. Deze mechanismen treden al in een vroeg stadium 
in werking, nog voordat veranderingen optreden in de waarden van conventionele 
hemodynamische parameters zoals bloeddruk en hartfrequentie. De perfusie van deze 
perifere weefsels is daarom een gevoelige indicator voor de vroege opsporing van een 
verstoring van de systemische circulatie, zoals tijdens acute circulatoire shock.
Als de juiste behandeling wordt gestart en de circulatie zich herstelt, zal de activiteit van 
de compensatiemechanismen bij de meeste patiënten verminderen. De vasoconstrictie in 
het perifere vaatbed neemt af en de perfusie van de huid en het spierweefsel herstelt zich 
weer; dit is een teken van een succesvolle behandeling. Bij sommige patiënten blijven de 
compensatiemechanismen – en dus de vasoconstrictie – echter actief en herstelt de perifere 
perfusie zich niet. Perifere vasoconstrictie kan ook optreden tijdens een gegeneraliseerde 
ontsteking en tijdens sepsis. Vasoconstrictie wordt dan gemedieerd door het sympathisch 
zenuwstelsel en is geen compensatie voor een verstoorde circulatie. De ernst en de duur 
van de vasoconstrictie zijn daarbij gerelateerd aan de ziekte-ernst van de patiënt; ondanks 
hemodynamische stabilisatie duurt de vasoconstrictie voort. Bij septische shock is de 
verstoorde perifere perfusie dus een weerspiegeling van de ernst van de shock en geen 
teken van een compensatiemechanisme zoals bij circulatoire shock.7,8
Monitoring van de perifere circulatie is gebaseerd op het concept dat perifere 
weefsels de eerste zijn die hypoperfusie laten zien tijdens circulatoire shock en de 
laatste die herstellen tijdens de behandeling. Met een aantal eenvoudige klinische 
beoordelingen en monitoringstechnieken kan de perifere circulatie op een non-
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invasieve wijze worden beoordeeld. Deze methoden worden hierna besproken en zijn 
ook samengevat in de tabel en de figuur.
Klinische beoordeling
Het uitgebreide huidvaatbed speelt een belangrijke rol bij de thermoregulatie van 
het lichaam. Veranderingen in de doorbloeding bepalen de kleur en de temperatuur 
van de huid: van warm en roze bij gezonde mensen tot koud, klam, wit en gevlekt bij 
ernstige vasoconstrictie.
Huidtemperatuur
De beoordeling van de huidtemperatuur – ‘warm’ of ‘koud’ – kan het best worden 
uitgevoerd met het dorsale oppervlak van de handen of vingers; deze oppervlakken zijn 
immers het gevoeligst voor de waarneming van temperatuur. Een afwijkende perifere 
perfusie bij deze manier van beoordelen is gerelateerd aan hogere lactaatspiegels en 
ernstiger orgaanfalen.3 Deze subjectieve waarneming van de temperatuur komt goed 
overeen met objectieve metingen van de huidtemperatuur en van de vingerdoorbloeding, 
en is daarom geschikt voor de beoordeling van de perifere circulatie.9
Capillaire-‘refill’-tijd
De capillaire-‘refill’-tijd is de tijd die nodig is om weer kleur te krijgen in een distaal 
capillair netwerk, bijvoorbeeld het nagelbed, nadat er gedurende 15 s zo veel druk op 
is uitgeoefend dat een bleke verkleuring is ontstaan. Bij gezonde volwassenen is de 
bovengrens van een normale CRT van het nagelbed 4,5 s. Bij ernstig zieke patiënten 
kan vertraagd herstel (> 5 s) worden beschouwd als een verminderde perifere 
perfusie.3 Op deze manier kunnen patiënten met een verstoorde perfusie al tijdens 
de eerste 24 h van opname op de IC worden geïdentificeerd. Verder is een verlengde 
capillaire-refill-tijd bij IC-patiënten en bij patiënten na reanimatie gerelateerd aan een 
verhoogd risico op orgaanfalen en op overlijden vergeleken met patiënten met een 
niet-afwijkende capillaire-refill-tijd (< 5 s).3,5 Dit risico blijft verhoogd na normalisatie 
van de waarden van conventionele hemodynamische parameters. De meting van 
capillaire-refill-tijd lijkt subjectief, maar toch komen de beoordelingen door zowel 
artsen als verpleegkundigen goed overeen.10
Marmering van de huid
Een marmerhuid is een reticulair, blauwrood huidaspect, meestal veroorzaakt door koude. 
Deze verkleuring is gemakkelijk te herkennen en komt typisch voor rondom de ellebogen 
of de knieën. Een marmerhuid wordt veroorzaakt door heterogene vasoconstrictie in het 
huidvaatbed en wordt vaak gezien bij ernstig zieke patiënten. Een recente studie bij 
patiënten met septische shock laat zien dat de mate van marmering – en dus de ernst 
van de hypoperfusie – goed kan worden beoordeeld met de ‘mottling’-score (zie figuur). 
Deze score loopt van 0 (‘geen marmering’) tot 5 (‘zeer ernstige marmering’). Een score 
van 4 (‘ernstige marmering’) of 5 binnen 6 h na de initiële behandeling is een sterk 
voorspellende factor voor de 14-daagse mortaliteit, onafhankelijk van de conventionele 
39
2b
Beoordeling van de perifere circulatie bij ernstig zieke patiënten
ta
b
el
. 
N
o
n-
in
va
si
ev
e 
m
et
ho
d
en
 v
o
o
r 
d
e 
b
eo
o
rd
el
in
g
 v
an
 d
e 
p
er
ife
re
 c
irc
ul
at
ie
M
et
ho
d
e
V
o
o
rd
ee
l
N
ad
ee
l
A
an
b
ev
o
le
n 
af
ka
p
p
un
t
K
lin
is
ch
e 
b
eo
o
rd
el
in
g
hu
id
te
m
p
er
at
uu
r
tij
d
en
s 
lic
ha
m
el
ijk
 o
nd
er
zo
ek
; w
aa
rd
ev
o
lle
 
aa
nv
ul
lin
g
 o
p
 h
em
o
d
yn
am
is
ch
e 
m
o
ni
to
rin
g
 
tij
d
en
s 
ci
rc
ul
at
o
ire
 s
ho
ck
su
b
je
ct
ie
f; 
m
o
g
el
ijk
 z
ijn
 g
ed
ig
ita
lis
ee
rd
e 
o
f g
ea
ut
o
m
at
is
ee
rd
e 
m
et
in
g
en
 w
el
 
o
b
je
ct
ie
f
ko
ud
,  
g
er
el
at
ee
rd
 a
an
 h
o
g
er
e 
m
o
rb
id
ite
it 
en
 m
o
rt
al
ite
it
ca
p
ill
ai
re
-‘
re
fil
l’-
tij
d
tij
d
en
s 
lic
ha
m
el
ijk
 o
nd
er
zo
ek
; w
aa
rd
ev
o
lle
 
aa
nv
ul
lin
g
 o
p
 h
em
o
d
yn
am
is
ch
e 
m
o
ni
to
rin
g
 
tij
d
en
s 
ci
rc
ul
at
o
ire
 s
ho
ck
su
b
je
ct
ie
f; 
m
o
g
el
ijk
 z
ijn
 g
ed
ig
ita
lis
ee
rd
e 
o
f g
ea
ut
o
m
at
is
ee
rd
e 
m
et
in
g
en
 w
el
 
o
b
je
ct
ie
f
>
 4
,5
 s
, g
er
el
at
ee
rd
 a
an
 h
o
g
er
e 
m
o
rb
id
ite
it 
en
 m
o
rt
al
ite
it
‘m
o
tt
lin
g
’-
sc
o
re
*
tij
d
en
s 
lic
ha
m
el
ijk
 o
nd
er
zo
ek
; m
ar
m
er
hu
id
 is
 
ee
nv
o
ud
ig
 t
e 
he
rk
en
ne
n 
en
 t
e 
b
eo
o
rd
el
en
b
eo
o
rd
el
in
g
 is
 la
st
ig
 b
ij 
p
at
ië
nt
en
 m
et
 
d
o
nk
er
e 
o
f z
w
ar
te
 h
ui
d
sc
o
re
 4
-5
, g
er
el
at
ee
rd
 a
an
 
m
o
rt
al
ite
it
H
ui
d
te
m
p
er
at
uu
rg
ra
d
ië
nt
o
nd
er
ar
m
-t
o
t-
vi
ng
er
to
p
g
ev
al
id
ee
rd
e 
m
et
ho
d
e 
vo
o
r 
b
eo
o
rd
el
in
g
 v
an
 
p
er
ife
re
 w
ee
fs
el
d
o
o
rb
lo
ed
in
g
g
ee
n 
re
al
tim
e 
w
ee
rg
av
e 
va
n 
ve
ra
nd
er
in
g
en
 in
 p
er
ife
re
 p
er
fu
si
e
>
 4
°C
, g
er
el
at
ee
rd
 a
an
 h
o
g
er
e 
m
o
rb
id
ite
it 
en
 m
o
rt
al
ite
it
O
p
ti
sc
he
 m
o
ni
to
ri
ng
p
er
ife
re
-p
er
fu
si
e-
in
d
ex
vo
o
r 
he
m
o
d
yn
am
is
ch
e 
m
o
ni
to
rin
g
 v
an
 e
rn
st
ig
 
zi
ek
e 
p
at
ië
nt
en
ni
et
 a
cc
ur
aa
t 
tij
d
en
s 
b
ew
eg
in
g
en
 v
an
 
p
at
ië
nt
<
 1
,4
%
, g
er
el
at
ee
rd
 a
an
 h
o
g
er
e 
m
o
rb
id
ite
it 
en
 m
o
rt
al
ite
it
‘n
ea
r-
in
fr
ar
ed
’-
sp
ec
tr
o
sc
o
p
ie
kw
an
tit
at
ie
ve
 in
fo
rm
at
ie
 o
ve
r 
w
ee
fs
el
o
xy
g
en
at
ie
 
en
 m
ic
ro
va
sc
ul
ai
re
 fu
nc
tie
 b
in
ne
n 
en
ke
le
 
m
in
ut
en
; e
en
vo
ud
ig
 t
e 
he
rh
al
en
vo
o
r 
d
e 
m
et
in
g
en
 z
ijn
 v
er
sc
hi
lle
nd
e 
ap
p
ar
at
en
 n
o
d
ig
; t
es
t 
vo
o
r 
va
sc
ul
ai
re
 
re
ac
tiv
ite
it 
is
 n
ie
t 
g
es
ta
nd
aa
rd
is
ee
rd
<
 7
0%
 o
f >
 7
5%
, g
er
el
at
ee
rd
 a
an
 
ho
g
er
e 
m
o
rb
id
ite
it 
en
 m
o
rt
al
ite
it
* 
D
e 
m
at
e 
va
n 
m
ar
m
er
in
g
 v
an
 d
e 
hu
id
 w
o
rd
t 
b
ep
aa
ld
 m
et
 d
e 
‘m
o
tt
lin
g
’-
sc
o
re
, d
ie
 lo
o
p
t 
va
n 
0 
(g
ee
n 
m
ar
m
er
in
g
) t
o
t 
5 
(z
ee
r 
er
ns
tig
e 
m
ar
m
er
in
g
).
40
Beoordeling van de perifere circulatie bij ernstig zieke patiënten
hemodynamische parameters.11 Dit scoringssysteem is eenvoudig te leren, heeft een 
goede interbeoordelaarsbetrouwbaarheid en kan aan het bed worden toegepast.
Huidtemperatuurgradiënt
Hoewel al lang bekend is dat de absolute huidtemperatuur een goede parameter is 
voor de ernst van circulatoire shock,1 laat recenter onderzoek zien dat de gradiënt in 
de huidtemperatuur de veranderingen in lokale doorbloeding beter weergeeft.11,12 
Deze gradiënt wordt bepaald door de temperatuurverschillen tussen een proximaal en 
distaal meetpunt te bepalen, zoals centraal-tot-grote-teen of onderarm-tot-vingertop, 
en wordt gemeten door middel van thermometer probes op de huid (zie figuur). De 
capillaire-‘rell’-tijd
‘mottling’-score
huidtemperatuurgradiënt
onderarm-tot-vingertop
‘near-infrared’-spectroscopie
perifere-perfusie-index
huidtemperatuur
subjectieve methoden objectieve methoden
1
2
3
4
5
15 s
Figuur. Non-invasieve methoden om de perifere circulatie te beoordelen aan het bed van de 
patiënt. Subjectieve methoden zijn de huidtemperatuur, de capillaire-‘refill’-tijd, en de ‘mottling’-
score voor het bepalen van de mate van marmering van de huid. Objectieve methoden zijn 
de huidtemperatuurgradiënt onderarm-tot-vingertop, de perifere-perfusie-index en de ‘near-
infrared’-spectroscopie.
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huidtemperatuurgradiënt onderarm-tot-vingertop wordt ‘Tskin-diff’ genoemd (afgeleid van 
‘skin-temperature gradient’). Het optreden van perifere vasoconstrictie tijdens circulatoire 
shock leidt tot een afname van de huidtemperatuur en tot een verminderd vermogen om de 
centrale temperatuur te regelen. Daardoor stijgt de centraal-perifere temperatuurgradiënt. 
Het gebruik van Tskin-diff is gebaseerd op de aanname dat de referentietemperatuur 
een plaats op de huid is die aan dezelfde omgevingstemperatuur is blootgesteld als de 
vingertop. Een andere omgevingstemperatuur heeft eenzelfde soort effect op de onderarm 
als op de vingertop, en heeft daardoor weinig invloed op de gradiënt.12
Het gebruik van Tskin-diff is gevalideerd voor het beoordelen van de perifere 
weefseldoorbloeding. Uit verschillende experimentele studies is gebleken dat een 
Tskin-diff > 4°C een teken is van een ernstige verstoring van de huidperfusie en dat 
deze gerelateerd is aan een verhoogd risico op orgaanfalen.5,13 Het is niet bekend wat 
de invloed van vaatvernauwende of -verwijdende medicatie is op de huidtemperatuur 
of op de Tskin-diff; onze groep doet momenteel onderzoek naar deze relatie.
Optische monitoring
Optische technieken maken gebruik van licht met verschillende golflengten. Met 
deze non-invasieve methoden kan de conditie van verschillende weefsels worden 
vastgesteld. De meest gebruikte optische methoden om de perfusie van de perifere 
circulatie te meten zijn fotoplethysmografie en ‘near-infrared’-spectroscopie.
Perifere-perfusie-index
De perifere-perfusie-index is afgeleid van het plethysmografiesignaal van de 
pulsoximeter. Pulsoximetrie wordt in de meeste ziekenhuizen gebruikt om de arteriële 
zuurstofsaturatie van een patiënt te bepalen. De pulsoximeter zendt licht van 2 
golflengtes door de distale falanx van de vinger. Door de pulsaties in het vaatbed 
resulteert dit in een pulsatiele fotoplethysmografische lichtgolf die aan de andere kant 
van vinger wordt opgevangen door een detector. Andere weefsels, zoals bindweefsel 
en bot, geven een niet-pulsatiele lichtgolf. De perifere-perfusie-index is de verhouding 
tussen het pulsatiele en het niet-pulsatiele deel van de opgevangen lichtgolven, 
uitgedrukt in een percentage. Omdat de grootte van het pulsatiele deel toeneemt 
bij vasodilatatie en afneemt bij vasoconstrictie, corresponderen veranderingen in 
perifere-perfusie-index met veranderingen in de perifere vasomotorische tonus. Dit is 
als eerste aangetoond met plexusblokkade tijdens locoregionale anesthesie, waarbij 
vasodilatatie van de extremiteit optreedt.14 Andersom neemt de perifere-perfusie-
index snel af bij vasoconstrictie na toediening van (nor)adrenaline.15
Bij een grote groep gezonde vrijwilligers was de mediane perifere-perfusie-index 1,4%.16 
Deze waarde was bij ernstig zieke patiënten een gevoelig afkappunt voor het bepalen van 
een afwijkende perifere perfusie, gedefinieerd als een verlengde capillaire-refill-tijd en een 
toegenomen huidtemperatuurgradiënt.3 Een perifere-perfusie-index < 1,4% is gerelateerd 
aan een toegenomen prevalentie van orgaanfalen.5 Deze eenvoudig te bepalen index kan 
dus worden gebruikt om de perifere circulatie te bepalen en te vervolgen.
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Near-infrared-spectroscopie
Met near-infrared-spectroscopie kan de zuurstofsaturatie van hemoglobine 
worden bepaald in oppervlakkig gelegen weefsels zoals spierweefsel. Naast de 
weefselzuurstofsaturatie wordt ook de absolute weefselhemoglobine-index bepaald. 
Deze index is een maat voor het bloedvolume in het weefsel.17 Ook kan de mate van 
vasculaire reactiviteit worden weergegeven na een kortdurende vasculaire occlusie.
Bij ernstig zieke patiënten geeft een afgenomen weefselzuurstofsaturatie de 
aanwezigheid van een inadequate weefselperfusie weer. Zo zijn negatieve veranderingen 
in de weefselzuurstofsaturatie sterk gerelateerd aan de ernst van orgaanfalen en aan 
de mortaliteit bij patiënten met septische shock.18 Ook tijdens de eerste 6 h van de 
behandeling van patiënten met septische shock lijkt de weefselzuurstofsaturatie een 
gevoelige indicator voor het monitoren van het behandeleffect en daardoor voor 
de 28-daagse mortaliteit.19 Deze parameter lijkt eerder te worden beïnvloed door 
veranderingen in de perifere circulatie, met name door vasoconstrictie, dan door 
veranderingen in de systemische circulatie.20
Hoewel near-infrared-spectroscopie mogelijk geschikt is voor het bepalen van 
weefseloxygenatie en -perfusie, wordt nog steeds aanvullend onderzoek gedaan om 
het belang ervan voor de behandeling van ernstig zieke patiënten te verduidelijken.
Consequenties voor de praktijk
Perifere circulatie als waarschuwing
Uit de hiervoor beschreven studies blijkt dat een afwijkende doorbloeding van het 
perifere vaatbed op 2 manieren geïnterpreteerd kan worden. In de eerste plaats is 
het een uiting van een primair circulatoire ontregeling (shock) die nog onvoldoende 
behandeld is. Daarnaast lijkt het, na herstel van de circulatie, een teken van de 
ziekte-ernst. In dat geval is een afwijkende perifere perfusie een onderdeel van de 
stressreactie van het lichaam die wordt veroorzaakt door een actief ziekteproces. 
Dit is echter alleen nog maar aangetoond in kleine studies, waarvan de omvang niet 
voldoende was om een duidelijke relatie aan te tonen tussen de toestand van de 
perifere circulatie en de veelgebruikte scores voor ziekte-ernst. Uit deze resultaten kan 
wel worden afgeleid dat een blijvend afwijkende perifere perfusie gepaard gaat met 
een hoog risico op een ongunstiger beloop.
Het klinisch beoordelen van de perifere perfusie is eenvoudig en gaat snel. Als 
deze beoordeling afwijkend blijft, is dit een alarmsymptoom.
Perifere circulatie als therapeutisch doel
Op grond van bovenstaande overwegingen komt vanzelf de vraag naar voren of de 
perifere circulatie ook een doel van de behandeling kan zijn. Als de waarden van 
conventionele hemodynamische parameters zich niet herstellen na initiële therapie of 
de therapie niet leidt tot een toename van de perifere perfusie, ligt het voor de hand 
te proberen deze conventionele parameters op een andere manier te verbeteren.5,21 
Ruim 40 jaar geleden werd al gesuggereerd dat hiervoor vaatverwijders kunnen 
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worden gebruikt.22 Recent bleek dat toediening van nitroglycerine aan patiënten 
met ernstig hartfalen een positief effect kan hebben op de weefselperfusie.23 Ook bij 
patiënten met ernstige septische shock leek de perifere circulatie te verbeteren na 
toediening van nitroglycerine.24 Deze studies waren echter te klein om een effect op 
het ziektebeloop aan te tonen. Ook werd niet naar de perifere circulatie gekeken op 
een gestructureerde manier, zoals in dit artikel beschreven.
Het kan natuurlijk niet worden uitgesloten dat het optreden van perifere vasoconstrictie 
ook een doel heeft als onderdeel van een autoregulatiemechanisme. Opheffing van 
dit mechanisme hoeft dus geen positief effect te hebben. Meer onderzoek naar dit 
mechanisme en naar de perifere circulatie als behandeldoel is nodig.
Aan het bed
Omdat er steeds meer verschillende diagnostische technieken beschikbaar zijn om 
metingen te verrichten aan het bed van de patiënt, kan men minder vertrouwen 
hebben in de meer traditionele methoden van lichamelijk onderzoek. In de kliniek is 
er een tendens om getallen op een scherm prioriteit te geven boven het lichamelijk 
onderzoek. Met de hier genoemde non-invasieve methoden kan de beoordeling van 
de perifere circulatie gemakkelijk worden meegenomen in het standaardonderzoek 
aan het bed. Zowel subjectieve methoden (de huidtemperatuur, de capillaire-refill-tijd 
en de mottling-score) als de meer objectieve methoden (de huidtemperatuurgradiënt 
en de perifere-perfusie-index) kunnen hiervoor worden gebruikt.
Conclusie
Tijdens circulatoire shock worden perifere weefsels als eerste minder doorbloed. Door 
de perifere perfusie te meten kan een verstoring van de circulatie al in een zeer vroeg 
stadium en op een eenvoudige wijze worden waargenomen. De relatie tussen de 
beoordeling van de perifere perfusie en waarden van conventionele hemodynamische 
parameters, zoals bloeddruk en hartfrequentie, is afhankelijk van het ziektebeeld. 
Toch lijkt een verstoring van de perifere circulatie gerelateerd te zijn aan een slechter 
klinisch beloop bij verschillende patiëntengroepen. De beoordeling van de perifere 
circulatie is daarmee niet alleen een referentiepunt voor de beoordeling van de 
circulatie, maar dient ook als waarschuwing voor de ernst van circulatoire shock. De 
rol van de perifere circulatie bij het bepalen van de juiste therapie bij ernstig zieke 
patiënten moet nog worden onderzocht.
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Abstract
Background
In healthy volunteers, we investigated the ability of the pulse oximeter–derived peripheral 
perfusion index (PPI) to detect progressive reductions in central blood volume.
Methods
Twenty-five awake, spontaneously breathing, healthy male volunteers were subjected 
to progressive reductions in central blood volume by inducing stepwise lower body 
negative pressure (LBNP) with 20 mm Hg for 5 minutes per step, from 0 to −20, −40, 
−60, and back to 0 mm Hg. Throughout the procedure, stroke volume (SV), heart 
rate (HR), and mean arterial blood pressure were recorded using volume-clamp finger 
plethysmography. Assessment of the PPI was done by pulse oximetry. Additionally, the 
forearm-to-fingertip skin-temperature gradient was measured. Data are presented as 
mean ± SE. PPI underwent log transformation and is presented as median (25th–75th).
Results
Of the 25 subjects, one did not complete the study because of cardiovascular collapse. 
After the first LBNP step (−20 mm Hg), PPI decreased from 2.2 (1.6–3.3) to 1.2 (0.8–1.6) (P 
= 0.007) and SV decreased from 116 ± 3.0 mL to 104 ± 2.6 mL (P = 0.02). The magnitude 
of the PPI decrease (41% ± 6.0%) was statistically different from that observed for SV 
(9% ± 1.3%) and HR (3% ± 1.9%). During progression of LBNP, SV decreased and HR 
increased progressively with the increased applied negative pressure, whereas the PPI 
remained low throughout the remainder of the protocol and returned to baseline values 
when LBNP was released. At −60 mm Hg LBNP, SV decreased and HR increased by 
36% ± 0.9 % and 33% ± 2.4% from baseline, respectively. Mean arterial blood pressure 
remained in the same range throughout the experiment.
Conclusions
These results indicate that the pulse oximeter–derived PPI may be a valuable adjunct 
diagnostic tool to detect early clinically significant central hypovolemia, before the 
onset of cardiovascular decompensation in healthy volunteers.
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Introduction
Peripheral vasoconstriction is an early warning sign of circulatory shock in critically 
ill patients, when blood flow is diverted from less important tissues to maintain 
vital organ perfusion at the cost of peripheral circulation.1,2 Because sympathetic 
neuroactivity predominates in the skin and muscle, the sympathetic neurohumoral 
response-induced vasoconstriction manifests primarily as decreased peripheral 
perfusion.3,4 Unfortunately, standard physiologic measurements, such as mean arterial 
blood pressure (MAP), are poor indicators for the early assessment of shock.5 Even 
standard examinations of mental status, pulse character, and heart rate (HR) provide 
late information about the severity of blood loss. Subsequently, the appearance of 
hypotension and other signs of shock do not mark the beginning of circulatory shock 
but rather represent the beginning of cardiovascular decompensation and do not 
allow for early intervention.6 Therefore, a more practical and convenient method to 
detect early circulatory shock is needed.
The peripheral perfusion index (PPI), derived from the photoelectric 
plethysmographic signal of the pulse oximeter, is able to monitor vascular reactivity 
in adult critically ill patients.2,7 Additionally, the PPI has been suggested to be a useful 
noninvasive method for the assessment of peripheral vasomotor tone in healthy 
volunteers, neonates, and critically ill patients.2,8 This index is calculated as the 
ratio between the pulsatile component (arterial compartment) and the nonpulsatile 
component (venous and capillary blood and other tissues) of the light reaching the 
detector of the pulse oximeter. Therefore, peripheral vasoconstriction, mainly reducing 
the pulsatile component, directly affects the ratio and thus decreases the PPI.9 Because 
a pulse oximeter is universally available in the operating room, emergency room, and 
intensive care unit, it could potentially be useful for the early detection of peripheral 
hypoperfusion in response to reductions in central blood volume in these settings.
In the present study, we investigated changes in PPI as an early marker of peripheral 
vasoconstriction induced by changes in central circulating volume, and hypothesized 
that PPI could be used for early detection of hypovolemia, before changes in 
conventional hemodynamic variables occur. To test this, we used a model of controlled 
central hypovolemia in healthy male volunteers by applying lower body negative 
pressure (LBNP). During application of LBNP, the circulating volume is progressively 
redistributed from the upper to the lower body, inducing central hypovolemia, which 
triggers similar compensatory mechanisms as during acute hemorrhage and clinical 
hypovolemia.10 Using this approach, we were able to study the potential use of 
PPI during progressive reductions in central blood volume and determine whether 
changes in this index precede changes in frequently monitored vital signs.
Material and methods
Subjects
This study was conducted in a research laboratory at a university-affiliated teaching 
hospital. We recruited 25 awake, spontaneously breathing, healthy male volunteers 
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without history of cardiac events nor receiving any vasoactive medication. To minimize 
potential confounding factors to different LBNP tolerances, all volunteers underwent 
an exercise electrocardiogram to determine equal physical fitness.11 The volunteers 
were instructed not to consume caffeine-containing drinks or practice intensive 
exercise ≤12 hours before the experiments, but fluid intake was not standardized 
or regulated. The study protocol was approved by the Medical Ethics Committee of 
the Academic Medical Center of the University of Amsterdam, and written informed 
consent was obtained from all subjects.
Measurements
Subjects were placed with their lower body in an air-tight chamber with a seal applied 
at the level of the iliac crests. The amount of negative pressure within the chamber 
could be manually adjusted using a variable vacuum source. Baseline recordings 
were made after a 10-minute stabilization period before LBNP application. LBNP was 
applied progressively in a 5-minute stepwise manner from 0 to −20, −40, and −60 
mm Hg, followed by a second baseline measurement of 0 mm Hg 10 minutes after 
the last LBNP step. Data were gathered at the completion of every 5-minute LBNP 
step when the PPI signal was adequate and subjects were hemodynamically stable. 
In this regard, the different LBNPs simulate different levels of beginning hypovolemia 
and can be categorized as “mild” (−10 to −20 mm Hg, corresponding with 400–550 
mL blood loss), “moderate” (−30 to −40 mm Hg, corresponding with 500–1000 mL 
blood loss), and “severe” (−40 to −60 mm Hg, corresponding with >1000 mL blood 
loss).10,11 The LBNP protocol was immediately terminated if the subject developed 
presyncope, which was defined as a decrease in systolic blood pressure of >15 mm Hg 
from baseline, or if the subject experienced symptoms of impending syncope such as 
dizziness, light-headedness, nausea, sweating, or visual disturbances.
Global Hemodynamic Parameters
MAP, HR, and stroke volume (SV) were continuously and noninvasively measured using 
volume-clamp plethysmography (Nexfin; BMEYE, Amsterdam, The Netherlands) with 
the cuff placed around the left index finger. The Nexfin device is extensively described 
elsewhere and is validated technically to measure hemodynamic variables.12,13 In brief, this 
method applies variable pressure in an inflatable cuff around the finger, countering the 
pulsatile arterial pressure. An optical  plethysmograph placed in this cuff measures arterial 
volume and a calibration system determines the volume at which the artery is unloaded 
(i.e., when transmural pressure equals zero and no interference of the arterial wall occurs). 
Because brachial and finger arterial pressure are physiologically different, waveform 
transformation and correction are applied in order to reconstruct brachial arterial pressure.
Peripheral Perfusion Index
The PPI is derived from the photoelectric plethysmographic signal of the pulse oximeter 
Masimo SET Radical-7 (Masimo Corp., Irvine, CA). The adhesive sensor was attached 
onto the right index finger (Masimo SET® LNCS Adtx, adult sensor).7 This index signal 
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has been used as a noninvasive measurement of peripheral perfusion in critically ill 
patients.2 The technique is based on 2 light sources that emit light at wavelengths of 
660 and 940 nm through the cutaneous vascular bed of the distal side of the index 
finger. Because other tissues, such as connective tissue, bone, and venous blood, 
also absorb light, the pulse oximeter distinguishes the pulsatile component of arterial 
blood from the nonpulsatile component of venous and capillary blood, and other 
tissues. Using a 2-wavelength system, the nonpulsatile component is then discarded 
and the pulsatile component is used to calculate the arterial oxygen saturation (Spo2). 
The PPI is calculated as the ratio between the amplitude of the pulsatile component 
(arterial compartment) and the nonpulsatile component (venous and capillary blood, 
and other tissues) of the light reaching the detector of the pulse oximeter. This ratio 
is independent of the hemoglobin oxygen saturation. Because a change in peripheral 
vasomotor tone primarily causes a corresponding change in the pulsatile component 
of the signal, the ratio changes accordingly. As a result, the PPI value reflects changes 
in peripheral vasomotor tone, with a median value of 1.4 for normality in healthy 
volunteers.2 Simultaneously Spo2 values were recorded.
Skin Temperature
We obtained the peripheral skin-temperature gradient (Tskin-diff) from 2 skin probes 
(Hewlett Packard 21078A, Palo Alto, CA) attached to the right ring finger and to the radial 
side of the forearm, midway between the elbow and the wrist. At constant environmental 
conditions, Tskin-diff increases during vasoconstriction and thereby provides a better 
measurement of peripheral vasomotor tone compared with only the local skin temperature. 
The ambient temperature was therefore actively set at 22°C during the entire protocol. 
Basically, when vasoconstriction decreases fingertip blood flow, finger skin-temperature 
decreases, and Tskin-diff increases. This temperature gradient was previously validated as 
an independent measurement of peripheral perfusion.14
Statistics
Unless otherwise specified, data are presented as mean ± SE. For statistical analysis, 
the different LBNP levels (0, −20, −40, −60, and 0 mm Hg) were plotted as points over 
time. Accordingly, HR, MAP, SV, Tskin-diff, and PPI were plotted versus the level of 
LBNP. PPI underwent log-transformation (Kolmogorov-Smirnov test P < 0.05) to achieve 
close to normal distribution and then qualified for longitudinal testing. Assuming 
equal variances and the same correlation between measures for all variables (Mauchly 
criterion “test for sphericity” not significant), statistical significance of differences 
between the progressive LBNP levels was explored using repeated-measures analysis 
of variance with a Bonferroni correction for multiple comparisons. Changes from 
baseline were computed dividing the parameter value at specific time points into the 
baseline value and was expressed as percentile changes (% of baseline × 100). We 
compared the magnitude of changes among PPI, SV, and HR at specific time points 
and differences were tested with the use of Mann-Whitney test for unpaired data. In 
case of cardiovascular collapse, data were excluded from the repeated-measurements 
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analysis. We used SPSS software (version 20.0; SPSS Inc., Chicago, IL) for statistical 
analysis. P < 0.05 was regarded as statistically significant.
Results
Of the 25 male subjects recruited, one did not complete the study because of cardiovascular 
collapse and was excluded from further analysis, but the results of this excluded subject 
are presented and discussed below. The mean ± SD of age, weight, and height of the 
remaining 24 subjects were 23 ± 6 years, 82 ± 2 kg, and 182 ± 1 cm, respectively.
Baseline values for global hemodynamic variables, PPI, and Tskin-diff stratified by the 
progressive LBNP levels are presented in Table 1. The mean PPI decreased substantially 
from baseline during the onset of mild central hypovolemia (i.e., LBNP −20 mm Hg) 
and remained in the same range during the remainder of the experiment (Fig. 1). SV 
progressively decreased and HR progressively increased in an opposite manner to the 
level of negative pressure in the chamber. On average, the magnitude of PPI decreasing 
(41% ± 6.0%) in the first LBNP step was statistically different from that observed for 
SV (9% ± 1.3%) and HR (3% ± 1.9%) (Fig.1). Progressive hypovolemia (i.e., LBNP = 
−60 mm Hg) resulted in a mean decrease in SV of 36% ± 0.9 % from baseline and a 
mean increase in HR of 33% ± 2.4% from baseline. MAP did not change significantly 
during progressive LBNP exposure (Table 1). Accordingly, Tskin-diff and Spo2 remained 
unchanged during the LBNP protocol (Table 1). Upon cessation of LBNP, all systemic 
hemodynamic variables and PPI returned to baseline values (Fig. 1, Table 1).
Figure 2A shows HR, SV, and PPI in the subject who experienced cardiovascular 
collapse during LBNP. Figure 2B shows a representative subject with a normal 
response. The subject who experienced cardiovascular collapse started with a low PPI 
(approximately 1) and displayed a lack of appropriate sympathetic baroreflex activation 
as reflected by an  absence of an increase in HR, despite a significant decrease in SV. 
Directly after the start of −60 mm Hg LBNP, this volunteer already had signs of nausea 
table 1. Descriptive analysis
LBNP level
0 mmHg -20 mmHg -40 mmHg -60 mmHg 0 mmHg(2nd)
Heart rate (bpm) 63 ± 1.8 64 ± 1.5 72 ± 1.5* 83 ± 2.0* 59 ± 1.7
Mean arterial pressure (mmHg) 89 ± 1.8 92 ± 1.8 90 ± 1.4 86 ± 1.7 90 ± 1.5
Stroke volume (mL) 116 ± 3.0 104 ± 2.6* 91 ± 2.4* 74 ± 2.1* 112 ± 2.1
Tskin-diff (0C) 0.0 ± 0.2 -0.1 ± 0.3 0.1 ± 0.2 0.9 ± 0.2 0.0 ± 0.3
PPI (a.u.) 2.2 [1.6-3.3] 1.2* [0.8-1.6] 1.2* [0.9-1.8] 1.3* [0.9-1.7] 2.2 [1.4-3.4]
Systemic hemodynamic variables, skin temperature difference between finger and forearm 
(Tskin-diff), and peripheral perfusion index (PPI) during progressive application of lower body 
negative pressure (LBNP) from 0 mmHg to -60 mmHg and back to 0 mmHg(2nd). 
Data are presented as mean ± SE and median [25th-75th] for PPI.  * P<0.05, vs. LBNP = 0 mmHg.
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Figure 1. Peripheral perfusion index (PPI; red line), heart rate (blue line), and stroke volume 
(green line) plotted as proportional changes from baseline during progressive application of 
lower body negative pressure (LBNP) from 0 mmHg to -60 mmHg and back to 0 mmHg. Bars 
represent mean ± 95% CI (n=24). Changes in PPI were statistically different from those observed 
for SV and HR (*P<0.05 vs. PPI, by Mann-Whitney test)
and dizziness, which were followed by signs of impending cardiovascular collapse with 
a further decrease in SV from 82 to 57 mL, and concomitant decreases in HR from 76 to 
56 bpm, systolic blood pressure from 136 to 97 mm Hg, diastolic blood pressure from 
83 to 68 mm Hg, and a decrease in MAP from 88 to 63 mm Hg. Paradoxically, his PPI 
increased from 2.1 to 8.4 (suggesting vasodilation), simultaneous to the development 
of clammy skin. Thereafter, decompression was immediately initiated, followed by 
discontinuance of the protocol. During this collapse, Tskin-diff did not change.
Discussion
We induced progressive central hypovolemia by controlled application of LBNP and 
studied changes in PPI. We found that PPI changed significantly with the onset of mild 
hypovolemia, and may have reflected induced compensatory peripheral vasoconstriction. 
In addition, PPI changed earlier than the peripheral Tskin-diff, suggesting that PPI may 
be a useful early indicator of mild central hypovolemia in an acute setting.
Early detection of hypovolemia is of key importance in the management of circulatory 
shock. Circulatory changes during LBNP resemble hemodynamic responses similar to 
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those reported during acute hemorrhage, such as tachycardia and reductions in SV 
as result of a neurohumoral response.3,10 However, physiologic compensatory factors, 
such as increased HR, limit the use of blood pressure and cardiac output as indicators 
for mild central hypovolemia in the early setting.6 Thus, hypotension is a late marker 
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Figure 2. Heart rate, stroke volume, and peripheral perfusion index (PPI) during the application of 
lower body negative pressure (LBNP); (A) a subject who presented with cardiovascular collapse during 
progressive LBNP; and (B) a representative subject with a normal response. The subject that collapsed 
displayed a remarkably low PPI at baseline, indicative of peripheral vasoconstriction well before the 
application of LBNP. Subsequently, with progressive stroke volume reduction, collapse occurred with 
a simultaneous fall in heart rate and sudden rise in the PPI. LBNP was released immediately, leading 
to the subjects recovery and return to baseline levels (02nd) of heart rate, stroke volume, and PPI. 
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of hypoperfusion, and almost 30% of circulating volume may already be lost before 
hypotension occurs.15 Therefore, recognizing hemodynamic instability before this point 
is of prime importance in the prevention of hypoperfusion induced organ failure.
To this end, monitoring the early compensatory mechanisms that act on the 
peripheral circulation might provide a better indication of the onset of compensated 
shock than systemic hemodynamic variables.16 PPI is able to reflect rapid changes in 
the peripheral vascular diameter.7 We chose the LBNP model to test our hypothesis, 
because previous studies, including those of our own group, have shown that 
peripheral vasoconstriction is a frequent abnormality in peripheral perfusion of 
critically ill patients, and its persistence has been associated with increased lactate 
levels and organ failure.2 Moreover, PPI has been linked to HR and the abdominal 
flank-to-forearm skin-temperature gradient, particularly in neonates.17 The marked 
decrease in PPI in our model provides evidence that PPI can be used to detect changes 
in peripheral vasomotor tone as an additional tool for hemodynamic monitoring. Our 
study expands these observations with the demonstration that PPI decreases well 
before the onset of cardiovascular instability. Thus, PPI seems to provide an early 
and continuous indication of central hypovolemia during preshock hemorrhage when 
arterial blood pressure and HR remain within clinically normal levels.
Except for the volunteer who collapsed, MAP was maintained around baseline levels 
during the entire protocol, which indicated adequate compensation of the reduced 
circulating volume. It should be noted, however, that PPI did not decrease further 
during progression of hypovolemia and did not differentiate between mild hypovolemia 
and progressive hypovolemia, which might be of vital importance for follow-up and 
resuscitation. It is important to note that there is no direct causal relation implied between 
hypovolemia and PPI. We demonstrated that PPI reflects the condition of peripheral 
vasomotor tone, such as hypovolemia-induced peripheral vasoconstriction, but one 
cannot predict hypovolemia looking at a single PPI value. Instead, one should look at 
the physiologic behavior of PPI as a marker of variations in peripheral vasomotor tone. 
Although changes in the PPI preceded significative changes in HR, our data demonstrate 
that measuring PPI together with HR can be a more elegant noninvasive technique to 
detect the onset of hypovolemia, and therefore can reflect hemodynamic instability earlier 
than arterial blood pressure. In this regard, the development of an algorithm capable of 
providing changes in the PPI together with HR could provide a valuable clinical tool for the 
early detection of hemodynamic instability in trauma and intensive care patients.
Interestingly, the subject who experienced cardiovascular collapse was already 
vasoconstricted at baseline (Fig. 2A). At the beginning of −60 mm Hg, his HR 
suddenly decreased followed by a rapid increase in PPI (vasodilation) and the actual 
collapse. Apparently, loss of sympathetic tone resulted in a simultaneous decrease in 
HR and a decrease in peripheral vasomotor tone, leading to low cardiac output and 
cardiovascular collapse. This observation emphasizes the value of the PPI as a monitor 
of sympathetic activity. Previous studies demonstrated the phenomenon of paradoxic 
vasodilation in patients with depressed baroreceptor unloading18 and congestive heart 
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failure19 during mild central hypovolemia induced by LBNP. Cardiovascular collapse 
becomes imminent when sympathetic activity decreases or vagal tone increases 
and cardiac chronotropic and peripheral vasoconstrictive mechanisms can no longer 
adequately compensate for progressive hypovolemia, resulting in reduced HR and 
vasodilation that occur at, or before, the onset of cardiovascular collapse.3,20 
Although Tskin-diff is associated with vasoconstriction, and is an independent 
indicator of peripheral blood flow,14 we found that changes in PPI occurred earlier than 
changes in the Tskin-diff. Because PPI is based on the photoelectric plethysmographic 
signal of the pulse oximeter, it can reflect real-time changes in the peripheral vasomotor 
tone, and therefore peripheral blood flow. In contrast, it takes much more time for the 
skin temperature to decrease as a result of peripheral vasoconstriction. This explains 
why the skintemperature gradient takes longer to reflect variations in peripheral blood 
flow. PPI may therefore be more suitable as an early indicator of acute changes in 
peripheral vasomotor tone in response to changes in central blood volume.
During hemorrhage, vasoconstriction is heterogeneous throughout the body, 
predominantly affecting peripheral skin and muscle and splanchnic circulation, 
to redirect blood flow to the heart and brain.21-23 As previously proposed by Lima 
et al., changes in peripheral circulation in critically ill patients can be reflected by 
changes in PPI.2 By using PPI in such a way, and in combination with HR, it can be 
used as a complementary hemodynamic monitoring technique for the early detection 
of conditions that can trigger variations in peripheral circulation secondary to 
hemodynamic instability in trauma and intensive care patients.
This study has some limitations that should be acknowledged. First, although 
volume redistributions with LBNPare similar to those that occur during hemorrhage, 
we did not induce severe hypovolemia or hypovolemic shock. Nevertheless, the 
LBNP model of  moderate hypovolemia provides an excellent opportunity to collect 
physiologic data on healthy human subjects, without confounding factors such as 
tissue injury, anesthesia, or hypothermia. Hence, we were interested in the ability of 
PPI to indicate the onset of clinically significant central hypovolemia. This was clearly 
demonstrated, as changes in PPI occurred before systemic hemodynamic changes. 
Our results may be the first to strictly reflect the relationship between reduced 
central blood volume and PPI in humans. Second, PPI changes as local vasomotor 
tone changes. Vasomotor tone is not only influenced by sympathetic activity due 
to hypovolemia and hypotension but also due to pain, emotional stress, or local 
conditions such as hypothermia. Such external factors should be considered when 
interpreting the PPI. Furthermore, our study involved awake, young, healthy subjects, 
which might not exactly mimic physiologic responses in older, ill patients, especially 
under general anesthesia. Third, we used a commercial pulse oximeter system 
with the Masimo SET software incorporated to derive the PPI. The sensors in such 
systems are not without limitations, and pulse oximeter–derived PPI can be affected 
by incorrect sensor placement and motion artifacts. Last, we did not measure MAP 
and SV with invasive methods such as an arterial or pulmonary artery catheter, but 
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instead used the noninvasive Nexfin device. Although the Nexfin has been validated 
previously12 and was shown to provide accurate measurements of MAP and SV during 
a LBNP protocol,24 it still might lead to inaccuracies when compared with conventional 
techniques that are frequently used in the clinical setting.25 
In conclusion, the pulse oximeter–derived PPI may be a valuable adjunct to 
systemic monitoring to detect acute hemodynamic responses to central hypovolemia, 
even before the onset of cardiovascular decompensation. Because the pulse oximeter 
is used extensively in many different clinical environments, the PPI can be easily 
obtained and can be used as a complementary hemodynamic monitor for the early 
detection of hemodynamic instability in trauma and intensive care patients.
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Abstract
Purpose
Near-infrared spectroscopy has been used as a noninvasive monitoring tool for tissue 
oxygen saturation (StO2) in acutely ill patients. This study aimed to investigate whether 
local vasoconstriction induced by body surface cooling significantly influences thenar 
StO2 as measured by InSpectra model 650.
Methods
Eight healthy individuals (age 26 ± 6 years) participated in the study. Using a cooling 
blanket, we aimed to cool the entire body surface to induce vasoconstriction in the skin 
without any changes in central temperature. Thenar StO2 was noninvasively measured 
during a 3-min vascular occlusion test using InSpectra model 650 with a 15-mm probe. 
Measurements were analyzed for resting StO2 values, rate of StO2 desaturation (RdecStO2, 
%/min), and rate of StO2 recovery (RincStO2, %/s) before, during, and after skin cooling. 
Measurements also included heart rate (HR), mean arterial pressure (MAP), cardiac output 
(CO), stroke volume (SV), capillary refill time (CRT), forearm-to-fingertip skin-temperature 
gradient (Tskin-diff), perfusion index (PI), and tissue hemoglobin index (THI).
Results
In all subjects MAP, CO, SV, and core temperature did not change during the procedure. 
Skin cooling resulted in a significant decrease in StO2 from 82% (80–87) to 72% (70–77) 
(P < 0.05) and in RincStO2 from 3.0%/s (2.8–3.3) to 1.7%/s (1.1–2.0) (P < 0.05). Similar 
changes in CRT, Tskin-diff, and PI were also observed: from 2.5 s (2.0–3.0) to 8.5 s 
(7.2–11.0) (P < 0.05), from 1.0°C (−1.6–1.8) to 3.1°C (1.8–4.3) (P < 0.05), and from 10.0% 
(9.1–11.7) to 2.5% (2.0–3.8), respectively. The THI values did not change significantly.
Conclusion
Peripheral vasoconstriction due to body surface cooling could significantly influence 
noninvasive measurements of thenar StO2 using InSpectra model 650 with 15-mm 
probe spacing.
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Introduction
Near-infrared spectroscopy (NIRS) is a noninvasive technique that allows the 
determination of tissue oxygenation based on spectrophotometric quantitation of oxy- 
and deoxyhemoglobin levels within a tissue. Since its advent as a noninvasive monitoring 
tool for peripheral tissue oxygenation, a relationship between the potential influences of 
skin circulation on tissue oxygen saturation (StO2) signals has been debated. Numerous 
studies have investigated different NIRS devices in various tissues and under various 
experimental conditions.1–4 These studies indicate that the StO2 signal is widely influenced 
by the volume of the vascular bed in the catchment area of the probe. Current clinical 
NIRS studies, particularly those performed in an intensive care setting seem to neglect 
this relationship when monitoring peripheral tissue oxygenation. One of the reasons may 
be the lack of studies that address the influence of thenar skin circulation on StO2 signal 
as measured with the most current commercial device available (InSpectra model 650).
We recently reported in an observational study that abnormalities in skin perfusion 
contribute significantly to the StO2-derived signal measured with an InSpectra model 
650 probe on the thenar, and this correlation was independent of disease condition or 
systemic hemodynamics.5 The question that remains is how important is the potential 
contribution of low skin blood flow, specifically of the thenar eminence, on StO2. To 
answer this question, we performed StO2-derived tissue oxygenation measurements 
during local vasoconstriction induced by extremity cooling. We hypothesize that the 
decrease in skin blood flow resulting from peripheral vasoconstriction during body 
surface cooling significantly influences the noninvasive measurement of thenar StO2 
using an InSpectra model 650 with 15-mm probe spacing.
Materials and methods
Study population
The study was conducted at a university-affiliated teaching hospital. We recruited 
healthy volunteers with no history of receiving any vasoactive medication. The 
volunteers were instructed to avoid caffeine-containing drinks for 24 h before the 
experiments. The local medical ethics committee approved this study protocol.
Measurements
StO2-derived tissue oxygenation
StO2-derived tissue oxygenation was continuously monitored using an InSpectra 
tissue spectrometer model 650 with a 15-mm probe over the thenar eminence. A 
vascular occlusion test (VOT) was performed by arrest of forearm blood flow using 
a conventional sphygmomanometer pneumatic cuff. The cuff was placed around the 
upper arm and was inflated to a pressure approximately 30 mmHg greater than patient 
systolic pressure for 3 min. On the completion of the ischemic period, the occluding 
cuff was rapidly deflated to 0 mmHg. VOT-derived StO2 parameters were divided into 
three components: resting StO2 values, rate of StO2 desaturation (RdecStO2, expressed 
as %/min), and rate of StO2 recovery (RincStO2, expressed as %/s).
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Peripheral perfusion
Peripheral perfusion was evaluated using conventional physical examination with 
capillary refill time (CRT), forearm-to-fingertip skin-temperature gradient (Tskin-diff), 
perfusion index (PI), and tissue hemoglobin index (THI). CRT was measured by applying 
firm pressure to the distal phalanx of the index finger for 15 s. A chronometer recorded 
the time for the return of the normal color. The Tskin-diff was obtained with two skin 
probes (Hewlett Packard 21078A) attached to the index finger and on the radial side 
of the forearm, midway between the elbow and the wrist. Tskin-diff can better reflect 
changes in cutaneous blood flow than skin temperature itself. When being evaluated 
under constant environmental conditions, Tskin-diff increases during vasoconstriction, 
and a threshold of 4°C has been shown to reflect vasoconstriction in critically ill patients.6 
The PI provides a noninvasive method for evaluating perfusion and has been shown to 
reflect changes in peripheral perfusion.7 In this study, the PI value was obtained using 
Masimo pulse oximetry, which displays a range from 0.02% (very weak pulse strength) 
to 20% (very strong pulse strength). The THI was derived from a second-derivative 
attenuation spectrum and is part of the StO2 algorithm of the NIRS monitor.
Global hemodynamic parameters
Global hemodynamic parameters included heart rate (HR), stroke volume (SV), cardiac 
output (CO), and mean arterial pressure (MAP). Global parameters were recorded 
using thoracic bioimpedance, as measured by a noninvasive cardiac output monitor 
(NICOM; Cheetah Medical Inc., Wilmington, DE, USA). The NICOM system and 
technology have been described elsewhere.8 In summary, connecting the NICOM to 
the subject requires four double electrode stickers placed on the thorax, according 
to the manufacturer’s instructions. Data are automatically recorded using a computer 
data logger on a minute-by-minute basis.
Cooling techniques and monitoring
Body surface cooling was achieved using circulating cold water blankets (Thermowrap, 
Or-Akiva Ind. Park, Israel). A cooling pump device (CSZ Blanketrol III, model 233, 
Cincinnati SubZero, Inc.) was connected to the blankets to pump cold water. The water 
temperature was set to the desired temperature. The blanket garment was attached 
directly to the patient’s body using medically approved adhesive.
Protocol
Individuals were positioned in supine position dressed with the cooling blankets on a 
comfortable bed. The blanket suit covered the entire body with the exception of the 
head, instrumented forearm, hands, and feet. The cooling pump device permitted 
control of blanket water temperature by changing the temperature of water perfusing 
the suit. The suit was then perfused with 32°C water. Electronic measurements were 
obtained continuously and the values are reported as averaged data for each interval. 
The time points included the following: baseline measurements prior to the cooling 
process (T0), after 30 min of peripheral cooling (T1), and after 30 min of the suspension 
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of cooling and initiation of the rewarming process (T2). For this protocol, peripheral 
cooling was designed mainly to chill the skin over the entire body to induce only 
skin vasoconstriction without any changes in central temperature. Therefore, core 
temperature was measured each 5 min with an infrared tympanic thermometer (First 
Temp Genius model 3000A). Ambient temperature was constant during all experiments 
(T = 22°C). Skin vasoconstriction was defined as a minimal 50% decrease either in the 
Tskin-diff temperature or the PI signal.
Statistical analysis
The results are presented as the median (25th–75th), unless otherwise specified. A 
one-way repeated-measures ANOVA was conducted to compare NIRS-derived and 
peripheral perfusion parameters prior, during, and after rewarming. The Bonferroni 
post hoc test was performed if a significant main effect was observed. SPSS (version 
15.0, SPSS, Chicago, IL) was used for statistical analysis. A P value less than 0.05 was 
considered statistically significant.
Results
Eight healthy individuals (4 male, 4 female) participated in the study. The mean age, 
height, and weight were 26 ± 6 years, 172 ± 5 cm, and 74.1 ± 6.2 kg, respectively. 
Table 1 lists the global hemodynamic variables stratified by the time points of the 
study. All subjects tolerated the cooling process well and did not develop shivering 
during the experiment. We found a nonsignificant tendency towards an increase in SV 
and CO during peripheral cooling at T1 (Table 1). Core temperature and heart rate did 
not change significantly during the experiment.
Figure 1 presents the time course of the NIRS dynamic variables and peripheral 
perfusion parameters before, during, and after the skin cooling process. Table 2 lists the 
absolute values of all peripheral parameters as stratified by time points. The peripheral 
table 1. Descriptive analysis of global hemodynamic variables and central temperature stratified 
by the time points
time point
t0 t1 t2
Heart rate (bpm) 76 [70;83] 67 [58;73] 70 [67;74]
Stroke volume (ml) 110 [76;125] 139 [132;147] 114 [106;164]
Cardiac output (L/min) 8.6 [8.0;9.4] 10.1 [8.9;12.2] 7.9 [7.3;10.1]
Mean arterial pressure (mmHg) 93 [88;101] 100 [92;107] 95 [87;100]
Central temperature (oC) 36,8 [36.6;36.9] 36.6 [36.4;36.9] 36.6 [36.4;36.9]
Data presented as median [25th;75th]
T0 prior to the cooling process, T1 after 30 min of peripheral cooling, T2 after 30 min of the 
suspension of cooling and initiation of the rewarming process
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cooling resulted in skin vasoconstriction in all volunteers with a significant decrease in 
the Tskin-diff temperature and in the PI signal: 55% (40–175) and 77% (62–83) compared 
with baseline, respectively. Concomitantly, we observed a significant decrease in StO2 
and RincStO2 values but not in RdecStO2. The rewarming process increased StO2 and 
RincStO2 values towards baseline levels. Similar changes in CRT, Tskin-diff, and PI were 
also observed. The THI values did not change significantly during the entire experiment.
We were also interested in investigating which of the NIRS variables was most 
affected by changes in skin circulation. Our results indicated that the magnitude 
of changes seem to be more prominent in RincStO2 than StO2 and that RincStO2 is 
more sensitive to changes in peripheral perfusion than StO2 itself. When compared 
with baseline values, the magnitude of the RincStO2 decreases was larger than that 
observed for StO2 [47% (30–62%) vs. 11% (9.2–13.1), P = 0.001].
Discussion
The key finding from this study is that changes in vasomotor tone in the skin of the 
thenar eminence contributed significantly to the StO2-derived parameters as measured 
with a NIRS InSpectra device. The main mechanistic theory of our study is that peripheral 
vasoconstriction due to surface cooling results in decreased perfusion of the skin and, 
therefore, in parallel, changes in the StO2 resting values and in the StO2 recovery rate. 
(A) (B) (C)
(D) (E) (F)
Figure 1. Time course of NIRS-derived variables and peripheral perfusion parameters. T0, prior 
to the cooling process; T1, after 30 min of peripheral cooling; T2, after 30 min of the suspension 
of cooling and initiation of the rewarming process. (A) StO2= peripheral tissue oxygenation 
(%); (B) RincStO2= rate of StO2 recovery after arterial occlusion (%/s); (C) RdecStO2= rate of 
StO2 desaturation during arterial occlusion (%/min); (D) Tskin-diff=  forearm-to-fingertip skin-
temperature gradient (°C); (E) PI= perfusion index (%); (F) CRT= capillary refill time (s). Lines 
represent individual values for each healthy volunteer. Bars are mean ± 95%CI
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Under resting conditions, the impact of peripheral perfusion alterations on NIRS-derived 
measurements can be expected to be magnified as the skin temperature decreases.
This finding was not totally unexpected because light from the NIRS system must 
pass through the skin and some absorbance in the resistance vessels that supply 
subepidermal capillaries would be anticipated. The 15-mm NIRS probe mainly 
covers approximately an 8-mm depth of tissue and focusing on the muscle. Skin 
and subcutaneous layers above the muscle definitely contribute to the overall StO2 
measured. It is likely that the decreasing StO2 effect after skin cooling is mainly due to 
the upper layers’ compromised perfusion because of cutaneous vasoconstriction. One 
may argue that it is possible that the cooling device induced changes beyond that 
of skin circulation and that flow in skeletal muscle was also altered. Our study does 
not allow us to conclude which of the two components (skin or muscle) is the major 
contributor to the changes in StO2-derived variables in our model. Nevertheless, we 
speculate that participation of muscle blood flow was not predominant because THI 
readings in our volunteers presented small changes during the cooling period. On the 
other hand, participation of skin blood flow was significant, as reflected by changes 
in skin temperature, PI, and CRT. The THI represents the total tissue concentration of 
hemoglobin in both extravascular and vascular tissue, and its physiological significance 
and clinical utility are still under investigation. Our model induced changes mainly on 
the arterial side of microcirculation and may explain why THI was not affected by the 
peripheral cooling device, as the sensitivity of THI is greater for vessels with high 
capacitance, such as post capillaries and venous compartments. This phenomenon 
table 2. Descriptive analysis of NIRS-derived variables and peripheral perfusion parameters 
stratified by the time points
time point
t0 t1 t2
StO2 (%) 82 [80;87] 72* [70;77] 80 [79;85]
RincStO2 (%/sec) 3.0 [2.8;3.3] 1.7* [1.1;2.0] 3.2 [3.0;4.2]
RdecStO2 (%/min) 9.5 [8.0;11.6] 8.6 [7.5;9.6] 8.8 [7.7;11.5]
THI (a.u.) 13.1 [12.8;13.9] 13.2 [12.6;13.9] 13.3 [12.9 ;14.2]
Tskin-diff (oC) 1.0 [-1.6;1.8] 3.1* [1.8;4.3] 1.2 [-0.3;2.7]
CRT (sec) 2.5 [2.0;3.0] 8.5* [7.2;11.0] 4.0 [3.0;5.7]
PI (%) 10.0 [9.1;11.7] 2.5* [2.0;3.8] 9.1 [8.2;11.7]
Data presented as median (25th;75th)
T0 prior to the cooling process, T1 after 30 min of peripheral cooling, T2 after 30 min of the 
suspension of cooling and initiation of the rewarming process, 
RincStO2= rate of StO2 increase after arterial occlusion; RdecStO2= rate of StO2 deoxygenation 
during arterial occlusion; THI= tissue hemoglobine index; Tskin-diff = forearm-to-fingertip skin-
temperature gradient; CRT= capillary refill time; PI= Perfusion Index.
* P<0.05 versus T0 and T2 (one-way repeated-measures ANOVA with Bonferroni post hoc test) 
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may explain why other NIRS researchers have reported low THI values and normal 
StO2 in patients with sepsis, as this is a condition related to vascular leak and low 
vascular density due to microcirculatory derangements.9, 10 Therefore, the decreased 
NIRS signal from oxygenated hemoglobin is likely the result of a decrease in arterial 
blood volume within the peripheral vasculature as a consequence of vasoconstriction.
We chose this model to test our hypotheses because previous studies, including one 
by our own group, have shown that peripheral vasoconstriction is a frequent abnormality 
in critically ill patients.11, 12 For instance, studies that employed NIRS as a peripheral 
tissue oxygenation monitoring device have shown that the fall in StO2 in peripheral 
tissues correlates well with the degree of hypotension in trauma and hemorrhagic 
shock.13–16 However, these findings were always related to acute shock states and 
the disturbance of the systemic circulation, which indicates that the pathological link 
between hypotension and the fall in StO2 may be explained by increased peripheral 
vasoconstriction as a result of the adrenergic response that follows the neurohumoral 
compensatory mechanisms induced by the low-flow systemic shock state. Peripheral 
vasoconstriction may very well explain the fall in StO2 levels in acute situations, such 
as in trauma and cardiogenic or hemorrhagic shock. In critically ill patients after 
resuscitation of the systemic circulation, during the stability phase, peripheral vascular 
tone may no longer reflect the acute compensatory mechanisms because others factors 
overcome this physiologic response; such factors include mechanical ventilation, 
vasopressors, vasodilators, sedatives, and opiate use. However, abnormalities in 
peripheral perfusion may persist despite patient systemic hemodynamic stability.11, 12, 17 
The noticeable decreases in StO2 and StO2 recovery rate in our model provide evidence 
that peripheral vasoconstriction markedly influences the NIRS measurements of thenar 
tissue oxygenation and may confound interpretation of StO2-derived parameters in 
critically ill patients, in whom peripheral perfusion constantly changes over time.
Another interesting finding was that we could induce significant changes in StO2-
derived tissue oxygenation values by maintaining unchanged systemic hemodynamics. 
We found a nonsignificant tendency towards an increase in SV and CO during 
peripheral cooling. This finding may be explained by the shift of blood volume from 
the vasoconstricted peripheral circulation to the central circulation with a subsequent 
increase in the cardiac preload, justifying the augmentation of cardiac output as a 
result of an increase in stroke volume. In one previous study conducted by our group, 
we found that changes in StO2-derived parameters were correlated with parameters of 
peripheral perfusion in critically ill patients but were independent of the hemodynamic 
status of the patient.5 In another recent study in a model of controlled central 
hypovolemia, a decreased venous return with a concomitant decrease in stroke volume 
did not lead to clinically significant changes in StO2 as measured on the thenar.
18 These 
findings strongly suggest that StO2-derived parameters are more affected by changes 
in peripheral vasomotor tone than by systemic hemodynamic conditions. Perhaps even 
more interesting to the clinician who applies NIRS for peripheral perfusion monitoring 
is the knowledge that abnormal StO2-derived parameters may reflect a condition of 
peripheral vasoconstriction independent of systemic hemodynamics.
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In conclusion, the presence of peripheral vasoconstriction due to body surface 
cooling could significantly influence the noninvasive measurement of thenar StO2 using 
an InSpectra model 650 with 15-mm probe spacing. Depending on the condition of 
peripheral circulation, significant decreases in peripheral blood flow can affect StO2-derived 
measurements, particularly StO2 and StO2 recovery rate, which are exclusively dependent 
on local vasodilation capacity. Therefore, careful consideration must be given when using 
NIRS to measure tissue oxygenation in critically ill patients, and consideration should be 
given to the peripheral circulation when interpreting peripheral tissue oxygenation.
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Peripheral perfusion after out-of-hospital cardiac arrest
Abstract
Objective
To evaluate sublingual microcirculatory and peripheral tissue perfusion parameters 
in relation to systemic hemodynamics during and after therapeutic hypothermia 
following out-of-hospital cardiac arrest.
Design
Prospective observational study.
Setting
Intensive Cardiac Care Unit at a university teaching hospital.
Subjects
We followed 80 patients, of whom 25 were included after out-of-hospital cardiac arrest.
Intervention
In all patients we induced therapeutic hypothermia to 33°C during the first 24 hours 
of admission.
Measurements and Main Results
Complete hemodynamic measurements were obtained directly on intensive cardiac care 
unit admission (baseline), during induced hypothermia (T1), directly after rewarming (T2), 
and another 24 hrs later (T3). In addition, the sublingual microcirculation was observed 
using sidestream dark-field imaging, and peripheral tissue perfusion was monitored 
with the peripheral perfusion index, capillary refill time, tissue oxygen saturation, and 
forearm-to-fingertip skin temperature gradient. During hypothermia, all sublingual 
microcirculatory parameters decreased significantly together with peripheral capillary 
refill time and the peripheral perfusion index, followed by a significant increase at T2. 
Changes in sublingual and peripheral tissue perfusion parameters were significantly 
related to changes in central body temperature, but not to changes in systemic 
hemodynamic variables such as cardiac index or mean arterial pressure. Surprisingly, 
these parameters were significantly lower in nonsurvivors (n = 6) at admission and after 
rewarming. Persistent alterations in these parameters were related with the prevalence 
of organ dysfunction and were highly predictive of mortality.
Conclusions
Following out-of-hospital cardiac arrest, the early postresuscitation phase is 
characterized by abnormalities in sublingual microcirculation and peripheral tissue 
perfusion, which are caused by vasoconstriction due to induced systemic hypothermia 
and not by impaired systemic blood flow. Persistence of these alterations is associated 
with organ failure and death, independent of systemic hemodynamics.
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Introduction
Profound tissue perfusion alterations have been correlated with the development of 
multiorgan dysfunction and poor outcome. Recent years have witnessed the development 
of new techniques that can either directly visualize or indirectly evaluate microvascular 
tissue perfusion in critically ill patients. Using sublingual sidestream dark-field imaging1 and 
different peripheral tissue perfusion parameters, such as the peripheral perfusion index 
(PPI),2 capillary refill time (CRT) (3), and forearm-to-fingertip skin temperature gradient (Tskin-
diff),3 has described these alterations in patients suffering from different pathophysiologic 
conditions, such as sepsis4 and cardiogenic shock,5 apparently independent of systemic 
hemodynamic variables. Therefore, early detection of inadequate tissue perfusion and 
oxygenation is crucial to institute prompt therapy, avoiding further organ damage. 
Because blood flow in different vascular beds is regulated by local vasomotor 
tone, it can be assumed that alterations in peripheral tissue perfusion parameters 
are predominantly caused by local mechanisms, i.e., vasoconstriction.3 Local 
vasoconstriction occurs when systemic blood flow is not sufficient to meet the body’s 
demands (hypodynamic shock) and/or when the autoregulatory mechanisms governing 
the distribution of systemic blood flow over different vascular beds are disturbed 
(redistributive shock).6 Until now, the relative contribution of either systemic blood flow 
or peripheral vasomotor tone (i.e., vasoconstriction) to parameters of microcirculatory 
tissue perfusion during disease and resuscitation has not been investigated. 
A group of patients in whom global and reversible vasoconstriction is induced are 
the patients who undergo mild systemic hypothermia following out-of-hospital cardiac 
arrest (OHCA) to protect their brain against ischemia-reperfusion injury.7 Following 
return of spontaneous circulation (ROSC), the extent of damage by the ischemia-
reperfusion reaction seems to be the major determinant of outcome following 
cardiac arrest as it leads to a systemic inflammatory response syndrome, resulting in a 
hyperdynamic systemic circulation that is associated with the occurrence of multiorgan 
failure.8–10 This post-ROSC “sepsis-like” condition has recently emerged as a critical 
window of opportunity for impact on survival from cardiac arrest.11 We hypothesized 
that hypothermia-induced peripheral vasoconstriction will lead to significant 
alterations in sublingual microcirculatory and peripheral tissue perfusion, independent 
of systemic hemodynamic variables. In addition, we studied the relation between the 
occurrence of peripheral tissue perfusion alterations and outcome following OHCA. 
Material and methods
Study design, setting and population
This prospective observational study was conducted between October 2010 and February 
2011 at the intensive cardiac care unit (ICCU) in patients who were treated with moderate 
therapeutic hypothermia after OHCA. Cardiac arrest was defined as the cessation of 
mechanical cardiac activity as confirmed by the absence of signs of circulation.12 The arrest 
was presumed to be of cardiac etiology unless it was caused by trauma, drowning, drug 
overdose, asphyxia, cerebrovascular accident, hypovolemic shock, or any other noncardiac 
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cause. Patients were eligible for inclusion if they were comatose (Glasgow Coma Scale ≤ 6) 
after ROSC, older than 18 yrs, not hypothermic (temperature >34°C) on study admission, 
and if peripheral perfusion measurements could be obtained ≤4 hrs after ICCU admission 
(Fig. 1). Patients were excluded if they, after right heart catheterization, turned out to have 
a persistent unstable systemic circulation, for instance due to persistent hypovolemia, 
severe myocardial infarction, severe aortic valve stenosis, or had an immediate indication 
for mechanical assistance to temporarily support heart function.13
Medical ethical approval was provided by the local Institutional Review Board. In all 
patients, written proxy consent was asked within 4 hrs after ICCU admission from a relative 
authorized to consent on behalf of such a patient. If possible, deferred patient consent was 
obtained at the moment the patient was conscious, and if it was ethically valid to do so.14
Hemodynamic monitoring
Systemic hemodynamic variables included heart rate, mean arterial pressure, central 
venous pressure, pulmonary capillary wedge pressure, mean pulmonary artery 
pressure, stroke volume, cardiac index, and systemic vascular resistance. All patients 
were monitored with a radial artery catheter and a pulmonary artery catheter (Edwards 
Lifesciences, Saint-Prex, Switzerland). After obtaining these measurements, arterial 
and mixed venous blood samples were withdrawn for the determination of blood 
gases, hemoglobin saturation, arterial hemoglobin, and arterial lactate concentrations 
(ABL700; Radiometer, Copenhagen, Denmark).
Treatment protocol
In agreement with our standard protocol, therapeutic hypothermia was induced to a 
target temperature of 33°C by insertion of an intravascular cooling catheter (CoolLine, 
Coolgard and Fortius, Alsius Corporation, Irvine, CA, USA) as soon as possible following 
admission. Target temperature was maintained for 24 hours while the patient continued 
to be sedated,15 followed by passive rewarming (0.5°C/hr) to normothermia (37°C). 
Central body temperature was measured continuously with the thermistor of the 
pulmonary-artery catheter and continuously checked with a rectal temperature probe.
Propofol, midazolam, or a combination of both was used for sedation, and fentanyl was 
used for analgesia. Shivering was treated with a bolus dose of fentanyl and/or by increasing 
the dosage of sedatives. According to our local protocol, MAP was maintained above 60 
mm Hg with a diuresis ≥ 0.5 mL/kg/hr with volume infusion and vasoactive medication. 
Additionally, patients were treated with volume infusion or inotropic medication to 
maintain a CI ≥ 2.0 L/min. Arterial blood gas values, corrected for temperature, were 
used to adjust the ventilator to maintain a PaO2 between 8,0 and 13,3 kPa and a PaCO2 
between 4,0 and 5,0 kPa, with a FiO2 of 40%. After cessation of cooling, sedation was 
stopped as soon as a core temperature of 35°C had been reached. 
Microcirculatory and peripheral perfusion assessment and analysis
Sublingual microcirculatory perfusion was assessed using the sidestream dark-field imager 
(MicroScan; Microvision Medical, Amsterdam, The Netherlands) as described previously.1 
79
5
Peripheral perfusion after out-of-hospital cardiac arrest
An investigator, blinded to the patients’ clinical course and the order of the sequences, 
analyzed the video images semiquantitatively. Vascular flow (i.e., microcirculatory flow 
index) and density (i.e., perfused capillary density and proportion perfused vessels) were 
calculated by the following flow classification: no flow, sluggish, intermittent, continuous, 
or hyperdynamic16 using dedicated software (Automated Vascular Analysis, AVA 3.0; 
Microvision Medical). This approach has been validated previously with low inter- and 
intraobserver variability.17 Capillaries were defined as microvessels with a diameter ≤20 μm. 
Tissue oxygen saturation was continuously obtained from the thenar using an 
InSpectra Tissue Spectrometer Model 650 (Hutchinson Technology, Hutchinson, MN) 
with a 15-mm near-infrared spectroscopy probe placed over the thenar eminence, as 
described previously.18, 19 
Peripheral tissue perfusion was evaluated using a combination of the peripheral 
perfusion index (PPI), capillary refill time (CRT), and forearm-to-fingertip skin 
temperature gradient (Tskin-diff). The PPI (Masimo SET® pulse oximetry Perfusion 
Index, Radical 7, Basingstoke, Hants, UK) provides a noninvasive indicator of peripheral 
vasomotor tone and peripheral perfusion, and is derived from the photo-electric 
plethysmographic signal of the pulseoximeter.20 CRT was measured by applying firm 
pressure to the distal phalanx of the index finger for 15 secs. The time to return of 
normal color was measured with a per second analog hospital clock present in every 
ICCU box.21 Tskin-diff was obtained from two skin probes, attached to the index finger 
and on the radial side of the forearm, midway between the elbow and the wrist. This 
temperature gradient can better reflect changes in cutaneous blood flow than the 
absolute skin temperature itself and increases during vasoconstriction.22
Study protocol
All systemic hemodynamic variables, temperature, metabolic state, and sublingual 
microcirculatory and peripheral perfusion parameters were collected within 4 hrs after 
admission to the ICCU (baseline). Measurements were repeated as soon as the patients 
reached their hypothermic core temperature and were hemodynamically stable (T1), 
directly after rewarming to normothermic temperature (T2), and another 24 hrs later 
(T3). All components of the Sequential Organ Failure Assessment (SOFA) score23 and 
Simplified Acute Physiology Score II score24 were collected for each patient at each 
time point. The total SOFA score was calculated by summing the scores for each of the 
components (i.e., cardiac, renal, nervous, respiratory, coagulation, and liver). Twenty-
eight-day survival was registered for all patients. The response rate was 100% and no 
patients were lost during follow-up.
Statistical analysis
The results are presented as median (25th–75th), unless otherwise specified. To study 
the effect of hypothermia over time on all systemic hemodynamic variables (i.e., heart 
rate, mean arterial pressure, central venous pressure, pulmonary capillary wedge 
pressure, mean pulmonary artery pressure, stroke volume, and cardiac index) and all 
peripheral and microcirculatory perfusion variables, we used the linear mixed model 
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analysis.25 We retrospectively divided the groups into survivors and nonsurvivors to 
test whether the averages were significantly different between both groups. Because 
microcirculation and peripheral perfusion parameters are quantitative results, cutoff 
values were necessary to discriminate abnormal from normal. We therefore assumed 
the mean response of sublingual microcirculatory and peripheral perfusion parameters 
over time in the nonsurvivors as appropriate cutoff to test our hypothesis. To allow 
determination of the accuracy of microcirculatory and peripheral perfusion parameters 
for prediction, we used mortality as our dichotomous outcome and abnormal 
microcirculation and peripheral perfusion parameters as our dichotomous predictor 
variables.26 We then summarized our results as sensitivity, specificity, positive likelihood 
ratio, and negative likelihood ratio, with their respective 95% confidence interval. 
To explore the effect of abnormal sublingual microcirculatory and peripheral 
perfusion parameters on organ (dys)function (see Materials and Methods for definition), 
we compared the individual SOFA organ systems and Simplified Acute Physiology 
Score II score between normal and abnormal perfusion after the rewarming period (T2 
and T3). Differences between group means were tested by Mann-Whitney U test. To 
correct for multiple testing, a p value < .025 was considered statistically significant. 
We used SPSS (version 16.0; SPSS, Chicago, IL) for the statistical analysis. 
Results
Clinical characteristics
Of the 26 patients fulfilling the inclusion criteria, we had to discontinue measurements 
in one patient due to early death. Of the 25 patients in whom we completed all 
measurements, 19 survived (Fig. 1).Table 1 summarizes the characteristics of all 
patients. Main hemodynamic and biochemical variables are presented in Table 2. 
Cardiac index, heart rate, and lactate were significantly different after rewarming (T2) 
when compared to admission (baseline) or during cooling (T1). In the nonsurvivors, 
time to ROSC was longer and lactate was higher on admission.
Time course of microcirculatory and peripheral perfusion parameters
Figure 2A and 2B show the time course of sublingual microcirculatory (Fig. 2A) and peripheral 
tissue perfusion (Fig. 2B) parameters. In addition, Table 3 shows the microcirculatory and 
peripheral perfusion values. During hypothermia (T1), there was no difference between 
survivors and nonsurvivors in all peripheral and microcirculatory perfusion variables. 
Immediately at baseline however, all sublingual microcirculatory parameters (microcirculatory 
flow index, perfused capillary density, and proportion perfused vessels) were lower in the 
nonsurvivors. This difference persisted following rewarming (T2 and T3) when sublingual 
perfusion improved significantly in the survivors compared to the nonsurvivors (Fig. 2A). 
Similar findings were observed in the peripheral perfusion parameters (with the exception 
of tissue oxygen saturation): CRT was shorter in survivors at admission and improved even 
further directly after rewarming, whereas Tskin-diff and PPI indicated good peripheral 
perfusion after rewarming compared to nonsurvivors (Fig. 2B).
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Out-hospital cardiac arrest 
patients N= 80 
Discontinued (death) 
(n= 1) (0.01%) 
Patients who met the inclusion 
criteria n= 32 (40%) 
Exclusion criteria 
12 Exceeded time window of inclusion (timing)  
11 Lack of proxy consent 
6 Cerebrovascular accident or intracranial bleeding  
5 No intravascular cooling  
4 Unability to include due to logistic reasons  
(timing) 
3 Severe aortic valve stenosis  
3 Persistent hypovolemic shock 
2 Drug overdose  
1 Drowning  
1 Non comatose on ICCU admission  
 
 
2 were already enrolled in another interventional study 
2 Died before start study 
2 Family withdrew consent  
Included 
n= 26 (32.5%) 
Non-survivors (n= 6)  
(24%) 
Survivors (n= 19) 
(76%) 
Figure 1. Study flow chart of inclusion.
Prediction of microcirculatory and peripheral perfusion levels on outcome
Based on the mean response of microcirculatory and peripheral perfusion parameters 
seen in the nonsurvivors (Table 3), abnormal sublingual microcirculation was defined as a 
microcirculatory flow index <2.8, perfused capillary density <12.6, or proportion perfused 
vessels <96.8; and abnormal peripheral perfusion was defined as CRT >11.5, Tskin-diff 
>5, or PPI < 0.4. Table 4 summarizes the accuracy of microcirculatory and peripheral 
parameters for mortality prediction at different time points. At admission, sensitivity 
indicated that approximately 93% in the nonsurvivor group had microcirculatory and 
peripheral perfusion abnormalities. The positive likelihood ratio obtained at both time 
points after rewarming indicated that the accuracy of microcirculatory and peripheral 
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table 1. Baseline characteristics
Survivors (n= 19) Non-survivors (n= 6)
Age (years) 59 [57-76] 71 [66-79]
Male/Female, n 17/2 5/1
Body mass index (kg/m2) 25.4 [24.1-26.9] 25.7 [24.6-27.8]
Acute Physiology and Chronic Health Evaluation II 19 [16-20] 22 [18-25]
Total Sequential Organ Failure Assessment  24h 6 [4-8] 11 [10-12]*
Return Of Spontaneous Circulation (min) 9.0 [7.0-10.0] 26.5 [13-32]*
Mechanical ventilation, n 19 6
First monitored rhythm, n 14 Ventricular  
fibrillation/tachycardia 
 2  Asystole
1  Pulseless electrical  
activity
 2 Other/unknown
2 Ventricular  
fibrillation/tachycardia 
 2  Asystole
1  Pulseless electrical  
activity
 1 Other/unknown
Dobutamine use, n (%) 2 (8) 4 (66)
Dobutamine  dose (µg/kg/min) 2.8 [3.1-5.2] 4.2 [3.0-6.6]
Noradrenaline use, n (%) 3 (16) 3 (50)
Noradrenaline dose  (µg/kg/min) 0.18 [0.08-0.31] 0.23 [0.08-0.45]
Intensive Cardiac Care Unit  stay (days) 5.0 [5.0-7.0] 10.0 [3.0-12.0]
Values are expressed as median (range). Return of spontaneous circulation is defined as the time 
between the witnessed cardiac arrest and the actual return of spontaneous circulation. *p < .05, 
by Mann-Whitney test (survivor vs. nonsurvivors).
perfusion parameters improved significantly with good predictive value. Abnormalities 
in microcirculatory and peripheral perfusion parameters are obtained approximately 
2.5–12 times more often in nonsurvivors than survivors.
Tables 5 and 6 shows the specific organ SOFA subscores and Simplified Acute 
Physiology Score II scores stratified by abnormal and normal sublingual microcirculatory 
(Table 5) and peripheral perfusion conditions (Table 6), directly after rewarming (T2), 
and 24 hrs thereafter (T3). At baseline and T1, there was no significant difference in 
individual SOFA scores between abnormal and normal microcirculatory and peripheral 
perfusion parameters. Total SOFA score was significantly higher at T2 and T3 for 
patients with abnormal microcirculatory perfusion and at T3 for patients with abnormal 
peripheral perfusion compared to those with normal peripheral perfusion (Table 5 and 
6). Looking at the organ system subscores, this can be attributed to the significantly 
higher scores for respiratory, cardiovascular, and renal SOFA at T2 and to an almost 
overall increased organ failure score at T3. The Simplified Acute Physiology Score II 
organ failure assessment was higher at both time points after rewarming for patients 
with either abnormal microcirculation or abnormal peripheral perfusion.
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table 4. Sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio for abnormal 
sublingual microcirculation and abnormal peripheral perfusion, as predictors of mortality
Sensitivity  
(95% CI) (%)
Specificity  
(95% CI) (%)
Positive 
Likelihood Ratio 
(95% CI)
Negative 
Likelihood Ratio 
(95% CI)
Abnormal 
microcirculation
Baseline 93 (54-99) 58 (44-64) 2.2 (1.1-2.5) 0.12 (0.01-0.8)
T1 7 (1.0-25) 93 (90-99) 0.9 (0.1-12) 1.0 (0.7-0.1)
T2 93 (54-99) 63 (49-65) 2.5 (1.1-2.8) 0.11 (0.1-0.9)
T3 78 (43-85) 98 (85-99) 12.0 (1.6-99.0) 0.35 (0.17-0.86)
Abnormal peripheral 
perfusion
Baseline 93 (55-99) 38 (24-40) 1.4 (0.8-1.6) 0.19 (0.09-1.8)
T1 93 (56-99) 33 (20-93) 1.4 (0.6-1.5) 0.22 (0.01-2.2)
T2 83 (42-99) 90 (76-94) 7.9 (1.8-17.0) 0.18 (0.01-0.8)
T3 67 (28-82) 94 (83-99) 12.6 (1.7-99.0) 0.35 (0.17-0.86)
CI, confidence interval; T1, during induced hypothermia; T2, directly after rewarming; T3, 24 
hrs after T2.
Abnormal perfusion is based on the mean response in the nonsurvivors and used as cutoff 
(microcirculatory flow index <2.8, perfused capillary density <12.6, or proportion perfused vessels 
<96.8; capillary refill time >11.5, forearm-to-fingertip skin temperature gradient >5, or peripheral 
perfusion index <0.4). After rewarming, an abnormal peripheral perfusion increases the odds to die 
7.9 (T2) and, respectively, 12.6 (T3) times more than patients who have a normal peripheral perfusion.
table 5. Specific organ Sequential Organ Failure Assessment subscores and Simplified Acute 
Physiology Score II stratified by abnormal and normal sublingual microcirculatory perfusion, 
directly after rewarming (T2) and 24 hrs thereafter (T3)
Sublingual Microcirculation
t2 t3
Abnormal (n=12) Normal (n=13) Abnormal (n=6) Normal (n=19)
SOFA respiratory 3.0 (2.0-4.0) 2.0 (1.0-2.0) 3.0 (2.0-3.0) 1.0 (1.0-2.0)
SOFA coagulation 1.0 (1.0-1.7) 1.0 (0.0-1.5) 2.0 (0.7-3.0) 1.0 (1.0-2.0)
SOFA cardiovascular 2.5 (1.2-3.7) 2.0 (0.0-2.0) 3.0 (2.7-3.2) 0.0 (0.0-2.0)
SOFA CNS 4.0 (3.0-4.0) 3.0 (2.0-4.0) 3.5 (2.0-4.0) 1.0 (1.0-4.0)
SOFA Renal 0.0 (0.0-1.0) 0.0 (0.0-1.0) 0.5 (0.0-1.2) 0.0 (0.0-1.0)
SOFA liver 0.0 (0.0-1.0) 0.0 (0.0-1.0) 0.0 (0.0-1.0) 0.0 (0.0-1.0)
SOFA total 11.0 (8.2-14.0) 6.0* (4.5-9.0) 12.0 (10.7-13.2) 5.0* (2.0-11.0)
Simplified Acute 
Physiology Score II
55.0  (37.8, 59.0) 40.0*  (26.0, 48.5) 46.5  (38.0, 57.0) 32.0* (24.0, 45.0)
CNS, central nervous system; SOFA, Sequential Organ Failure Assessment. *p < .025, by 
Mann-Whitney test (abnormal vs. normal) for SOFA total and Simplified Acute Physiology Score 
II. Values are expressed as median (interquartile range). Patients with abnormal sublingual 
microcirculation (see Materials and Methods for definition) have more organ failure at both time 
points after rewarming than patients with normal sublingual microcirculation.
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table 6. Specific organ Sequential Organ Failure Assessment subscores and Simplified Acute 
Physiology Score II stratified by abnormal and normal peripheral perfusion, directly after 
rewarming (T2) and 24 hrs thereafter (T3)
Peripheral perfusion
t2 t3
Abnormal (n=12) Normal (n=13) Abnormal (n=6) Normal (n=19)
SOFA respiratory 2.0 (2.0-3.5) 2.0 (1.0-2.7) 3.0 (2.0-3.0) 1.0 (1.0-2.0)
SOFA coagulation 1.0 (0.0-1.5) 1.0 (0.3-1.7) 2.0 (0.7-3.0) 1.0 (1.0-2.0)
SOFA cardiovascular 2.0 (2.0-3.5) 1.0 (0.0-2.7) 3.0 (2.7-3.2) 0.0 (0.0-2.0)
SOFA CNS 4.0 (3.0-4.0) 3.0 (3.0-4.0) 3.5 (2.0-4.0) 1.0 (1.0-4.0)
SOFA Renal 0.0 (0.0-0.5) 0.0 (0.0-1.0) 0.5 (0.0-1.2) 0.0 (0.0-1.0)
SOFA liver 0.0 (0.0-1.0) 0.0 (0.0-1.0) 0.0 (0.0-1.0) 0.0 (0.0-1.0)
SOFA total 11.0 (8.2-14.0) 8.0 (5.0-12.0) 12.0 (10.7-13.2) 5.0* (2.0-11.0)
Simplified Acute 
Physiology Score II
55.0 (37.8, 59.0) 40.0* (26.0, 48.5) 46.5 (38.0, 57.0) 32.0* (24.0, 45.0)
CNS, central nervous system; SOFA, Sequential Organ Failure Assessment. *p < .025, by 
Mann-Whitney test (abnormal vs. normal) for SOFA total and Simplified Acute Physiology Score 
II. Values are expressed as median (interquartile range). Patients with abnormal peripheral 
perfusion (see Materials and Methods for definition) have more organ failure at both time points 
after rewarming than patients with normal peripheral perfusion.
Discussion
Our study demonstrates that the postcardiac arrest phase is characterized by profound 
changes in sublingual microcirculation and peripheral tissue perfusion, independent 
of systemic hemodynamics. This confirms our hypothesis that the indices of both 
sublingual and peripheral perfusion are more influenced by changes in local vasomotor 
tone than changes in systemic blood flow. Although sublingual microcirculatory and 
peripheral tissue perfusion alterations were initially similar in all patients during 
hypothermia, these parameters improved toward normalization in survivors, but not in 
the nonsurvivors. Abnormal sublingual and peripheral microcirculatory tissue perfusion 
was indicative for unfavorable outcome, reflected as higher organ dysfunction score 
and high probability, and a good predictor of ICCU mortality as well.
Although vasoconstriction appears to be the major determinant of peripheral 
perfusion, the response of the different parameters to hypothermia was not 
similar. For instance, only sublingual microcirculatory perfusion decreases due to 
vasoconstriction during hypothermia, whereas the peripheral circulation is already 
in a vasoconstricted state at admission. Only after rewarming, when the systemic 
circulation becomes hyperdynamic, the lack of any relation between systemic and 
regional perfusion becomes apparent. Sublingual microcirculatory and peripheral 
perfusion parameters improved in the survivors, but remained significantly impaired 
in the patients who did not.
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Vasoconstriction is a result of compensatory sympathetic nervous system activation, 
especially active in the cutaneous vascular bed, to preserve blood flow to vital 
organs under conditions of reduced systemic blood flow. Persistent vasoconstriction, 
independent of systemic hemodynamics, suggests ongoing sympathetic activity in 
the patients who ultimately died after OHCA.27, 28 A similar relation was observed in 
patients with septic shock.29 This analogy is not surprising considering that as in sepsis, 
the ischemia-reperfusion phase following cardiac arrest is characterized by the release 
of inflammatory mediators leading to a systemic inflammatory syndrome–like response, 
which has been associated with loss of autoregulation and tissue perfusion alterations.30 
Hence, the autonomic nervous modulation in the initial phase following OHCA patients 
might resemble that of severe sepsis.31 On the other hand, it has been shown that 
vasoconstriction and altered microcirculation are also present in an experimental 
model of hypothermic circulatory arrest.32 Therefore, it is not clear whether induced 
hypothermia augments or inhibits these alterations, leading to respectively prolonging 
of impaired perfusion at admission or postponing the increase following rewarming.
Our observations are in accordance with similar observations in other patient 
groups. Previously, multiple studies have shown that the severity and persistence 
of sublingual microvascular alterations are associated with unfavorable outcome in 
patients with severe sepsis or septic shock,29, 33 cardiac failure,34 cardiogenic shock,5 or 
abdominal surgery.35 Although less sensitive, assessment of the peripheral perfusion 
is much more practical than sidestream dark-field monitoring of the sublingual 
microcirculation, as it is much easier to perform at the bedside and does not require 
elaborate analyses. In fact, the latter is an important obstacle for the practical 
implementation of sidestream dark-field monitoring in the daily bedside care.36 In 
contrast, peripheral skin temperature difference and finger plethysmography are 
easily implemented, are part of standard monitoring techniques, and are observer 
independent. In addition, observations from our own group have shown that in adult 
critically ill patients impaired peripheral perfusion was associated with higher lactate 
levels, higher organ failure scores, and worse outcome.37
Interestingly, the lactate levels were highest in the nonsurvivors at admission (Tables 
2 and 3). Over time, lactate decreased in this group to similar levels as the survivors at 
T3. As such, only the admission levels can be used to predict outcome after OHCA, not 
the course in time. As we have shown in a previous study, this seems to be typical for this 
group of patients (i.e., post–low-flow state) compared to patients with sepsis, where not 
the lactate level at admission but the reduction over time was associated with outcome.38–40
The potential role for the assessment of peripheral perfusion in an intensive 
care unit population applied by multiple clinicians must be further investigated to 
address whether aiming at normalization of peripheral perfusion will have an impact 
on outcome. These findings imply that if the clinician stops the resuscitation after 
the traditional end points have been normalized, patients might still remain in a 
compensatory vasoconstricted state. The presence of abnormal peripheral perfusion 
after initial resuscitation identifies patients with a more unfavorable outcome. Therefore, 
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assessment of peripheral perfusion during resuscitation has the potential to optimize 
vasomotor tone, microcirculatory alterations, and as such resuscitation procedures.
Some limitations of our study need to be acknowledged. First, we used different 
flow and density parameters as indices of sublingual microvascular perfusion. These 
software-derived parameters do not take into account the heterogeneity of perfusion, 
which can be increased in disease states41; still an interobserver variability of 5% has 
been reported.42 Second, although sublingual perfusion was significantly different 
between survivors and nonsurvivors, it is not clear whether this was caused by the 
worse condition of the nonsurvivors or by differences in the preceding resuscitation 
procedure, for instance, the difference in time to ROSC, which was shorter in the 
survivors, or by the amount of epinephrine used during resuscitation. Finally, because 
our study was an observational study, significant correlations between microcirculatory 
hypoperfusion and changes in SOFA score and mortality rates do not prove causality. 
Due to the small sample size, our results have to be interpreted with caution. Future 
studies will have to prove whether recruitment of the peripheral circulation could be a 
valuable addition to the resuscitation of the systemic circulation.
In conclusion, following OHCA, sublingual and peripheral microcirculatory tissue 
perfusion alterations are frequent, and are aggravated by induced hypothermia 
independent of systemic hemodynamics. Persistence of these tissue perfusion 
alterations is independently associated with the development of organ failure and 
mortality. Monitoring of peripheral tissue perfusion might therefore be a valuable 
adjunct to identify those patients after cardiac arrest eligible for additional therapy, 
aimed at recruitment of the peripheral circulation.
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Abstract
Introduction
Altered peripheral perfusion is strongly associated with poor outcome in critically 
ill patients. We wanted to determine whether repeated assessments of peripheral 
perfusion during the days following surgery could help to early identify patients that 
are more likely to develop postoperative complications.
Methods
Hemodynamic measurements and peripheral perfusion parameters were collected one 
day prior to surgery, directly after surgery (D0) and on the first (D1), second (D2) and third 
(D3) postoperative days. Peripheral perfusion assessment consisted of capillary refill 
time (CRT), peripheral perfusion index (PPI) and forearm-to-fingertip skin temperature 
gradient (Tskin-diff). Generalized linear mixed models were used to predict severe 
complications within ten days after surgery based on Clavien-Dindo classification.
Results
We prospectively followed 137 consecutive patients, from among whom 111 were 
included in the analysis. Severe complications were observed in 19 patients (18.0%). 
Postoperatively, peripheral perfusion parameters were significantly altered in patients 
who subsequently developed severe complications compared to those who did not, 
and these parameters persisted over time. CRT was altered at D0, and PPI and Tskin-
diff were altered on D1 and D2, respectively. Among the different peripheral perfusion 
parameters, the diagnostic accuracy in predicting severe postoperative complications 
was highest for CRT on D2 (area under the receiver operating characteristic 
curve = 0.91 (95% confidence interval (CI) = 0.83 to 0.92)) with a sensitivity of 0.79 
(95% CI = 0.54 to 0.94) and a specificity of 0.93 (95% CI = 0.86 to 0.97). Generalized 
mixed-model analysis demonstrated that abnormal peripheral perfusion on D2 and D3 
was an independent predictor of severe postoperative complications (D2 odds ratio 
(OR) = 8.4, 95% CI = 2.7 to 25.9; D3 OR = 6.4, 95% CI = 2.1 to 19.6).
Conclusions
In a group of patients assessed following major abdominal surgery, peripheral 
perfusion alterations were associated with the development of severe complications 
independently of systemic hemodynamics. Further research is needed to confirm these 
findings and to explore in more detail the effects of peripheral perfusion–targeted 
resuscitation following major abdominal surgery.
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Introduction
Despite reductions in postoperative mortality, the occurrence of severe complications 
remains high.1 The development of postoperative complications affects the prognosis 
of surgical patients and substantially increases the utilization of resources and the 
cost of care.1-3  Early recognition of patients more likely to develop postoperative 
complications is therefore of prime importance.
Because postoperative complications better predict short- and long-term mortality 
than preoperative and intraoperative factors,3-5 recent research has been focused on 
identifying preoperative factors that predispose patients to postoperative complications. 
Several scoring systems, such as the Acute Physiology and Chronic Health Evaluation 
II (APACHE II) score, the American Society of Anesthesiologists (ASA) score and the 
Portsmouth Physiological and Operative Severity Score for the enumeration of Mortality 
and Morbidity (P-POSSUM) score can be applied in a general surgery population. These 
scores are based on preoperative and perioperative variables specific to different types of 
surgery. Despite the great number of identified predictors, these scores do not take into 
consideration the individual patient’s postoperative situation, are difficult to calculate6, 
cannot be calculated over time and are still doubted for their specific predictive value for 
assessing the individual high-risk surgery patient.7 Therefore, in clinical practice, a simple, 
easy-to-use approach is needed to recognize patients at risk for severe complications and 
to ensure timely initiation of interventions to improve outcomes.
There is increasing evidence that altered tissue perfusion in high-risk surgical patients 
could be helpful for the detection of those at risk for complications8,9 and optimally improve 
outcomes.10 In this regard, the success of early, goal-directed hemodynamic therapy has 
demonstrated the importance of maintaining and improving tissue oxygenation and has 
shown that early detection and correction of altered tissue perfusion reduce postoperative 
complications.2,11 Accordingly, their importance is also the basis for stressing the need to 
monitor postoperative early warning signals for occult tissue hypoperfusion.2,12 Likewise, 
lactate level, a potential marker of occult hypoperfusion, is used as a resuscitation target, 
although its relationship with regional circulation is still not clear.13,14 Therefore, early 
recognition of regional tissue perfusion abnormalities remains important to avoid further 
organ damage and improve outcomes following major surgery. Postoperative monitoring 
is still based on conventional hemodynamic variables, which are known to be insensitive 
to determination of the presence of regional tissue hypoperfusion. 
Recently, we and others have shown that assessment of perfusion of the peripheral 
circulation enables the identification of patients who will have unfavourable outcome. 
In critically ill patients,15 after out-of-hospital cardiac arrest16 and during septic shock,17 
impaired peripheral perfusion has been shown to be associated with organ failure and 
increased mortality. By use of the capillary refill time (CRT), the peripheral perfusion 
index (PPI) (Masimo SET Radical-7 pulse oximeter on a rainbow and SatShare platform; 
Masimo UK, Basingstoke, UK) and the forearm-to-fingertip body temperature gradient 
(Tskin-diff ), peripheral perfusion can easily and noninvasively be evaluated at the 
bedside and may thus be a more simple and generally useful tool for identifying 
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patients at risk for postoperative complications.18 In this context, we were interested 
in determining whether repeated assessment of the peripheral circulation in the days 
following surgery could help in the early identification of patients who are more likely 
to develop postoperative complications. We hypothesized that a disturbance of the 
peripheral perfusion might be present more frequently in patients who develop severe 
complications after major abdominal surgery.
Material And Methods
Study population 
We conducted this single-centre, prospective observational study between September 
2011 and June 2012. We included consecutive patients scheduled to undergo major 
abdominal surgery. All procedures were performed by senior surgeons and were 
defined as any intervention in which extensive resection was performed, a body cavity 
was entered, organs were removed or normal anatomy was significantly altered. 
Operations included colorectal, gastric, hepatic, pancreatic and oesophageal surgery 
for benign and malignant disease. Patients were suitable for inclusion if they met the 
following criteria: (1) age ≥18 years, (2) ASA Physical Status between 1 and 4 and (3) 
expected duration of surgery ≥120 minutes. Patients were excluded if they met the 
following criteria: (1) known neurologic or peripheral arterial occlusive disease, (2) 
refusal of consent, (3) pregnancy, (4) emergency surgery or (5) minor abdominal surgery. 
Medical ethical approval was provided by the Human Research Ethics Committee of 
the Erasmus University Medical Centre (Erasmus MC), Rotterdam, the Netherlands. 
Written informed consent was obtained from all patients at least 1 day prior to surgery.
Data collection
Hemodynamic variables, metabolic state and peripheral perfusion parameters were 
collected 1 day before surgery (BL), directly after surgery (D0) and on the first (D1), 
second (D2) and third (D3) postoperative days. Before surgery, basic demographic 
characteristics and routine biological, standard hemodynamic and peripheral perfusion 
parameters were recorded. Standard hemodynamic monitoring included continuous 
recording of electrocardiographic data, heart rate (HR), mean arterial pressure (MAP), 
body temperature and pulse oximetry. Concurrently at each time point, arterial 
blood samples were taken for blood gas analysis, arterial hemoglobin and lactate 
concentration (Radiometer Copenhagen ABL700 blood gas analyzer; Radiometer 
Medical, Copenhagen, Denmark). Additionally, surgery duration, operative blood 
loss, vasopressor therapy (any dose of norepinephrine), ICU and hospital length of 
stay, length of ventilator support and 30-day mortality were recorded.
We assessed all data needed to calculate the APACHE II score,19 Sequential Organ 
Failure Assessment (SOFA) score20 and P-POSSUM score21. The total SOFA score was 
calculated by summing the scores for each of the components (that is, cardiac, renal, 
respiratory, coagulation, and liver). We did not record the data for second surgeries in 
patients who underwent reoperation during the same hospitalization.
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Definition of complications
Complications were defined as the presence of complications within the first 10 
days after surgery. We also scored in-hospital 30-day postoperative complications. 
Postoperative complications were graded according to the Clavien-Dindo classification 
system.22,23 In short, grades I and II complications are defined as any deviation from the 
normal postoperative course, without the need for surgical, endoscopic or radiological 
interventions (grade I) but with the need for pharmacological treatment (grade II). Grade 
III complications required a surgical, endoscopic or radiological intervention during 
local (grade IIIa) or general anaesthesia (grade IIIb). Grade IV complications include 
those requiring ICU care because of single organ failure (grade IVa) or multiorgan 
failure (grade IVb). Postoperative overnight monitoring in the ICU was routinely 
performed in patients after oesophagectomy with gastric tube reconstruction and after 
liver transplantation, and therefore was not scored as a complication per se, unless 
a complication, as described in the Clavien-Dindo classification scheme, occurred 
and prolonged expected ICU stay, or in cases where continuous ICU admission was 
necessary for treatment. Additionally, we recorded 30-day survival to evaluate grade 
V complications (that is, death during the postoperative period). Grades III and IV 
complications and death (grade V) are classified as severe complications24
In addition, we defined infectious complications as one of the following infections: 
pneumonia (infiltrate noted on chest radiograph or positive sputum culture), sepsis 
and related syndromes according to the international sepsis consensus guidelines,25 
urinary tract infection (white blood cells in urine) and wound infection. Leakage was 
defined as anastomotic or chyle leakage. Pleural effusion was diagnosed by chest 
radiography and/or computed tomography.
Peripheral perfusion assessment
Peripheral perfusion was evaluated using the CRT, the PPI and the forearm-to-fingertip 
(Tskin-diff ) body temperature gradient. These methods are more extensively described 
elsewhere.18 In short, CRT is defined as the time required for a distal capillary bed (that 
is, the nail bed) to regain its colour after pressure has been applied to cause blanching. 
The time to return of normal colour was measured with a per-second analog hospital 
clock, which was present in every hospital room. A delayed return to normal colour (>5 
seconds) is regarded as impaired peripheral perfusion and has been related to tissue 
hypoperfusion and an increased likelihood of worsening organ failure.15 Additionally, to 
investigate the reliability of CRT, which is a subjective assessment, in terms of variability 
between different health-care workers, two examiners evaluated CRT in each patient—a 
trained researcher and a random nurse at the ward at the  concurrent time point.
The PPI, which we measured using the Masimo SET Radical-7 pulse oximeter on 
a rainbow and SatShare platform, provides a noninvasive indicator of the peripheral 
vasomotor tone and peripheral perfusion and is derived from the photoelectric 
plethysmographic signal of the pulse oximeter, which is placed on the finger. A 
threshold value of 1.4 represents a very sensitive cutoff point for determining abnormal 
peripheral perfusion associated with vasoconstriction.26 
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Tskin-diff values was obtained from two skin probes attached to the index finger and on 
the radial side of the forearm, midway between the elbow and the wrist. This temperature 
gradient can reflect changes in cutaneous blood flow better than the absolute skin 
temperature itself and is related to blood flow. Tskin-diff increases during vasoconstriction. 
A threshold value of 2°C has been shown to reflect intermediate vasoconstriction, and a 
threshold >4°C reflects severe vasoconstriction, in critically ill patients.15 
Statistical analysis
Data are presented as mean ± SE, unless otherwise specified. We used a Kolmogorov–
Smirnov test to test for normality (P > 0.05). Differences between group means were tested 
by Student’s t-test or Mann–Whitney U test. To analyse changes in the different systemic 
hemodynamic and biological variables over time and between groups, we used linear 
mixed-model analysis. We retrospectively divided the groups into group A (nonsevere) 
and group B (severe) complications. Briefly, patients without complications and grades I 
and II complications were combined as group A, and grades III, IV and V complications 
were labelled group B. Group B complications (grades III to V) are known as severe 
complications because of the necessity of surgical intervention (grade III) or due to their 
severity (that is, organ failure (grade IV or death (grade V)) and are therefore defined as 
the primary outcome.6,24 Because peripheral perfusion parameters are quantitative results, 
cutoff values were necessary to determine outcome associations. We therefore used 
predefined cutoffs for abnormal peripheral perfusion (cutoffs: CRT >4.5 seconds, PPI <1.4 
and Tskin-diff >2°C) to evaluate the relationship with outcome.15,18 We then constructed 
receiver operating characteristic (ROC) curves (plotted as continuous variables). To calculate 
sensitivity, specificity, positive likelihood ratio and negative likelihood ratio, we used the 
predefined cutoffs for abnormal perfusion. We also performed a generalized mixed-model 
analysis to calculate the predictive value, which was estimated using odds ratios (ORs) 
with 95% confidence intervals (CIs), for each postoperative day. This multivariate model 
was confirmed by using forward stepwise selection. We selected the variables based on 
differences between groups and on previous reports of prognostic factors for peripheral 
perfusion perfusion.15,27 We therefore corrected for MAP, HR, vasopressor therapy, C-reactive 
protein (CRP) and hemoglobin. We used severe complications as our dichotomous 
outcome variable and any combination of abnormal peripheral perfusion parameters as 
our dichotomous predictor variable. Subsequently, we performed binary logistic regression 
to further explore the predictive value of the more traditional predictive scores (APACHE 
II, ASA, P-POSSUM and SOFA scores). The Bonferroni correction was applied to correct 
for multiple testing, assuming an α of 0.05 for the three independent tests (CRT, PPI and 
Tskin-diff ). Therefore, P-values <0.017 were considered statistically significant.
Interobserver variability for subjective assessment of peripheral perfusion based on 
CRT was assessed by calculating Cohen’s κ (clinical cutoff >5 seconds). A κ-value ≥0.7 
was regarded as adequate. Most analyses were conducted using SPSS version 20.0 
software (SPSS, Chicago, IL, USA). The ROC analyses were performed in SigmaPlot 
11.0 software (Systat Software, San Jose, CA, USA).
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Results
From among the 137 patients who were eligible for inclusion during the study period, 
111 patients were ultimately included (Figure 1). There were no other discontinuations or 
patients lost to follow-up. Table 1 summarizes the demographic, biochemical and surgical 
characteristics of all patients. There was no significant difference between groups.
Postoperative outcomes
Of the 111 patients included, 19 patients (18%) developed severe complications 
(grade III, IV or V) (Table 2 and Figure 1). The mean occurrence of severe postoperative 
complications was 5.2 (±0.7) days. Importantly, 87% of the patients developed 
complications after the last peripheral perfusion measurement was obtained. The 
overall postoperative mortality rate was 3.6%, and the overall morbidity rate was 38.7%. 
Of the nonsurvivors, one patient died due to liver failure and three patients died due 
to infectious complications. Operative blood loss tended to be greater in patients who 
developed severe complications compared to patients who developed nonsevere 
complications, although this difference was not significant (P = 0.245). Fluid balance 
at D0 did not differ between groups (724 ± 83 ml vs. 829 ± 170 ml). ICU and hospital 
lengths of stay were significantly longer in patients who developed severe complications
Eligible postoperative patients 
for inclusion 
n= 137 
Patients included 
n= 111 (100%) 
Patients excluded: 
14 patients: researchers were unable to make 
measurements 
9 patients refused study cooperation  
3 patients withdrew consent 
Grade III-V complications 
n= 19 (18%) 
Grade I-II complications 
n= 92 (72%) 
Figure 1. Flowchart of patient inclusion in the study.
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table 1.  Patients’ characteristics
Characteristics
All patients 
(n=111)
Nonsevere  
complications
(n=92)
Severe  
complications 
(n=19)
Age (years), median [IQR] 60 [54-69] 60 [52-69] 61 [55-72]
Sex (Male/Female), n 76/35 62/30 14/5
Body mass index (kg/m2) 26.4 (0.7) 26.6 (0.8) 25.0 (1.3)
APACHE II 13.8 (0.4) 13 (0) 15 (1)
Total SOFA D0 4.8 (0.3) 5 (0) 6 (1)
P-POSSUM 31.6 (0.6) 31.0 (0.7) 33.6 (1.7)
Blood Loss (mL) 1068 (149) 971(174) 1493 (234)
Surgery time (min) 324 (12) 322 (13) 337 (32)
ASA score
- Grade I 11 11 0
- Grade II 59 48 11
- Grade III 40 32 8
- Grade IV 1 1 0
type of surgery, n
- Transthoracic esophagectomy 22 16 6
- Transhiatal esophagectomy 13 11 2
- Pancreaticoduodenectomy 23 18 5
- Kidney transplantation 24 23 1
- Liver transplantation 7 4 3
- Hemihepatectomy 7 6 1
- Partial gastrectomy 4 4 0
- Hepatico-jejunostomy 2 2 0
- Gastroenterostomy 2 2 0
- Pancreatico-jejunostomy 1 1 0
- Aortic bypass 1 1 0
- Colon interposition 1 0 1
- Colorectal surgery 1 1 0
- Distal pancreaticotectomy 2 2 0
- Subtotal colectomy 1 1 0
APACHE II, Acute Physiology and Chronic Health Evaluation II; ASA, American Society of 
Anesthesiologists; P-POSSUM, Portsmouth Physiological and Operative Severity Score for the 
enUmeration of Mortality and Morbidity; SOFA, Sequential Organ Failure Assessment. Data 
are presented as the number of patients, n (%), or as the mean (SE), unless otherwise specified. 
Nonsevere complications category comprises no complications to grade II complications. 
Severe complications category comprises grades III to V complications.
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Systemic and peripheral perfusion parameters over time  
and relationship to outcomes
Hemodynamic and biological data are presented in Table 3. On the different 
postoperative days, there was no difference in cardiac index (n = 39), MAP or central 
venous pressure between patients who developed severe complications and those 
who did not. Immediately after surgery (D0), however, HR was higher in patients who 
developed severe complications and persisted over time until D3. In patients who 
received vasopressor therapy postoperatively, the dose of vasopressor did not differ 
between groups in linear mixed-model analysis. Overall fluid balance during the study 
period did not differ between groups (2,462 ± 155 ml vs. 2,879 ± 334 ml).
Table 4 shows the time course for the different peripheral perfusion parameters. 
Before surgery there were no differences between groups in these parameters. 
However, at D0, CRT was significantly longer in patients who subsequently developed 
severe complications (P = 0.005). This difference persisted over time until D3. Similarly, 
there was a downward trend for PPI (increasingly altered), which reached a significant 
difference between groups on D2. Concurrently on D3, there was a significant 
difference between groups in Tskin-diff. Importantly, mean CRT exceeded the clinical 
cutoff for delayed refill time (>5 seconds) at D0, whereas mean PPI and mean Tskin-diff 
values did not exceed the cutoff for abnormality.
table 2. Postoperative complications
All patients 
(n=111)
Nonsevere 
complications
(n=92)
Severe
complications 
(n=19) P-values
ICU stay (days), median (IQR) 2 [2-4] 2 [0-3] 6 [3-9] <0.001
Hospital stay (days), median [IQR] 13 [11-20] 12 [10-17] 27 [17-36] <0.001
Highest complication grade
- No complications 68 68 - -
- Grade I 11 11 - -
- Grade II 13 13 - -
- Grade IIIa 3 - 3 -
- Grade IIIb 4 - 4 -
- Grade IVa 6 - 6 -
- Grade IVb 2 - 2 -
- Grade V (death) 4 - 4 -
According to the Clavien-Dindo classification scheme, the most severe complication is scored 
when those of lesser severity are clearly a step in the process leading to the serious event. 
Data are presented as the number of patients, unless otherwise specified. P-values represent 
differences between groups, and the statistical significance threshold was set at P < 0.017. Dash 
(–) indicates not applicable. Nonsevere complications category comprises no complications- to 
grade II complications. Severe complications category comprises grades III to V complications.
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table 3. Systemic hemodynamic and biological data
Systemic hemodynamics
Baseline D0 D1 D2 D3
Nonsevere 
complications
Severe
complications
Nonsevere 
complications
Severe
complications
Nonsevere 
complications
Severe
complications
Nonsevere 
complications
Severe
complications
Nonsevere 
complications
Severe
complications
Heart rate (beats/min) 74 (1) 76 (4) 77 (1) 87 (5)* 80 (2) 91 (5)* 83 (1) 91 (4)* 81 (2) 92 (3)*
Mean arterial pressure (mmHg) 96 (2) 95 (4) 89 (2) 85 (3) 90 (2) 87 (5) 93 (2) 93 (4) 96 (1) 91 (4)
pH 7.36 (0.02) 7.41  (0.02) 7.36  (0.01) 7.37  (0.01) 7.39 (0.01) 7.39 (0.02) 7.40 (0.02) 7.43  (0.01) 7.40 (0.02) 7.43  (0.01)
PaO2 (kPa) 10.5 (5.8) 11.1 (0.05) 17.6 (0.9) 15.8 (1.3) 12.7 (0.5) 11.7 (0.7) 11.3 (0.5) 13.6 (2.3) 10.2 (0.6) 11.4 (1.1)
Base Excess -4 .0 (2.08) -3.0 (3.0) -2.92 (0.29) -2.69 (1.08) -2.20 (0.34) -2.0 (1.06) -0.59 (0.47) -0.36 (1.59) -0.22 (0.85) 0.5 (1.29)
Lactate (mmol/L) 1.3 (0.2) 1.6 (0.01) 1.3 (0.1) 1.6 (0.3) 1.2 (0.1) 1.5 (0.2) 1.1 (0.1) 1.1 (0.1) 1.1 (0.1) 1.3 (0.2)
Hemoglobin (g/dL) 7.7 (0.2) 8.0 (0.3) 7.1 (0.1) 6.9 (0.3) 6.8 (0.1) 6.5 (0.3) 6.5 (0.1) 5.9 (0.3)* 6.4 (0.1) 5.8 (0.3)
Creatinine (µmol/L) 81 (7) 85 (12) 84 (6) 94 (13)* 76 (5) 89 (10)* 69 (5) 86 (9) 68 (6) 82 (10)
C-reactive protein mg/L 8 (2) 21 (18) 35 (9) 96 (33) * 86 (10) 121 (26) * 135 (15) 156 (24) 120 (15) 153 (29)
White blood cells (109/l) 6.7 (0.3) 9.7 (2.5) 8.7 (0.4) 10.8 (1.4) 11.6 (0.5) 11.5 (0.7) 11.3 (0.4) 11.3 (0.4) 10.2 (0.5) 9.7 (0.5)
Central temperature (oC) 36.7 (0.1) 36.7 (0.1) 36.7 (0.1) 36.7 (0.1) 37.1 (0.1) 37.3 (0.1) 37.0 (0.1) 37.2 (0.1) 37.0 (0.1) 37.2 (0.1)
Vasopressor use, n (%) - - 36 (39) 11  (58) 25 (27) 10 (52) 9 (10) 7 (37) 3 (3) 3 (16)
Vasopressor dose, (μg/kg.min) - - 0.17 (0.12) 0.07 (0.03) * 0.05 (0.33) 0.04 (0.02) 0.01 (0.05) 0.01 (0.07) 0 0.18 (0.01)
Baseline, Prior to surgery; D0, Directly after surgery; D1 First postoperative day; D2, Second 
postoperative day; D3, Third postoperative day; PaO2, Arterial blood gas oxygen tension. Dash 
(–) indicates not applicable. Nonsevere complications category comprises no complications- to 
grade II complications. Severe complications category comprises grades III to V complications. 
Data are presented as mean (SE). *P < 0.05 indicates statistical significance between groups 
(nonsevere complications vs. severe complications) at the specific time point. Differences between 
groups on the different postoperative days were assessed by linear mixed-model analysis
table 4. Peripheral perfusion parameters
Measurement parameters
Baseline D0 D1 D2 D3
Nonsevere 
complications
Severe
complications
Nonsevere 
complications
Severe
complications
Nonsevere 
complications
Severe
complications
Nonsevere 
complications
Severe
complications
Nonsevere 
complications
Severe
complications
CRT (s) 2.4 (0.1) 2.8 (0.2) 3.6 (0.2) 5.2 (0.5) * 2.9 (0.2) 6.2 (0.7)* 2.7 (0.1) 5.9 (0.6)* 2.8 (0.2) 5.7 (0.7)*
PPI (a.u.) 3.9 (0.3) 2.9 (0.3) 3.5 (0.4) 2.7 (0.8) 4.9 (0.0) 2.4 (0.7) 3.9 (0.3) 1.7 (0.4)* 4.4 (0.3) 2.2 (0.5)*
Tskin-diff (°C) 2.1 (0.2) 2.5 (0.5) 2.7 (0.2) 3.1 (0.4) 2.3 (0.2) 3.3 (0.5) 2.2 (0.2) 3.9 (0.6)* 2.2 (0.2) 3.6 (0.7)*
a.u., Arbitrary units; Baseline, Prior to surgery; CRT, Capillary refill time; D0, Directly after 
surgery; D1 First postoperative day; D2, Second postoperative day; D3, Third postoperative 
day; PPI, Peripheral perfusion index; Tskin-diff, Forearm-to-fingertip skin temperature gradient. 
Nonsevere complications category comprises no complications to grade II complications. 
Severe complications category comprises grades III to V complications. Data are presented as 
mean ± SE for the total patient sample (N = 111). *P < 0.017 indicates significant difference 
between groups at specific time point by linear mixed-model analysis.
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table 3. Systemic hemodynamic and biological data
Systemic hemodynamics
Baseline D0 D1 D2 D3
Nonsevere 
complications
Severe
complications
Nonsevere 
complications
Severe
complications
Nonsevere 
complications
Severe
complications
Nonsevere 
complications
Severe
complications
Nonsevere 
complications
Severe
complications
Heart rate (beats/min) 74 (1) 76 (4) 77 (1) 87 (5)* 80 (2) 91 (5)* 83 (1) 91 (4)* 81 (2) 92 (3)*
Mean arterial pressure (mmHg) 96 (2) 95 (4) 89 (2) 85 (3) 90 (2) 87 (5) 93 (2) 93 (4) 96 (1) 91 (4)
pH 7.36 (0.02) 7.41  (0.02) 7.36  (0.01) 7.37  (0.01) 7.39 (0.01) 7.39 (0.02) 7.40 (0.02) 7.43  (0.01) 7.40 (0.02) 7.43  (0.01)
PaO2 (kPa) 10.5 (5.8) 11.1 (0.05) 17.6 (0.9) 15.8 (1.3) 12.7 (0.5) 11.7 (0.7) 11.3 (0.5) 13.6 (2.3) 10.2 (0.6) 11.4 (1.1)
Base Excess -4 .0 (2.08) -3.0 (3.0) -2.92 (0.29) -2.69 (1.08) -2.20 (0.34) -2.0 (1.06) -0.59 (0.47) -0.36 (1.59) -0.22 (0.85) 0.5 (1.29)
Lactate (mmol/L) 1.3 (0.2) 1.6 (0.01) 1.3 (0.1) 1.6 (0.3) 1.2 (0.1) 1.5 (0.2) 1.1 (0.1) 1.1 (0.1) 1.1 (0.1) 1.3 (0.2)
Hemoglobin (g/dL) 7.7 (0.2) 8.0 (0.3) 7.1 (0.1) 6.9 (0.3) 6.8 (0.1) 6.5 (0.3) 6.5 (0.1) 5.9 (0.3)* 6.4 (0.1) 5.8 (0.3)
Creatinine (µmol/L) 81 (7) 85 (12) 84 (6) 94 (13)* 76 (5) 89 (10)* 69 (5) 86 (9) 68 (6) 82 (10)
C-reactive protein mg/L 8 (2) 21 (18) 35 (9) 96 (33) * 86 (10) 121 (26) * 135 (15) 156 (24) 120 (15) 153 (29)
White blood cells (109/l) 6.7 (0.3) 9.7 (2.5) 8.7 (0.4) 10.8 (1.4) 11.6 (0.5) 11.5 (0.7) 11.3 (0.4) 11.3 (0.4) 10.2 (0.5) 9.7 (0.5)
Central temperature (oC) 36.7 (0.1) 36.7 (0.1) 36.7 (0.1) 36.7 (0.1) 37.1 (0.1) 37.3 (0.1) 37.0 (0.1) 37.2 (0.1) 37.0 (0.1) 37.2 (0.1)
Vasopressor use, n (%) - - 36 (39) 11  (58) 25 (27) 10 (52) 9 (10) 7 (37) 3 (3) 3 (16)
Vasopressor dose, (μg/kg.min) - - 0.17 (0.12) 0.07 (0.03) * 0.05 (0.33) 0.04 (0.02) 0.01 (0.05) 0.01 (0.07) 0 0.18 (0.01)
Baseline, Prior to surgery; D0, Directly after surgery; D1 First postoperative day; D2, Second 
postoperative day; D3, Third postoperative day; PaO2, Arterial blood gas oxygen tension. Dash 
(–) indicates not applicable. Nonsevere complications category comprises no complications- to 
grade II complications. Severe complications category comprises grades III to V complications. 
Data are presented as mean (SE). *P < 0.05 indicates statistical significance between groups 
(nonsevere complications vs. severe complications) at the specific time point. Differences between 
groups on the different postoperative days were assessed by linear mixed-model analysis
table 4. Peripheral perfusion parameters
Measurement parameters
Baseline D0 D1 D2 D3
Nonsevere 
complications
Severe
complications
Nonsevere 
complications
Severe
complications
Nonsevere 
complications
Severe
complications
Nonsevere 
complications
Severe
complications
Nonsevere 
complications
Severe
complications
CRT (s) 2.4 (0.1) 2.8 (0.2) 3.6 (0.2) 5.2 (0.5) * 2.9 (0.2) 6.2 (0.7)* 2.7 (0.1) 5.9 (0.6)* 2.8 (0.2) 5.7 (0.7)*
PPI (a.u.) 3.9 (0.3) 2.9 (0.3) 3.5 (0.4) 2.7 (0.8) 4.9 (0.0) 2.4 (0.7) 3.9 (0.3) 1.7 (0.4)* 4.4 (0.3) 2.2 (0.5)*
Tskin-diff (°C) 2.1 (0.2) 2.5 (0.5) 2.7 (0.2) 3.1 (0.4) 2.3 (0.2) 3.3 (0.5) 2.2 (0.2) 3.9 (0.6)* 2.2 (0.2) 3.6 (0.7)*
a.u., Arbitrary units; Baseline, Prior to surgery; CRT, Capillary refill time; D0, Directly after 
surgery; D1 First postoperative day; D2, Second postoperative day; D3, Third postoperative 
day; PPI, Peripheral perfusion index; Tskin-diff, Forearm-to-fingertip skin temperature gradient. 
Nonsevere complications category comprises no complications to grade II complications. 
Severe complications category comprises grades III to V complications. Data are presented as 
mean ± SE for the total patient sample (N = 111). *P < 0.017 indicates significant difference 
between groups at specific time point by linear mixed-model analysis.
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Peripheral perfusion parameters were treated as continuous variables and analysed 
accordingly over time. Amongst these different parameters, the diagnostic accuracy 
of predicting severe postoperative complications on D1 was highest using CRT (ROC 
area under the curve (AUC) = 0.79 (95% CI = 0.66 to 0.90); P < 0.001) (Figure 2A). 
This value increased marginally and had the largest AUC on D2 (0.91 (0.83 to 0.92); P 
< 0.001) (Figure 2B). Moreover, CRT was a significantly better predictor than PPI (P = 
0.001) and Tskin-diff (P < 0.001) at D1.
For discriminatory analyses of the individual assessment of peripheral perfusion, we 
used predefined cutoff values for abnormal peripheral perfusion on each independent 
parameter. Table 5 shows the diagnostic accuracy of the different peripheral perfusion 
parameters for the early identification of patients with severe complications. For 
testing on D2, the sensitivity (0.79, 95% CI = 0.54 to 0.94) for CRT was very good, with 
a specificity of 0.93 (95% CI = 0.86 to 0.97). Similarly, PPI and Tskin-diff had the highest 
sensitivity (0.74 (95% CI = 0.49 to 0.91) and 0.84 (95% CI = 0.60 to 0.97), respectively) 
on D2 compared to the other postoperative days.  Subsequently, the positive likelihood 
ratio obtained on D1 and D2 indicated that the accuracy of peripheral perfusion 
parameters improved significantly, respectively 1 and 2 days, after surgery with good 
predictive value. Abnormalities in peripheral perfusion parameters were already 
predictive on D1, and over time these abnormalities were present approximately two 
to twelve times more often in patients with severe complications.
Interrater reliability of CRT between observers at the different postoperative days 
demonstrated a good overall agreement. Cohen’s κ analyses demonstrated κ-values 
Figure 2. Receiver operating characteristic curves of peripheral perfusion parameters for prediction of 
severe complications. Receiver operating characteristic curves for capillary refill time (CRT), peripheral 
perfusion index (PPI) and forearm-to-fingertip skin temperature gradient (Tskin-diff) to predict severe 
complications on the first postoperative day (D1) (a) and the second postoperative day (D2) (b). Full 
details, including sensitivity and specificity values of the curves, are given in Table 5.
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of 0.91 (95% CI = 0.80 to 0.97) on D0, 0.81 (95% CI = 0.65 to 0.93) on D1, 0.74 (95% 
CI = 0.52 to 0.89) on D2 and (95% CI = 0.70 to 0.98) on D3. Importantly, the interrater 
reliability of CRT at D2, which had the best predictive value for severe complications 
(see Table 5), showed good agreement between the different observers.
Accuracy of peripheral perfusion for predicting postoperative complications
We performed a generalized linear mixed-model analysis to further explore the association 
of abnormal peripheral perfusion with outcomes. After adjusting for hemodynamic variables 
(MAP and HR), vasopressor therapy, CRP and hemoglobin, the condition of abnormal 
peripheral perfusion was found to have a major predictive effect. The predictive value for 
severe complications was calculated for each postoperative day separately, and the results 
are presented in Table 6. Postoperatively, abnormal peripheral perfusion was predictive 
for  development of severe complications. Notably, abnormal peripheral perfusion on D2 
had the best predictive value; patients with abnormal peripheral perfusion were almost 
nine times more likely to develop postoperative complications (OR = 8.40 (95% CI = 2.72 
to 25.87); P < 0.001). More importantly, this effect persisted over time. When we scored 
the occurrence of 30-day postoperative complications, abnormal peripheral perfusion was 
still predictive at the different subsequent time points: D1 (OR = 2.87 (95% CI = 1.23 to 
6.71); P = 0.015), D2 (OR = 3.46 (95% CI = 1.46 to 8.23); P = 0.005) and D3 (OR = 3.34 
(95% CI = 1.40 to 7.96); P = 0.007).
The following commonly used risk stratification scores had no predictive value for 
the occurrence of complications in our population: ASA score (OR = 2.62 (95% CI = 
0.71 to 9.56); P = 0.14), P-POSSUM score (OR = 1.04 (95% CI = 0.92 to 1.18); P = 0.52), 
APACHE II score (OR = 1.11 (95% CI = 0.94 to 1.32); P = 0.24) and SOFA score on D0 
(OR = 1.08 (95% CI = 0.81 to 1.43); P = 0.62).
table 6. Predictive value of abnormal peripheral perfusion for severe complications 
Abnormal peripheral 
perfusion measurement Odds Ratio (95% CI) P-value
D0 4.49 1.38-14.56 0.013
D1 3.70 1.29-10.63 0.015
D2 8.40 2.72-25.87 <0.001
D3 6.43 2.11-19.64 0.001
CI, Confidence interval; D0, Directly after surgery; D1, First postoperative day; D2, Second 
postoperative day; D3, Third postoperative day. Abnormal peripheral perfusion is defined as at 
least one abnormal peripheral perfusion variable capillary refill time >4.5 seconds, peripheral 
perfusion index <1.4 or a forearm-to-fingertip skin temperature gradient >2°C. We used a 
generalized mixed-model analysis to calculate the predictive value of abnormal peripheral 
perfusion for severe complications at each postoperative day. Mean arterial pressure, heart rate, 
vasopressor therapy, C-reactive protein and hemoglobin were used to adjust the predictors in 
the multivariate analysis. P < 0.017 is considered significant.
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Discussion
The principal findings in the present study illustrate that, following elective major abdominal 
surgery, peripheral perfusion alterations were more marked in patients who were more likely 
to develop severe complications. Peripheral perfusion alterations were already present in 
these patients immediately after surgery and became even more predictive on D1 and D2. 
Further  research is required to confirm these findings and to investigate whether targeted 
treatment based on peripheral perfusion assessment could improve outcomes.
Surprisingly, the diagnostic accuracy of peripheral perfusion assessment was 
highest using CRT, as compared to PPI and Tskin-diff. This finding has major clinical 
implications. First, this parameter provided high levels of accuracy and discrimination, 
as soon as D2, in the prediction of patients more likely to develop severe complications. 
Second, the subjective inspection and palpation of peripheral perfusion is safe, 
noninvasive, cheap and easy to perform at the bedside and enables physicians to 
identify early on those patients more likely to deviate from the normal postoperative 
course and have severe complications, even before continuing to invasive procedures. 
Moreover, despite the current questions raised about the clinical utility of CRT, we 
found that it had very good interrater reliability between observers. The results of 
our study extend the findings of a recent single-centre study15 which showed that 
subjective assessment of peripheral perfusion with CRT could identify early on those 
critically ill patients with more severe organ dysfunction.
Since the introduction of the Clavien-Dindo classification system in 200423, 
an increasing consensus has been formed on how to define and grade adverse 
postoperative events and evaluate surgical procedures.22 Early identification of patients 
who subsequently developm life-threatening complications or who are at risk for 
longterm disability due to postoperative complications enables timely recognition of 
patients who may benefit from early intensive management. Several prediction models, 
such as the Colorectal Physiological and Operative Severity Score for the Enumeration 
of Mortality and Morbidity28, the Rotterdam score29 and a new score described by 
of Braga et al.6 have been proposed to predict standardized complications based 
on several physiological and operative measurements. These prediction models are 
usually organ- and surgery-specific, however, and tend to overestimate poor outcomes 
in a surgical case mix population, and are even outranked by a surgeon’s intuition.30 
Therefore, an individual assessment, such as the assessment of peripheral perfusion, 
to predict postoperative patients at risk for severe adverse postoperative events 
could be very useful in comparing the postoperative performance of patients in a 
heterogeneous population. Maybe more importantly, we observed peripheral perfusion 
alterations before the clinical occurrence of postoperative complications, with a mean 
occurrence on the fifth postoperative day. Because of the preliminary nature of our 
findings, comparison with other measures of individual surgical risk assessment, such 
as exercise testing or plasma biomarkers, could confirm our observations.
From an etiological perspective, compromised peripheral circulation in the 
postoperative course may resemble the early, initial period of that in both septic and 
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nonseptic shock. In the latter case, increased sympathetic activity, as a response to 
circulatory shock, leads to increased vasomotor tone and is usually induced by the 
baroreceptor reflex. During this period, in which compensatory mechanisms predominate, 
the neurohumoral response-induced vasoconstriction preserves the perfusion of the 
heart and brain at the expense of perfusion of the skin, muscle and gastrointestinal 
vascular beds.27,31 On the other hand, this increased adrenergic response could also well 
be the result of inflammation-induced vasoconstriction due to intraoperative stress and 
surgical trauma, independent of systemic hemodynamics.32,33 For instance, Boerma et 
al. showed that severe inflammation affects intestinal and sublingual tissue perfusion.34 
Furthermore, using an experimental model of abdominal surgery, Hiltebrand et al. 
found that treatment of hypotension with norepinephrine had no adverse effects on 
microcirculatory perfusion or tissue oxygen tension in the intestinal tract, proving that 
administering low to moderate doses of norepinephrine to increase perioperative blood 
pressure does not adversely affect peripheral tissue perfusion.35
Others have confirmed that this postsurgical systemic inflammatory response 
syndrome (SIRS)–induced vasoconstriction could be seen as a surrogate marker for 
impaired tissue healing, increased metabolic demands and organ hypoperfusion.36,37 In 
our patient population, the observed delayed CRT and increased Tskin-diff in patients 
who developed severe complications may similarly reflect the release of inflammatory 
mediators, leading to SIRS,38 loss of  autoregulation, increased endothelial damage 
and tissue perfusion alterations.
Although the presence of abnormal peripheral perfusion identifies patients at 
increased risk for unfavourable outcomes, no study has been conducted to date, to 
the best of our knowledge, that has been focused on resuscitation based on these 
parameters. Current perioperative ‘goal-directed therapy’ studies have been focused 
mainly on systemic hemodynamic parameters11,39 and may contribute to improvements 
in survival after major surgery by using perioperative plasma volume expansion12,39 or 
a more restricted fluid approach.40 Moreover, there is to date no uniform goal-directed 
strategy aimed at resuscitation of regional peripheral blood flow. Some researchers 
have shown positive effects of regional perfusion-based resuscitation,41,42 whereas 
others have reported contrasting findings.43 Our findings in the present study have 
important clinical implications, however, as our results demonstrate the importance of 
adequate tissue perfusion and thus may provide a foundation for developing a tissue 
perfusion-based approach for use even before critical illness.44,45 The role of individual 
peripheral perfusion assessment as a potential additional tissue perfusion endpoint 
must be investigated further to address whether aiming at normalization has an impact 
on outcome. Given the results we report here, one can imagine that serial peripheral 
perfusion measurements in a postoperative population could provide an additional 
window to monitoring and treating occult hypoperfusion caused by inflammation or 
infection. As such, these measurements might be used for earlier treatment of surgical 
or infectious postoperative complications and thereby result in a reduction of organ 
failure and mortality. However, a large multicentre trial, preferably randomized and 
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controlled, is needed to demonstrate the effect of interventions based on impaired 
peripheral perfusion parameters.
Some limitations of our study need to be acknowledged. First, because our study 
was an observational study, significant correlations between peripheral perfusion 
alterations and the occurrence of complications do not prove causality. It has been 
shown previously, however, that persistent vasoconstriction, independently of 
systemic hemodynamics, suggests ongoing sympathetic activity associated with organ 
dysfunction after out-of-hospital cardiac arrest,16 and during septic shock.17,46 As such, 
there is now evidence that an elevated SIRS response before and directly after major 
surgery (within 24 hours) is associated with increased morbidity9,47 and mortality 48 and 
is an independent predictor of survival.  
Second, in this study we chose to correlate peripheral hypoperfusion to clinical 
outcomes according to the Clavien-Dindo grading system.23 Although this grading 
system is relatively new, it is not unfamiliar amongst surgeons and it is considered more 
reliable by observers.22 This classification system is simple and reproducible, correlates 
with treatment cost and length of stay and can be used to semiquantitatively score 
postoperative complications in severity in varying fields of surgery. Although 30-day 
follow-up is often used, we focused on a 10-day time window. We believe that the 
scoring of complications within 10 days after surgery better permits distinctions between 
procedure-related complications and those related to disease progression, especially 
when related to perioperative perfusion abnormalities. Nevertheless, we found that the 
predictive effect of impaired peripheral perfusion persisted over 30 days as well.
Third, paired measurements of global blood flow (cardiac output) were not done in 
all postoperative patients. Our main focus in this study was to assess the relationship 
between abnormal peripheral perfusion and the occurrence of severe complications. 
It remains to be elucidated to what extent peripheral perfusion alterations reflect 
systemic hemodynamics, as others have reported that peripheral circulation behaves 
independently of systemic hemodynamic resuscitation, even despite early goal-
directed therapy.18,46 Despite this knowledge, we observed a significant difference in 
HR between groups at the different postoperative time points. Although HR is indeed 
an important prognostic parameter, our  objective in this study was to examine whether 
peripheral perfusion assessment could improve risk stratification, and we therefore 
corrected for HR in the multivariate analysis.
We did not include other methods of peripheral blood flow monitoring, such as 
cutaneous laser Doppler flowmetry. We previously showed that CRT, PPI and Tskin-
diff are well validated methods of estimating cutaneous blood  flow15 and provide a 
ready to use, simple, cheap instrument at the bedside. Moreover, real-time evaluation 
of the (subjective) assessment of peripheral perfusion is easily obtainable by using 
noninvasive monitoring techniques, and it can be rapidly applied throughout the 
hospital under different circumstances and by different health-care workers.
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Conclusions
By simple clinical assessment of peripheral perfusion immediately after surgery, 
clinicians are able to discriminate patients at high risk for developing severe 
complications. These findings suggest that assessment of peripheral perfusion can be 
used for early identification of postoperative patients in need of additional therapy and 
open a perspective on new (tissue perfusion) goal-directed therapies. Further research 
designed to confirm these findings, and to explore them in more detail, is needed. 
Such research needs to be conducted in a powered, randomized, controlled fashion 
to assess the effects on outcome of a peripheral perfusion targeted resuscitation 
following major abdominal surgery.
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Abstract
Purpose
Recently, noninvasive assessment of the peripheral perfusion has been shown to be 
strongly predictive of poor outcome in septic shock patients. The predictive value of 
the evolution over time of these different peripheral perfusion parameters has however 
not been studied. To address this matter we evaluated whether repeated assessment of 
the peripheral perfusion, with parameters readily available at the bedside, could reflect 
response to initial standard treatment and could predict outcome in septic shock patients. 
Materials and Methods
Thirty-five septic patients admitted to the intensive care unit (ICU) undergoing 
protocolized resuscitation between March and June 2011 were included in this 
retrospective cohort analysis. Study entry was after initial resuscitation at the ICU at 
the first day of admission (D0) and on the second day of ICU admission (D1). Peripheral 
perfusion assessment consisted of the CRT and the peripheral perfusion index (PPI). 
Abnormal peripheral perfusion was predefined as CRT > 5 seconds, PPI < 1.4 %. 
Results
Overall APACHE II score was 25 (1); ICU mortality rate was 40%. Unfavorable evolution 
of the peripheral perfusion was associated with higher odds ratio for mortality, 
respectively, OR 7.33 (95% CI 1.53 - 35.11) for CRT and OR 7.65 (95% CI 1.64 – 
35.80) for PPI. Generalized mixed model analysis demonstrated that the odds of 
unfavorable evolution over time were more predictive for mortality compared to a 
single observation of abnormal peripheral perfusion. 
Conclusions
Unfavorable evolution of the peripheral perfusion in the first days following initial 
resuscitation is strongly predictive of poor outcome in septic shock patients. These 
results indicate that serial peripheral perfusion assessment could be incorporated as 
additional target during septic shock resuscitation.  Further research is needed to 
confirm these findings and to explore in more detail the effects of peripheral perfusion 
targeted resuscitation.
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Introduction
Circulatory failure is associated with an impairment in tissue perfusion which can contribute 
to the development of organ dysfunction. Until recently, adequacy of tissue perfusion
has been determined from systemic hemodynamic variables such as mean arterial 
pressure, cardiac output, and biochemical variables such as lactate. However, the 
peripheral circulation is one of the few windows of circulatory dysfunction that is 
readily available at the bedside in almost every patient.[1]
The rationale of peripheral perfusion monitoring is based on the concept that peripheral 
tissues are the first to reflect vasoconstriction and hypoperfusion during shock, and the 
last to reperfuse during resuscitation. In different patient populations we and others have 
demonstrated that peripheral perfusion assessment enables the identification of patients 
with unfavorable outcomes.[2-7] The capillary refill time (CRT) [2] and the peripheral 
perfusion index (PPI) [8] both adequately represent the state of the peripheral circulation. 
Both parameters are readily available and can easily be obtained at the bedside. Especially 
in septic shock patients single observations of the peripheral circulation demonstrated 
that profound alterations are associated with the development of organ failure and poor 
outcome, independent of initial systemic hemodynamic parameters.[4,9] 
These observations however ignore the evolution over time during the course of 
an Intensive Care Unit (ICU) stay. Although Hernandez et al. nicely demonstrated that 
early recovery of the peripheral perfusion 24 hours after ICU admission anticipates a 
successful resuscitation in septic shock patients, they did not analyze trends over time.
[10] In fact, to date no study has evaluated patient specific peripheral perfusion changes 
over time in septic shock patients. This could provide valuable insights about the role of 
peripheral perfusion as a target for resuscitation to optimize tissue perfusion. 
Our aim was therefore to evaluate patient specific peripheral perfusion evolution 
in septic shock patients following initial standardized resuscitation during the first two 
days of ICU admission. In particular, we investigated whether unfavorable evolution 
over time for each individual peripheral perfusion parameter could identify an 
inadequate response to initial treatment in terms of outcome.
Materials and Methods
Study design, setting, and patient population
We conducted a retrospective observational cohort analysis of prospectively collected 
data in septic shock patients admitted between March and June 2011 of whom 
peripheral perfusion measurements where available. The local Institutional Review 
Board approved the protocol and waived the need for informed consent for an 
retrospective analysis of an observational study without any specific intervention with 
parameters already assessed in critically ill patients.
Adult patients with septic shock were considered eligible for study analysis. Septic 
shock, at ICU admission, was defined according to the most recent International Sepsis 
guidelines.[11] Patients were included in the analysis if they were hemodynamically stable 
(mean arterial pressure >65 mm Hg, no change in vasopressor infusion rate for at least 
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2 hours, and core temperature >35.5 °C) during peripheral perfusion assessment and 
if peripheral perfusion measurements were available for two consecutive days. Patients 
with subarachnoid hemorrhage (SAH), stroke in the cerebellum or brainstem, isolated 
brain trauma, known neuromuscular disease, severe peripheral vascular disease, severe 
arrhythmias, liver failure, and comatose patients (Glasgow Coma Scale ≥ 7) were excluded. 
Hemodynamic management 
Systemic hemodynamic resuscitation was guided by our local protocol, adapted from 
the international Surviving Sepsis Campaign Guidelines.[12,13] In short, patients 
were equipped with an arterial and central venous catheter if the treating physicians 
considered it clinically indicated. Hemodynamic support in all patients – including 
vasopressor therapy (noradrenaline) and volume infusion (repeated fluid challenges 
with crystalloid or colloid solutions) based on fluid responsiveness – was aimed to 
maintain HR <100/minute, MAP ≥60 mmHg, central venous pressure of 8 to 12 mmHg, 
urinary output ≥0.5 ml/kg/hour and ScvO2 ≥70%. In mechanically ventilated patients 
arterial blood gas values corrected for temperature were used to adjust the ventilator 
to maintain PaO2 between 8.0 and 13.3 kPa and a PaCO2 between 4.0 and 5.0 kPa.  
Data collection and measurements
General characteristics and data on the first (D1) and second (D2) of ICU admission were 
collected. Peripheral perfusion data were collected once patients were hemodynamically 
stable at the first and second day of ICU admission, respectively D1 and D2. 
Simultaneously, different systemic hemodynamic parameters were collected, i.e. heart 
rate (HR), mean arterial pressure (MAP), and central venous pressure (CVP). If available, 
data of arterial and central venous blood samples were collected for the determination 
of  hemoglobin saturation, arterial hemoglobin and arterial lactate concentrations 
(ABL700; Radiometer, Copenhagen, Denmark). Additionally we collected the Acute 
Physiology and Chronic Health Evaluation II (APACHE II), the Sequential Organ Failure 
Assessment (SOFA), and ICU mortality to further evaluate outcome.
Peripheral perfusion measurements
Peripheral perfusion was evaluated using a combination of the CRT and the PPI. 
CRT is defined as the time required for a distal capillary bed (i.e. the nailbed) to regain its 
color after pressure has been applied for 15 seconds to cause blanching. The time to return 
of normal color is standardly measured with a per second analog hospital clock present 
in every ICU box.(21) A delayed return of normal color (>5 seconds) can be regarded as 
decreased peripheral perfusion and has been related to tissue hypoperfusion and a greater 
likelihood of worsening organ failure.[4] A CRT ≥ 15 seconds was accounted as 15 seconds.
The PPI (Masimo SET® pulse oximetry Perfusion Index, Radical 7, Basingstoke, 
Hants, UK) provides a noninvasive indicator of peripheral vasomotor tone and 
peripheral perfusion, and is derived from the photo-electric plethysmographic signal 
of the pulseoximeter, used routinely. A PPI < 1.4% represent a very sensitive cutoff 
point for determining abnormal peripheral perfusion related with vasoconstriction. [14]
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Statistical analysis 
Data is presented as mean (SE), unless otherwise specified. We used a Kolmogorov-
Smirnov test to test for normality (p > 0.05).  We retrospectively divided the patients 
into survivors and non-survivors and tested differences between group means by 
Student’s t tests or Mann-Whitney U test if not normally distributed. Correlations were 
computed using Kendall’s tau-b formula. Because peripheral perfusion parameters 
are quantitative results, cutoff values were necessary to discriminate abnormal from 
normal peripheral perfusion. We therefore used predefined cut-offs for abnormal 
peripheral perfusion in intensive care unit patients (cut-offs: CRT > 5 seconds, PPI < 
1.4%) to evaluate the relationship with outcome.[15] 
To evaluate the peripheral perfusion evolution over time and its relationship 
with outcome, we first determined whether the peripheral perfusion was normal or 
abnormal (based on cut-offs) per time point for each parameter and subsequently 
calculated differences between groups. To analyze trends over time for each 
individual peripheral perfusion parameter (T0 –T1), we defined unfavorable peripheral 
perfusion evolution as a combination of worsening (normal-abnormal) and persistent 
abnormal (abnormal-abnormal) peripheral perfusion for each individual patient. We 
then used a generalized linear model procedure to evaluate the predictive value, 
estimated as odds ratios with 95% confidence intervals, using abnormal peripheral 
perfusion evolution as binary to predict ICU mortality and organ failure (Δ-SOFA ≥ 0). 
This multivariate model was confirmed by using the forward stepwise selection. We 
selected the variables based on differences between groups and on previous reports 
on prognosticating factors of peripheral perfusion.[4,16] We therefore corrected for 
SOFA admission, MAP and HR. 
A p value < .05 was considered statistically significant. We used SPSS (version 20.0, 
SPSS, IBM, Chicago, IL) for statistical analysis.
Results
During the study period, 154 patients had documented peripheral perfusion 
assessment of whom 146 had subsequent peripheral perfusion assessment. Of these 
patients, thirty-five patients had septic shock. Of this cohort, 14 patients (40%) died 
during their ICU stay. Clinical characteristics of the patients are presented in Table 1. 
The mean SOFA score on admission was mean, SE: 11 (1), obviously, SOFA score was 
significantly higher in the non-survivors compared to the survivors. All patients were 
treated with norepinephrine at the time of peripheral perfusion assessment on the first 
day of admission (mean vasopressor dose 0.30(0.06) μg/kg/min). There was no overall 
difference in vasopressor dosage used between survivors and non-survivors (Table 2). 
Systemic and peripheral perfusion parameters
Systemic hemodynamic and biochemical variables are presented in Table 2. On 
both days of ICU stay, there was no difference in the systemic hemodynamic and 
biochemical parameters between survivors and non-survivors. 
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table 1. Demographic characteristics 
All  
(n=35)
Survivors  
(n=21)
Nonsurvivors 
(n=14)
Age, years 61 (2) 58 (3) 66 (4)
Gender, [Male; n (%)] 24 (69) 12 (50) 12 (50)
Acute Physiology and Chronic Health Evaluation II 25 (1) 23 (1) 28 (2)
Sequential Organ Failure Assessment score at  admission 11 (1) 10 (1) 13 (1)*
Length of Intensive Care Unit stay, days 12 (2) 10 (2) 16 (3)
Admission category
Source of sepsis 21 Abdomen 
10 Lung 
2 Urinary tract
2 Primary bacteremia
Data is presented as mean (SE) unless otherwise stated. 
Both CRT and PPI were not significantly different in the non-survivors compared to 
the survivors at D1. However at D2, both CRT and PPI were significantly different in the 
non-survivors compared to the survivors (P = 0.005). Interestingly, mean CRT did not 
exceed the clinical cut-off for abnormality (>5 seconds) in the survivors. Additionally, CRT 
exceeded the clinical cut-off for an abnormal capillary refill time (>5 seconds) on this day 
in the non-survivors. The same accounted for the PPI, which exceeded the clinical cut-off 
for abnormality (<1.4) in non-survivors in contrast to the survivors whom had a normal PPI. 
Peripheral perfusion to predict outcome
We performed a generalized linear mixed-model analysis to explore the association of 
abnormal peripheral perfusion with outcomes. Both abnormal CRT and abnormal PPI 
on D1 were not predictive for either organ dysfunction or for ICU mortality. However 
regarding the evolution over time for each independent parameter, unfavorable 
evolution was found to have a major predictive value for outcome (Table 3). Patients 
with unfavorable evolution over time (day 1 vs day2) were roundabout seven to eight 
times more likely to die compared to patients with a favorable evolution. Additionally, 
generalized linear model analysis showed that the odds ratio for progressive organ 
failure (Δ –SOFA ≥ 0) was 4.74 ((1.14–5.87 ; p = 0.03) for CRT) times higher for a patient 
with abnormal peripheral perfusion than for a patient with normal peripheral perfusion 
at T0, independent of systemic hemodynamics and vasopressor therapy. Contrastingly, 
changes of PPI over time were not associated with progressive organ failure.
We also analyzed correlations between peripheral perfusion and systemic 
hemodynamics. CRT did not correlate with any systemic hemodynamic or biochemical 
parameter. In contrast, we observed a weak correlation between unfavorable PPI 
evolution and arterial lactate level (r=0.32, p=0.03). There was no significant correlation 
between PPI and systemic hemodynamics.
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table 2. Systemic hemodynamic and peripheral perfusion parameters
D1 D2
Survivors Nonsurvivors Survivors Nonsurvivors
Systemic hemodynamic and biochemical parameters
Central temperature (°C) 37.0 (0.2) 37.0 (0.2) 37.0 (0.1) 37.0 (0.2)
Heart rate (bpm) 101 (5) 101 (8) 101 (5) 98 (6)
Mean arterial pressure (mmHg) 76 (4) 69 (2) 79 (3) 77 (11)
Central venous pressure (mmHg) 14 (2) 18 (7) 15 (3) 15 (4)
ScvO2 (%) 74 (4) 74 (2) 75 (3) 73 (4)
Lactate (mmol/L) 2.9 (0.6) 3.6 (0.9) 1.7(0.2) 4.5 (1.9)
Hemoglobin 7.0 (0.3) 6.4 (0.4) 6.0 (0.3) 5.9 (0.4)
Vasopressor use, n (%) 16 (55) 13 (45) 11 (55) 9 (45)
Vasopressor dose, μg/kg/mina 0.30 (0.09) 0.30 (0.08) 0.18 (0.09) 0.44 (0.17)
Peripheral perfusion parameters
CRT 6.7 (1.2) 9.0 (1.8) 4.5 (0.6) 9.8 (1.4)*
PPI 2.9 (0.6) 2.0 (0.6) 3.2 (0.6) 1.4 (0.4)*
D1, first day of ICU admission; D2, second day of ICU admission; Survivors (n = 21 ; Nonsurvivors 
(n = 14); CRT, capillary refill time; PPI, peripheral perfusion index.
* P <.05, between groups (survivors and nonsurvivors) in the specific time point, using the 
students T-test or Chi-square test.
avasopressor use (norepinephrine or epinephrine) at the time of peripheral perfusion assessment.
Discussion
The main finding of the present study is that unfavorable evolution of the peripheral 
perfusion following initial resuscitation is independently associated with poor 
outcome in septic shock patients. Interestingly, these peripheral perfusion alterations 
are independent of initial systemic hemodynamic resuscitation goals. 
Recently several studies addressed the importance of peripheral perfusion assessment 
in septic shock patients. In a large database study, de Backer et al [9] demonstrated that 
sublingual microcirculatory alterations are stronger predictors of outcome than global 
hemodynamic variables in septic shock patients. Additionally non-invasive bedside 
parameters of peripheral perfusion demonstrated to have a similar predictive power 
for mortality, as sublingual microcirculatory assessment.[6] In septic shock patients, 
impaired peripheral perfusion demonstrated to be predictive of mortality after systemic 
hemodynamic resuscitation.[2,17,18] The main difference between the previous studies 
and the current study is the focus on patient specific dynamic peripheral perfusion 
changes over time after initial guideline targeted resuscitation.
We found that serial assessment of peripheral perfusion, i.e. unfavorable 
evolution of both CRT and PPI, was more predictive for mortality when compared 
to a single assessment of peripheral perfusion at the first or second day of 
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admission. Surprisingly, despite the current questions raised about the clinical 
utility of CRT, CRT assessment is reliable in septic shock patients and unfavorable 
CRT evolution was, besides ICU mortality, also predictive for progressive organ 
failure.[2] CRT has gained widespread acceptance as one of the strongest red flags 
to identify infection and tissue hypoperfusion in pediatric patients and interest 
is recently shifted to determine its usefulness in critically adult patients [19,20]. 
  A recent study by He et al.[18] showed that a single measurement of lower PPI was 
associated with increased ICU mortality in septic patients after resuscitation. In addition 
to their study we demonstrated that unfavorable evolution of PPI is independently 
associated with increased odds to die. In contrast to their findings, we however did not 
find a predictive value for mortality of a single assessment of PPI at T0. This could be 
due to differences in study design and sample size. Nevertheless our patient population 
was sufficient to highlight significant results and therefore the probability of a type I 
error is fairly low independent of the included number of patients. One can also argue 
that this difference could be due to the use of different cut-off values for abnormality: 
they used a cut-off of 0.2 to distinguish between survivors and nonsurvivors, whereas 
we used a previously defined cut-off of 1.4 to define abnormality. Interestingly, they 
reported a similar cut off to discern critically ill patients (mean PPI: 1.4 ± 1.4)  from non-
critically ill patients (mean PPI: 2.6 ± 0.7). 
We found a significant but weak negative correlation between PPI and the arterial 
lactate level. In addition, He et al [18] also reported an association between abnormal 
peripheral perfusion and hyperlactatemia. The correlation between hyperlactatemia and 
table 3. Sequential peripheral perfusion parameters as predictor of mortality
A
D1
Odds Ratio (95% CI)
CRT 1.83 0.38 – 8.78
PPI 2.95 0.72 – 11.91
B
D2
Odds Ratio (95% CI)
CRT 5.96 1.26 – 28.10
PPI 5.76 1.31 – 25.42
C
Unfavorable evolution over time
Odds Ratio (95% CI)
CRT 7.33 1.53 -35.11
PPI 7.65 1.64 – 35.80
D1, first day of ICU admission; D2, second day of ICU admission; CRT, capillary refill time; PPI, 
peripheral perfusion index. Odds ratios are calculated using generalized mixed model analysis 
(see material and methods).
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abnormal PPI in our patients is not surprising, as hyperlactatemia in sepsis is associated 
with the presence of organ dysfunction and poor outcome. Interestingly we found 
no correlation between systemic hemodynamics and peripheral perfusion. It could 
be hypothesized that the combination of hyperlactatemia and abnormal peripheral 
perfusion following resuscitation is a reflection of (persistent) occult hypoperfusion [21]. 
Noninvasive bedside assessment of the peripheral perfusion could therefore provide 
the clinician with important additional information during and after initial resuscitation.
Despite the clinical evidence of the additional value of peripheral perfusion, 
the place of these parameters in resuscitation is still not clear. Although recovery 
of the peripheral perfusion during initial resuscitation is associated with improved 
outcome  and worsening thereafter is associated with poor outcome[5,10]currently, 
goal directed hemodynamic resuscitation is still solely aimed at conventional systemic 
hemodynamic parameters.[13,22]. It can be hypothesized that peripheral perfusion 
measurements during resuscitation could provide an additional window to monitor and 
treat occult hypoperfusion, as assessment of peripheral perfusion during resuscitation 
has the potential to optimize vasomotor tone, microcirculatory alterations, and as such 
resuscitation procedures.[6] One next logical step would be to study the capability 
of peripheral perfusion as a target of resuscitation, to strive towards a more tissue 
perfusion-based approach [20,22]. 
This study has some limitations. First, we defined abnormal evolution as a combination 
of persistent abnormal peripheral perfusion and peripheral perfusion that evolved from 
normal to abnormal over 24 hours. Due to the small sample size, calculations of odds 
ratios for each individual course was not possible. Further research is indicated to 
investigate which individual course has the highest predictive value for poor outcome. 
Second, measurements of global blood flow (cardiac output) were not made in this 
study. Recent studies have however shown that peripheral perfusion alterations persist, 
even when systemic hemodynamics are resuscitated to satisfactory goals [15,23]. Third, 
observations were made in a single center and do not truly represent care across other 
centers. However initial resuscitation was guided by our local protocol, adapted from 
international guidelines and represent current national and international care. 
In conclusion, serial evaluation of the peripheral perfusion during the first two 
days of ICU admission has profound implications on outcome in septic shock 
patients. Unfavorable evolution of the peripheral perfusion, following initial systemic 
hemodynamic optimization, is associated with progressive organ failure and higher 
odds to die. These findings add important knowledge to the discussion whether or 
not we should focus on a more tissue perfusion based fluid resuscitation approach. 
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Prevention of postoperative sublingual microcirculatory derangement
Abstract
Introduction
Esophagectomy with gastric tube reconstruction is characterized by high postoperative 
morbidity rates. Recently it was shown that decreased sublingual microvascular blood 
flow (MBF) preoperatively was associated with increased rate of complications after 
abdominal surgery. Similar observations in severely septic patients could be treated 
with dobutamine, independent of cardiac output. Based on these considerations 
we hypothesized that sublingual MBF derangements are more likely to be found in 
patients undergoing high risk surgery such as esophagectomy, and if  present, might 
be prevented with administration of low dose dobutamine.
Methods
In this single-centre, prospective, double-blinded study, we randomized 20 patients 
admitted to the Intensive Care Unit following esophagectomy with gastric tube 
reconstruction into two groups. The intervention group (D) received a small dose of 
dobutamine (2.5 µg/kg/min) directly postoperative until two days postoperatively, 
whereas the placebo group (P) received a similar volume of saline. A subset of patients 
undergoing pancreaticoduodenectomy surgery was included as control group (C) for 
comparison with the study group. Sublingual MBF was determined one day prior to 
surgery until two days postoperatively.
Results
At the first postoperative day, patients in the esophagectomy/placebo group (P), showed 
a significant lower microvascular flow index, perfused vessel density and proportion of 
perfused vessels compared to baseline (p < 0.001) and the pancreaticoduodenectomy 
group (C) (p < 0.001). Administration of dobutamine significantly prevented the overall 
decrease in microvascular blood flow the first postoperative day.
Conclusion
Postoperative sublingual MBF is markedly impaired in esophagectomy patients 
compared to patients who underwent a pancreaticoduodenectomy and could be 
prevented by early administration of a small dose dobutamine.
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Introduction
Esophagectomy with gastric tube reconstruction remains the most successful therapy 
for esophageal cancer, but is still associated with high morbidity rates. Typical surgical 
complications are leakage and stenosis of the cervical anastomosis, which have been 
attributed to decreased gastric tissue blood flow.1,2 Recently, we have demonstrated 
that decreased gastric tube tissue blood flow could be improved with topical 
administration of nitroglycerin, but not with a low dose of intravenous nitroglycerine.3,4 
Recently, Jhanji and coworkers have shown that preoperative impairments in 
sublingual microvascular blood flow (MBF) in patients who underwent major abdominal 
surgery, were associated with the occurrence of postoperative complications 
independent from global hemodynamic parameters.5 Similar changes in sublingual 
MBF (i.e. obstructed, stagnant blood flow in the smallest capillaries with near to 
normal flow in the larger microvessels) have been observed in septic patients, and 
were also associated with poor outcome.6,7 Administration of dobutamine in these 
septic patients was able to improve sublingual MBF independent of outcome, and 
again independent from systemic hemodynamic parameters.8
Based on these considerations we hypothesized that similar sublingual MBF 
derangements are more likely to be found in patients undergoing high risk surgery 
such as esophagectomy, and if present, might be prevented with administration of 
low dose dobutamine. 
Material and methods
After receiving approval of the local institutional human review board, and after 
obtaining written informed consent from every patient, this study was conducted. The 
study was officially registered as a clinical trial (NTR2279, 10-apr-2010–22-apr-2010).
This was a single-centre, prospective, double-blinded study, conducted in the adult 
intensive care unit (ICU) at Erasmus Medical Centre, Rotterdam. Between March and 
June 2010, patients who underwent esophagectomy with gastric tube reconstruction 
were included. All patients were postoperatively admitted to the mixed ICU and were 
in physical status I and II, according to the American Society of Anesthesiologists 
classification.9 Previous cardiac events, diabetes mellitus and drug abuse were 
contraindications for enrollment.
Furthermore, one subset of patients was included as control group for comparison 
with the study group on the days pre- and postoperatively (group C). These patients 
underwent a pancreaticoduodenectomy, according to the Whipple procedure and 
were postoperatively admitted to the post anesthetic care unit.
Protocol
After the initial surgical procedure with the gastric tube reconstruction, patients were 
directly admitted to the ICU. By protocol, patients were randomly assigned, in a 1 : 1 
ratio, to receive either a low dose of dobutamine directly after admission at the ICU 
(2.5 μg/kg/min) (group D) or a placebo (2.5 μg/kg/min of isotonic saline; Group P) 
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according to a computer-generated random list. To ensure masking of treatment 
allocation during the SDF measurements, patients randomly assigned to the placebo 
group were given a similar volume of saline. To make sure that the investigator was 
not aware of the randomization of each patient, both study infusions were prepared 
as identical syringes by a research nurse who was not involved in the measurements. 
A subset of patients undergoing pancreaticoduodenectomy surgery was included as 
control group (C). Age, gender, ICU-days, complications and systemic hemodynamic 
data during ICU stay were documented.
Anesthesia and surgery
In all patients, general anesthesia was standardized and consisted of a combination 
of propofol, sufentanil and rocuroniumbromide for induction and isoflurane for 
maintenance of anesthesia. Before induction of general anesthesia, a thoracic epidural 
catheter was placed to provide peroperative and postoperative analgesia. Epidural 
blockade started with a bolus of ropivacaine before the operation, followed by 
continuous administration of a mixture of ropivacaine and fentanyl after 90 minutes. 
Standard hemodynamic monitoring consisted of continuous arterial blood pressure 
and right atrial pressure. The attending physicians administered intravenous fluids and 
vasoactive medication in order to maintain blood pressure, right atrial pressure, heart 
rate and urine output within the normal range. If necessary, measures were taken to 
ensure adequate oxygenation, body temperature and hemoglobin levels. Following 
surgery, all patients were transferred to the ICU or to the post anesthetic care unit.
Esophagectomy was performed either through a transthoracic or a transhiatal 
approach. Although these methods differ, the construction of the gastric tube was 
similar and performed by the same surgical team according to the classical method.10,11 
Another surgical team was responsible for all pancreaticoduodenectomy surgeries, 
which was carried out according to the standard method described by Whipple.12 
Microvascular measurements
Sublingual MBF was performed at four time points, the day before surgery (BL), 
directly postoperative (T0), and on the first and second day after surgery (T1 and T2 
respectively), using the SDF imager. The SDF technique, as described in detail by 
Goedhart et al.13 is a technique that allows observation of the human microcirculation 
at the bedside. In short, after removal of saliva and other secretions with a sponge, 
the device was applied without pressure on the lateral side of the tongue. If a good 
image (adequate focus and contrast adjustment) was seen on the screen, sequences 
of 20 seconds from five adjacent areas were recorded. Due to heterogeneity of flow of 
microvascular alterations, images were made for a total of 5 different sublingual areas. 
Hereafter, images were randomly assigned for the evaluating investigator; analysis was 
performed using the semiquantative method described in international guidelines.14 
All microvascular scores were calculated for two different vessel cohorts, divided 
as medium and large (> 20 µm, mainly venules) and small vessels (≤ 20 µm, mainly 
capillaries). Microvascular flow index (MFI) was calculated after dividing each image 
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into four equal quadrants. Quantification of flow was determined using an ordinal scale 
(0, no flow; 1, intermittent flow; 2, sluggish flow; 3, normal flow). MFI is the average 
score of all quadrants for a given time point. The vascular density (VD; defined as 
the number of vessels containing red blood cells independent of flow) was calculated 
as the number of vessels crossing the lines divided by the total grid length (mm). 
Vessel perfusion (PPV; defined as the proportion of perfused vessels) was calculated 
as the number of vessels continuously perfused during this period, divided by the 
total number of vessels of the same type. This score is based on the determination of 
the predominant type flow in 4 quadrants. Finally, perfused vessel density (PVD) was 
calculated by measuring total length of perfused vessels divided by the image area.
SDF-imaging was performed according to the described guidelines.14 This analysis score 
has been validated previously with an inter- and intra-observer variability of around 5%.15,16 
Analysis was performed using the MAS analysis system (MicroVision Medical; Amsterdam, 
The Netherlands 2007, v3.0). SDF-images were randomized for all groups by computer-
generated random sequence, so analysis was blind for the evaluating investigator.
Statistical analysis
Data are shown as mean ± SD. For evaluating changes over time between groups, two way 
repeated measures analysis of variance (ANOVA) was used. Post hoc two sided Student’s 
t tests were performed at the different time points using the Bonferroni correction for 
multiple testing. Analysis was performed using GraphPad Prism version 3.0 (GraphPad 
Software, San Diego, USA). P values < 0.05 were considered statistically significant. 
Results
Baseline characteristics and physiological variables between the study groups 
were comparable (Tables 1 and 2). All postoperative esophagectomy patients were 
mechanically ventilated directly after surgery, normally followed by extubation at 
the first postoperative day by protocol. All control patientswere extubated prior to 
admission to the post anesthetic care unit. Mean arterial blood pressure, heart rate 
table 1. Patient characteristics 
D (n = 10) P (n = 10) C (n = 10)
Male/female (n) 8/2 8/2 7/3
Age (years) 66 ± 6 62 ± 9 67 ± 11
Bodyweight (kg) 81 ± 10 82 ± 21 74 ± 29
Length (cm) 176 ± 10 176 ± 8 167 ± 10
Fluid balance during operation or ICU stay or both (L) 3.2 ± 2.0 3.8 ± 1.3 3.1 ± 2.4
Operation time (min) 409 ± 88 416 ± 63 365 ± 85
D, esophagectomy patients with dobutamine; P, esophagectomy patients with placebo; C, 
pancreaticoduodenectomy/control patients.
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table 2. Physiological variables
Parameter Group
time point
t0 t1 t2
MAP (mmHg) D 80 ± 10 84  ± 19 82  ± 15
P 75  ± 11 88  ± 17 94  ± 18
C 72  ±  7 79  ± 16 80  ± 10
HR (beats/min) D 85  ± 13 76  ± 10 78  ± 12
P 82  ± 12 86  ± 13 90  ± 12
C 80  ± 24 81  ± 15 82  ± 9
SaO2 (%) D 99 ± 1 97 ± 2 97 ± 2
P 99 ± 1 98 ± 2 96 ± 4
C 99 ± 1 96 ± 4 99 ± 0
PaO2 (kPa) D 19 ± 4 12 ± 5 10 ± 3
P 17 ± 4 11 ± 4 11 ± 2
C 19 ± 5 12 ± 4 18 ± 2
Hb (mmol/L) D 6.8 ± 0.8 6.8 ± 0.9 6.2 ± 0.8
P 7.3 ± 0.9 7.3 ± 0.8 6.6 ± 1.1
C 6.9 ± 1.2 7.1 ± 1.1 6.8 ± 1.0
Lactate (mEq/L) D 1.5 ± 0.8 1.1 ± 0.2 0.9 ± 0.3
P 1.5 ± 0.6 1.1 ± 0.3 1.0 ± 0.3 
C 1.4 ± 1.0 1.0 ± 0.3 1.0 ± 0.3
Norepinephrine (no. pts ) D 5 5 1 
P 5 5 1 
C 0 0 0 
D, esophagectomy patients with dobutamine; P, esophagectomy patients with placebo; C, 
pancreaticoduodenectomy/control patients.
and blood lactate concentrations were similar and did not change significantly in 
either group during the postoperative stay.
At the first postoperative day, patients in the placebo group (P) showed a 
significant decrease in microvascular flowindex, perfused vessel density and 
proportion of perfused vessels compared to baseline (p < 0.001). These parameters 
where significantly lower compared to the dobutamine (D) (p < 0.001) and to the 
control group (C) (p < 0.001) (Table 3). Despite these derangements in microvascular 
parameters at the first postoperative day, at the second postoperative day most of the 
parameters recovered. Perfused vessel density was the only parameter which was not 
yet recovered at the second postoperative day.
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table 3. Effects on microcirculatory perfusion (n = 30)
 Sublingual small vessels (<20 µm)
Parameter Group
time point
Baseline (t-1) t0 t1 t2
VD (n/mm²) D 11.74 ± 1.43 11.17 ± 0.72 11.56 ± 0.43 11.10 ± 0.88
P 11.51 ± 0.47 10.73 ± 1.45 10.77 ± 1.20 10.71 ± 1.44 C
C 12.25 ± 2.55 11.45 ± 1.57 11.62 ± 1.84 12.10 ± 1.03
PPV % D 100 ± 0 99 ± 1 99 ± 1 100 ± 0
P 100 ± 0 97 ± 1 68 ± 8 A, D,E 98 ± 2
C 100 ± 0 97 ± 2 99 ± 1 100 ± 0
PVD (n/mm²) D 11.74 ± 1.43 11.13 ± 0.72 11.83 ± 0.47 11.37 ± 0.86
P 11.51 ± 0.47 10.45 ± 1.33 7.42 ± 1.50 A,D,E 8.84 ± 1.56 A,D,E
C 12.06 ± 2.02 11.07 ± 1.37 11.49 ± 1.85 12.68 ± 0.97
MFI D 2,94 ± 0,09 2,91 ± 0,12 2,80 ± 0,20 2,90 ± 0,12
P 2,97 ±0,04 2,89 ±0,12 1,52 ±0,56 A,D,E 2,74 ±0,15
C 2,97 ±0,06 2,91 ± 0,09 2,88 ± 0,16 2,96 ± 0,07
D, esophagectomy patients with dobutamine; P, esophagectomy patients with placebo; C, 
pancreaticoduodenectomy/control patients; VD, vascular density; PPV, proportion perfused 
vessels; PVD, perfused vessel density; MFI, microvascular flow index.
A: P<0.05 vs. baseline, B: P<0.05 vs. C, C: P<0.05 vs. D, D: P<0.001 vs. D, E: P<0.001 vs. C.
Administration of dobutamine significantly prevented the overall decrease 
in microvascular blood flow the first postoperative day. Compared to the placebo 
group the dobutamine group had a higher proportion of perfused vessels (p < 0.001) 
(Fig. 1A), perfused vessel density (p < 0.001) (Fig. 1B) and microvascular flow index (p 
< 0.001) (Fig. 1C) at the first postoperative day. 
All venules (vessels > 20 μm) showed no change in perfusion nor density, 
independent of the time point, and were not affected by dobutamine administration. 
Parameters of sublingual MBF were not related to systemic hemodynamic parameters, 
at baseline or after dobutamine administration (data not shown).
Discussion
The principle finding of the present study is that in esophagectomy patients 
sublingual MBF was markedly impaired compared to patients who underwent 
a pancreaticoduodenectomy. In addition, early administration of a low dose 
of dobutamine could prevent this overall microvascular impairment in patients 
undergoing esophagectomy with gastric tube reconstruction.
Our findings are consistent with the results of a previous study that observed 
impairment of microvascular blood flow during gastrointestinal surgery and that this 
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Figure 1. A: Proportion of perfused vessels (PPV) is expressed as percentage and is calculated 
as the number of vessels continuously perfused divided by the total number of vessels of the 
same type. B: Perfused vessel density (PVD) is expressed as the number of vessels per square 
millimeter and is calculated as; VD*PPV. C: Bar plot of microvascular flow index (MFI) of small 
vessels (<20 µm) at BL, directly postoperative (T0) until 2 days postoperatively (T1, T2). Group C, 
pancreaduodenectomy group; Group P, placebo group; Group D, dobutamine group. All Values 
are expressed as mean ± SD, *p <0.001
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was associated with an increased incidence of postoperative complications. In patients 
undergoing colorectal cancer surgery, intraoperative MBF reduction at the rectal stump 
was associated with an increased risk of anastomotic leak.17 In patients undergoing thoracic 
esophagectomy, decreased tissue blood flow of the gastric tube during the intraoperative 
period was associated with more postoperative anastomotic insufficiency.18
It has been suggested that adequate perioperative global oxygen delivery might 
play an important role in anastomotic healing. Although this has yet to be demonstrated, 
it is well established that high-risk surgical patients,19 especially esophagectomy 
patients,20,21 who fail to mount an postoperative adequate global oxygen delivery 
will more frequently develop postoperative complications. Additionally, a number of 
investigators have described abnormalities in gastro-intestinal mucosal blood flow in 
patients who developed postoperative complications, associated with an increased 
incidence of anastomotic leakage following esophagectomy.18 
Recently, Sakr et al.6 demonstrated that microcirculatory alterations were present in 
patients with septic shock, which is also a profound pro-inflammatory state, and that 
persistence of these alterations was associated with organ dysfunction and death. It has 
been shown that the stress-response after esophagectomy with gastric tube reconstruction 
is also profound.22 Although it can be assumed that in our postoperative patients the 
stress response was less severe than in septic shock patients, there could be a role for a 
low dose of dobutamine in order to prevent the impairment of sublingual MBF.
A recent report about the effects of dobutamine in septic shock on microcirculatory 
alterations, independent of systemic hemodynamic changes, seems to be in accordance 
with our presented data.8 On the first postoperative day, sublingual MBF was recruited 
by a small dose of dobutamine independent of systemic hemodynamic values. Whether 
this is a true effect due to recruitment itself, or a net result of a complex of therapeutic 
interventions, remains to be established. Our observation provides however additional 
confirmation on the beneficial effects of dobutamine on microvascular perfusion, not 
only in sepsis but also following high-risk surgery with a severe inflammatory response. 
Although we did not determined cardiac output, several studies have already shown 
that microvascular alterations are present during sepsis, regardless of cardiac output6,23 
and other systemic hemodynamic variables.24 In surgical patients the occurrence of 
decreased sublingual MBF and its relation to complications were also shown to be 
independent of blood pressure and cardiac output.5,25
Conclusion
Dobutamine was able to prevent the microvascular disturbances observed in the 
first two days postoperatively after esophagectomy surgery. These disturbances 
were not seen after other large abdominal surgery, i.e. pancreatecoduodenectomy. 
Further research is warranted to establish the clinical effects of these microvascular 
derangements after high risk surgery and whether preventing this with dobutamine 
could decrease complication rate and improve clinical outcome.
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Abstract
Objective
To study regional perfusion during experimental endotoxemic and obstructive shock 
and compare the effect of initial cardiac output-targeted fluid resuscitation with 
optimal cardiac output-targeted resuscitation on different peripheral tissues.
Design
Controlled experimental study.
Setting
University-affiliated research laboratory.
Subjects
Fourteen fasted anesthetized mechanically ventilated domestic pigs.
Interventions
Domestic pigs were randomly assigned to the endotoxemic (n = 7) or obstructive 
shock (n = 7) model. Central and regional perfusion parameters were obtained at 
baseline, during greater than or equal to 50% reduction of cardiac output (T1), after 
initial resuscitation to baseline (T2), and after optimization of cardiac output (T3).
Measurements and Main Results
Regional perfusion was assessed in the sublingual, intestinal, and muscle vascular 
beds at the different time points and included visualization of the microcirculation, 
measurement of tissue oxygenation, and indirect assessments of peripheral skin 
perfusion. Hypodynamic shock (T1) simultaneously decreased all regional perfusion 
variables in both models. In the obstructive model, these variables returned to 
baseline levels at T2 and remained in this range after T3, similar to cardiac output. In 
the endotoxemic model, however, the different regional perfusion variables were only 
normalized at T3 associated with the hyperdynamic state at this point. The magnitude 
of changes over time between the different vascular beds was similar in both models, 
but the endotoxemic model displayed greater heterogeneity between tissues.
Conclusions
This study demonstrates that the relationship between the systemic and regional 
perfusion is dependent on the underlying cause of circulatory shock. Further research 
will have to demonstrate whether different microvascular perfusion variables can be 
used as additional resuscitation endpoints.
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Introduction
Systemic hemodynamic variables, such as blood pressure, heart rate, and cardiac 
output, are routinely used as indicators of shock severity and target for intervention. 
Accordingly, it is well known that inadequate systemic circulation in hypodynamic 
and hyperdynamic shock states may also be accompanied by impaired tissue 
perfusion.1 Especially in septic shock, impaired vasomotor tone and the disturbed 
regulation of regional tissue perfusion lead to microcirculatory dysfunction and a 
regional mismatch of tissue oxygenation.2;3 Even when systemic hemodynamics 
are normalized, microcirculatory alterations can be present and may impair tissue 
perfusion and oxygenation.4 Monitoring of regional tissue perfusion is therefore of 
prime importance to assess the adequacy of resuscitation. The development of new 
techniques that directly visualize the microcirculation,5 measure tissue oxygenation 
(Sto2),
6 or determine peripheral perfusion7 has improved the evaluation of the effect 
of various hemodynamic interventions in different peripheral tissues. The current 
Surviving Sepsis Campaign guidelines recommend early structured resuscitation 
that targets systemic hemodynamic variables, which underscores the importance of 
the early identification and resuscitation of tissue perfusion alterations.8 Although 
early fluid resuscitation protocols have been demonstrated to improve outcomes in 
patients with severe sepsis,9-11 still little is known about the use of regional tissue 
perfusion variables as a direct target for resuscitation. This is remarkable because 
microcirculatory abnormalities are more prevalent in nonsurvivors after circulatory 
shock due to cardiac arrest,12 following cardiogenic shock,13 and after septic shock.14 
Because these abnormalities recover over time only in survivors,15 the question rises 
if early optimization of circulatory conditions (i.e., cardiac output) could exert a 
beneficial effect on microvascular perfusion. This is supported by the positive effects 
of early goal-directed therapy on outcome in acute sepsis patients16 However, it is 
as yet unknown whether microvascular perfusion abnormalities in the early phase 
of circulatory shock are caused by relatively insufficient systemic hemodynamic 
resuscitation or by local microvascular pathology. For this purpose, we examined 
the effect of cardiac output resuscitation on different microvascular perfusion 
and peripheral perfusion variables during different endotoxemic and obstructive 
shock states. We hypothesized that only in endotoxemic shock, microvascular and 
peripheral perfusion abnormalities would persist after the resuscitation of systemic 
hemodynamics to preshock levels and that these abnormalities would be remedied 
with additional resuscitation of cardiac output in a different magnitude for the 
different peripheral tissues and the different regional perfusion variables.
Material and methods
The local animal experimental committee approved these studies in accordance 
with the National Guidelines for Animal Care and Handling. Fourteen female pigs 
(Yorkshire, Landrace of Durok) with a mean body weight ± SD of 30.2 ± 2.1 kg were 
included in our study.
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Animal preparation
Animals were fasted overnight with free access to water and premedicated with 
intramuscular ketamine (30 mg/kg) and midazolam (1 mg/kg). IV access was obtained 
by cannulation of an ear vein. Anesthesia was maintained with a combination of IV 
midazolam (0.2 mg/kg bolus followed by 0.3 mg/kg/hr) and propofol (2 mg/kg/hr). 
Analgesia was provided with continuous administration of fentanyl (20 μg/kg/hr) and 
supplemented with bolus doses (20–50 μg) when needed. Muscle relaxation was 
obtained with pancuronium bromide (0.1 mg/ kg bolus followed by 0.2 mg/kg/hr).
Through a midline cervical tracheostomy, an endotracheal tube (9.0F) was placed in 
the trachea. Ventilation was performed in a volume-controlled mode (Servo 300; Siemens-
Elema, Solna, Sweden) with a minimal oxygen-in-air fraction of 0.40, frequency adjusted 
to achieve normocapnia, and a positive end-expiratory pressure of 5 cm H2O to prevent 
atelectasis. Core temperature was monitored by the thermistor at the tip of the pulmonary 
artery catheter and was maintained at approximately 37°C with a heating pad or external 
cooling if necessary. Normoglycemia (arterial blood glucose level 4.5–7 mmol/L) was 
maintained throughout the whole experiment using 20% glucose infusion as needed. 
Catheters were placed in the right carotid artery to measure arterial blood pressure 
and collect arterial blood samples and in the right jugular vein to administer fluid. A 
pulmonary artery thermodilution catheter (Edwards Lifesciences, Irvine, CA) was 
positioned in the pulmonary artery. With the pig in supine position, a urinary catheter was 
placed into the bladder for drainage of urine. In the animals randomized to the obstructive 
shock group, the pericardial sac was accessed through the midline incision, after removal 
of the xiphoid. After making a small opening in the pericardium, a purse-string suture 
was placed with polydioxanone 4.0 and a 8.0F tube. Urinary catheter was inserted in 
the pericardium. The purse-string suture was knotted watertight, fixing the catheter to 
the pericardium. When all surgical procedures were completed, the abdominal wall was 
closed and the animal was covered in blankets to minimize heat loss.
Different regional perfusion measurements 
Regional perfusion was assessed using different microvascular perfusion and 
peripheral perfusion variables. Accordingly we evaluated microvascular perfusion in 
the sublingual, intestinal, and muscle vascular beds using a sidestream dark field (SDF) 
imager (Microscan; Microvision Medical, Amsterdam, the Netherlands) as described 
previously. The SDF imager contains a × 5 stroboscopic light-emitting diode whose light 
is absorbed by hemoglobin of the RBCs, making the capillaries of the microcirculation 
visible in different tissues. To obtain access to the intestinal tissue, a loop of the ileum 
was exteriorized through a 5-cm lateral abdominal incision, and a small ileum segment 
was opened along its antimesenteric border using electrocautery. With the mucosal 
surface facing upward, the edges of the opened intestinal segment were fixed at the 
skin, creating a double-lumen ileostomy. In the proximal part of this ileostomy, the 
microcirculation was visualized with the SDF imager at 5–7 cm from the margin of 
the loop. In between measurements, the ileostomy was protected with moisturized 
wet gauze to prevent desiccation. To obtain a view on muscle microcirculation, a 
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skin incision was made in the lateral side of the upper hind leg, and the tip of the 
SDF imager was cautiously positioned on the exposed muscle tissue. Muscle tissue 
was protected with moisturized wet gauze to prevent desiccation. The sublingual 
microcirculation was assessed by placing the tip of the SDF imager gently on the 
sublingual mucosa, avoiding the midline region and the salivary glands. 
An investigator, blinded to the study model and the order of sequences, analyzed 
the video images semiquantitatively.17 Vascular flow (i.e., microcirculatory flow index, 
MFI) and density (i.e., perfused capillary density, PCD and; proportion of perfused 
vessels, PPV) were calculated by the following flow classification: no flow, sluggish, 
intermittent, or continuous using dedicated software (Automated Vascular Analysis, 
AVA 3.0, Microvision Medical, Amsterdam, the Netherlands).18 This approach has been 
validated previously with low interobserver and intraobserver variability. Capillaries 
were defined as microvessels with a diameter less than or equal to 20 μm.
Using near-infrared spectroscopy (NIRS), Sto2 was continuously monitored using an 
InSpectra Tissue Spectrometer Model 650 (Hutchinson Technology, Hutchinson, MN) 
in the different peripheral vascular beds. Sublingual and intestinal Sto2 were assessed 
with a 15-mm probe. Simultaneously, sublingual Sto2 was determined by placing the 
NIRS probe under the base of the tongue and the intestinal Sto2 by inserting the 
probe into the distal part of the ileostomy, which was closed and reinserted into the 
abdominal cavity afterward. Muscle Sto2 was assessed with a multidepth NIRS probe 
attached over the biceps femoris muscle eminence.
Peripheral perfusion was assessed using the proximal-to-distal leg (peripheral Tskin-
diff) and central-to-distal leg (central Tskin-diff) skin temperature gradients, which were 
obtained from two skin probes that were attached to the proximal and distal leg as 
estimates of peripheral skin perfusion. Central temperature was observed by inserting 
the tip of the thermistor into the rectum. Temperature gradients can better reflect 
changes in cutaneous blood flow than the absolute skin temperature itself, and they 
increase during vasoconstriction.19
Hemodynamic measurements
Heart rate, mean arterial pressure (MAP), central venous pressure (CVP), pulmonary artery 
occlusion pressure, mean pulmonary artery pressure, and cardiac output were measured. 
Cardiac output was continuously monitored using a thermodilution method (Vigilance; 
Edwards Lifesciences), indexed to body surface area, and presented as a cardiac index.20 
Mixed venous hemoglobin oxygen saturation (SvO2) from the pulmonary catheter and 
arterial blood gases were measured using a blood gas analyzer (ABL 825FLEX, Radiometer, 
Copenhagen, Denmark). Systemic oxygen delivery, systemic oxygen consumption, and 
the oxygen extraction ratio were calculated using standard equations.21
Experimental procedure
The pigs were randomly assigned to the endotoxemic or obstructive shock model 
after baseline measurements were obtained (Fig. 1). Shock initiation (T1) was defined 
as a decrease in cardiac output of approximately 50% compared with baseline in both 
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models. Endotoxemic shock was  induced by an IV infusion of a bolus of 5 μg/kg 
lipopolysaccharide (LPS—Escherichia coli O127:B8, L-3880; Sigma, St. Louis, MO) 
in 1 minute, followed by a continuous infusion of 2 μg/kg/hr during the rest of the 
experiment. Obstructive shock was induced by infusing 0.9% saline solution of 37°C 
(via knotted catheter in the pericardium) into the pericardial space.22 
Initial resuscitation (T2) was performed by the withdrawal of pericardial fluid 
content and additional fluid administration in the obstructive model, if necessary, and 
with continuous fluid administration to achieve baseline cardiac output values in the 
endotoxemic model. Finally, in both models, optimal fluid resuscitation was continued 
with repeated fluid challenges until cardiac output increased no more than 10% 
(T3). Fluid resuscitation was performed with an infusion of colloidal fluids (Voluven, 
Fresenius-Kabi, Belgium). All systemic hemodynamic variables, metabolic state, and 
peripheral microcirculatory perfusion variables were collected after a stable 60-minute 
period once each physiological endpoint was reached in both models.
Remove tamponade + Fluid resuscitation  to BL CO
Cardiac tamponade (= 50% ↓ BL CO) 
Fluid resuscitation  to BL CO
LPS 2 µg/kg/hr (= 50% ↓ of BL CO)
Optimal CO resuscitation
T2
T1
Randomization (n=14)
Sepsis ModelObstructive Model 
T3
Baseline
Repeated fluid challenges
until  ≤ 10% CO increase
Figure 1. Overview of model classification and hemodynamic support. Obstructive shock is 
induced with cardiac tamponade, and endotoxemic shock is induced with lipopolysaccharide 
(LPS). BL = baseline, CO = cardiac output, T1 = 60 minutes after shock state, T2 = 60 minutes 
after successful resuscitation back to BL, T3 = 60 minutes after CO was optimized.
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Statistical analysis
Data are presented as mean ± SD unless otherwise specified. After logarithmic 
conversion of not normally distributed data (Kolmogorov-Smirnov test p > 0.05) to 
normalize distributions where appropriate, data were suitable for mixed-model analysis. 
Accordingly, we used a linear mixed-model analysis to assess differences in the different 
systemic hemodynamic variables and between the different microvascular perfusion and 
peripheral perfusion variables, over time (BL, T1, T2, and T3), and between models 
(endotoxemic shock vs obstructive shock). Changes from baseline were computed 
dividing the variable value at specific time points into the baseline value and expressed as 
percentile changes (% of baseline × 100). We then compared the magnitude of changes 
between models (endotoxemic shock vs obstructive shock) for cardiac output and the 
different microvascular perfusion variables (i.e., MFI, PCD, and PPV) for the different 
vascular beds at specific time points to evaluate the effect of resuscitation on these 
variables. Differences between model means were compared using nonparametrical 
Mann-Whitney U test or Student t test, if normally distributed. A p value of less than 
0.05 was considered statistically significant. Note that because the distribution of the 
percentile changes often showed differences in the variances between the groups 
and considerable skewness, these results have to be interpreted cautiously. Statistical 
analysis was performed using SPSS (version 20.0; IBM, SPSS, Chicago, IL).
Results
Systemic hemodynamics
Systemic hemodynamic and oxygenation variables at each of the three equivalent time 
points in both models are presented in Table 1. The baseline characteristics were similar 
in both models, and shock initiation (T1) produced a similar decrease in cardiac output 
in both models (Fig. 2). Accordingly, MAP and Svo2 decreased at T1 (p < 0.05 vs all time 
points). This was paralleled by a marked reduction in systemic oxygen delivery and an 
increase in oxygen extraction rate. Concurrently, lactate concentrations increased almost 
five-fold, and urine output decreased significantly in both models (Tables 1 and 2).
Initial volume resuscitation (T2) normalized cardiac output, MAP, and Svo2 in both 
models. Systemic oxygen delivery and oxygen extraction rate returned to pre-shock levels. 
Following additional fluid resuscitation (T3) however, cardiac output reached significantly 
higher values in the endotoxemic model compared with the obstructive model (+65% vs 
+22% of baseline, respectively, p= 0.001) (Fig. 2). As a result, systemic oxygen delivery 
increased (p= 0.007) and the oxygen extraction rate decreased further compared with T2. 
Notably, systemic oxygen consumption, which had remained unchanged as yet, increased 
as well at this point. Lactate clearance was comparable between both models after 
initial resuscitation (obstructive shock, -18% [0.01] vs endotoxemic shock, -20% [0.14]). 
After additional resuscitation, lactate persisted to elevate in the endotoxemic model, 
whereas in the obstructive model, lactate decreased further with 50% (0.06); (p= 0.007 vs 
endotoxemic shock). Additional fluid had been administered to achieve optimal cardiac 
output, although this fluid did not produce a significantly higher cumulative fluid balance 
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Figure 2. Behavior of cardiac output during the experimental procedure. Cardiac output plotted 
as proportional changes from baseline for each time point for both models. Following T2, IV fluid 
resuscitation was maintained to maximize cardiac output, until no more than 10% increase in cardiac 
output was observed (T3). At this stage, cardiac output reached significative higher values in the 
endotoxemic shock model (dashed line) compared with the obstructive shock model (continuous 
line) (*p<0.05 vs obstructive shock by Mann-Whitney test). Initial volume resuscitation (T2) normalized 
cardiac output in both models. Following additional fluid resuscitation (T3) however, cardiac output 
reached significantly higher values in the endotoxemic model compared with the obstructive model.
compared with the obstructive model (3.110 [1.035 mL] vs 2.100 [528 mL]; p = 0.062, 
respectively). Still, CVP increased in both groups. 
Regional perfusion 
The time course of the different microvascular perfusion variables, observed with the 
SDF imager, is presented in Figure 3. At baseline, there was no statistical difference 
between the different microvascular perfusion variables and between both models. 
All these variables decreased simultaneously in a similar magnitude during shock in 
both models and increased toward baseline levels in the obstructive model at T2 and 
remained in this range after T3. However, in the endotoxemic model, microvascular 
variables increased after initial resuscitation, and they did not reach baseline values. 
These variables improved toward baseline levels only after additional resuscitation of 
cardiac output at T3. Hence, although the PCD (n/mm2) increased significantly during 
this stage compared with T2, this index was lower than the baseline values in the 
intestinal tissue (T3, 21.8 [1.22] vs baseline, 23.2 [0.64]; p= 0.040) (Fig. 3B) and for PPV 
(%) in the sublingual (T3, 98.5 [0.47] vs baseline, 99.8 [0.13]; p= 0.034) and intestinal 
tissue (T3, 93.2 [1.72] vs baseline, 99.2 [0.32]; p= 0.014) (Fig. 3C).
Changes in the peripheral Tskin-diff and central Tskin-diff are presented in Table 3. 
Similar to the different microvascular perfusion variables (i.e., MFI, PCD, and PPV), these 
different peripheral perfusion variables exhibited the same magnitude of change at T1 
in both models (Table 3). Peripheral Tskin-diff returned to baseline values after T2 and 
remained in this range after T3 in the obstructive model but not in the endotoxemic 
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model. In this model, peripheral Tskin-diff only increased toward baseline levels after 
additional fluid resuscitation of cardiac output. Central Tskin-diff followed the same 
pattern of changes as peripheral Tskin-diff during resuscitation, but these changes were 
not significant. Additionally, Sto2 followed an identical pattern of change as the other 
microvascular perfusion and peripheral perfusion variables in the obstructive shock model 
(Table 3). In the endotoxemic model however, StO2 was similarly decreased during shock 
but persisted following initial resuscitation and additional resuscitation of cardiac output.
Discussion
This experimental study demonstrated that the correction of cardiac output to normal 
levels is adequate for resuscitation of the peripheral circulation in different tissues after 
obstructive shock but not after endotoxemic shock. In the endotoxemic model, only 
table 1. Evolution of systemic hemodynamic variables over time in the endotoxemic shock 
model (n = 7) and the obstructive shock model (n = 7)
Variables Shock model Baseline t1 t2 t3
Cardiac index (L/min·m2) Endotoxemic 2.6 (0.5) 1.2 (0.3) a 2.6 (0.5) 4.4 (0.6)
Obstructive 2.3 (0.3) 0.9 (0.2) a 2.4 (0.3) 2.8 (0.5) a, b
Heart rate (beats/min) Endotoxemic 106 (29) 200 (12) a 150 (29) a 137 (23) a
Obstructive 98 (17) 215 (31) a 137 (28) a 90 (48) b
Mean arterial pressure (mm Hg) Endotoxemic 110 (16) 71 (27) a 95 (22) 118 (30)
Obstructive 112 (18) 61 (15) a 95 (17) 108 (18)
Central venous pressure (mm Hg) Endotoxemic 8 (2) 8 (4) 10 (2) a 14 (3) a
Obstructive 8 (3) 15 (6) a, b 10 (6) 13 (6) a
Pulmonary artery occlusion 
pressure (mm Hg)
Endotoxemic 9 (3) 16 (6) a 13 (8) 13 (9)
Obstructive 10 (3) 11 (7) 11 (6) 11 (8)
Mean pulmonary artery pressure  
(mm Hg)
Endotoxemic 24 (9) 39 (7) a 41 (6) a 43 (3) a
Obstructive 23 (7) 25 (5) b 23 (3) b 26 (7) b
Fluid volume (mL) Endotoxemic 688 (74) 223 (127) a 778 (112) 1425 (117) a
Obstructive 1022 (171) 190 (74) a 398 (114) a, b 492 (78) a, b
Urine output (mL) Endotoxemic 121 (51) 57 (45) a 20 (31) a 35 (23) a
Obstructive 262 (108) b 55 (19) a 90 (54) a, b 88 (74) a
T1 = during ≥ 50% reduction of cardiac output, T2 = after initial resuscitation to baseline, T3 = 
after the optimization of cardiac output.
ap < 0.05 versus baseline.
bp < 0.05 between models (endotoxemic and obstructive) in the specific time point, by linear 
mixed-model analysis.
Data are presented as mean ± SD.
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additional cardiac output-targeted fluid resuscitation could further improve microvascular 
and peripheral perfusion abnormalities. These data confirm our hypothesis and highlight 
that additional resuscitation at the microcirculatory level might be a complementary 
target if the conventional global resuscitation goals have been achieved.
Despite success associated with the implementation of early resuscitation 
during sepsis, the value of microcirculatory abnormalities as resuscitation target 
table 2. Oxygenation and metabolic variables in endotoxemic and obstructive shock
Variables Shock model Baseline t1 t2 t3
Hemoglobin 
concentration (mmol/mL)
Endotoxemic 6.8 (0.3) 8.5 (0.6) a 6.3 (0.7) 5.3 (0.9) a
Obstructive 7.2 (0.4) 8.8 (0.5) a 7.2 (1.0) 5.6 (1.2) a
Lactate (mmol/L) Endotoxemic 1.1 (0.6) 5.5 (1.6) a 4.0 (2.1) a 3.6 (1.6) a   
Obstructive 0.7 (0.1) 5.1 (1.5) a 4.2 (1.2) a 2.1 (0.8) a, b
Oxygen delivery  
(ml/min/m2)
Endotoxemic 501.5 (144.6) 331.3 (100.5) a 513.3 (125.3) 731.9 (183.6) a 
Obstructive 521.6 (48.1) 211.9 (24.7) a, b 546.9 (75.6) 505.5 (86.7) b
Oxygen consumption 
(ml/min/m2)
Endotoxemic 173.6 (77.7) 177.7 (20.2) 231.2 (128.3) 267.0 (102.2) a
Obstructive 195.4 (47.6) 180.1 (27.5) 218.4 (33.9) 183.1 (54.1)
Oxygen extraction rate 
(ml/min/m2) 
Endotoxemic 0.33 (0.15) 0.56 (0.11)a 0.44 (0.14) 0.36 (0.07)
Obstructive 0.37 (0.08) 0.85  (0.06)a, b 0.40 (0.03) 0.38 (0.09)
Arterial pH Endotoxemic 7.52 (0.05) 7.30  (0.05) a 7.32 (0.06) a 7.36  (0.02) a
Obstructive 7.50 (0.03) 7.36 (0.09)a 7.37(0.05) a 7.42 (0.05) a, b
PaO2 (mm Hg) Endotoxemic 229 (102) 103 (29)
 a 104 (32) a 121 (43) a
Obstructive 214 (41) 149 (53) 183 (20) b 184 (24) b
PaCO2 (mm Hg) Endotoxemic 34 (5) 44 (9)
 a 43 (5) a 42 (6) a
Obstructive 34 (4) 34 (9) 36 (6) 36 (6) b
Bicarbonate 
concentration (mmol/L)
Endotoxemic 27.9 (0.9) 20.7 (1.3) a 20.8 (2.0) a 22.0 (2.5) a
Obstructive 27.7 (0.7) 21.0 (2.9) a 21.8 (1.2) a 23.2 (1.1) a
Mixed venous oxygen 
saturation (%)
Endotoxemic 61 (7) 42 (12) a 53 (12) 60 (10)
Obstructive 63 (9) 14 (4) a, b 60 (3) 62 (7)
Central temperature ( °C) Endotoxemic 38.8 (0.3) 38.8 (0.3) 39.0 (0.3) 38.7 (0.5)
Obstructive 38.9 (0.4) 38.6 (0.2) 38.8 (0.3) 38.5 (0.3)
T1 = during ≥ 50% reduction of cardiac output, T2 = after initial resuscitation to baseline, T3 = 
after the optimization of cardiac output.
ap < 0.05 versus baseline.
bp < 0.05 between models (endotoxemic and obstructive) in the specific time point, by linear 
mixed-model analysis.
Data are presented as mean ± SD.
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table 3. Tissue perfusion variables in three different vascular beds.
Variables Shock model Baseline t1 t2 t3
tissue oxygen saturation
Sublingual Sto2 Endotoxemic 66 (9) 33 (16)
 a 44 (9) a 52 (9) a
Obstructive 74 (7) 29 (9) a 64 (12) b 66 (6) b
Intestinal Sto2 Endotoxemic 78 (12) 53 (14)
 a 64 (16) a 66 (15) a
Obstructive 76 (12) 37 (6) a, b 72 (13) 77 (9)
Muscle Sto2 Endotoxemic 69 (2) 37 (6)
 a 53 (4) a 56 (7) a
Obstructive 68 (6) 27 (9) a, b 61 (8) a, b 63 (9)
tskin-diff
Tskin-diff peripheral Endotoxemic 1.3 (1.63) 3.3 (1.48) a 3.3 (1.04) a 0.7 (2.42)
Obstructive 2.2 (1.71) 4.7 (2.25) a 3.7 (1.09) 3.2 (2.00)
Tskin-diff central Endotoxemic 9.2 (2.42) 11.2 (3.52) a 10.3 (3.25) 7.1 (2.78)
Obstructive 9.5 (1.43) 11.0 (1.57) a 11.6 (2.40) 9.8 (2.69)
T1 = during ≥ 50% reduction of cardiac output, T2 = after initial resuscitation to baseline, T3 = 
after the optimization of cardiac output, Tskin-diff = body temperature gradient (Materials and 
Methods section).
ap < 0.05 versus baseline.
bp < 0.05 between models (endotoxemic and obstructive) in the specific time point, by linear 
mixed-model analysis.
Data are presented as mean ± SD.
remains uncertain.23;24 Obstructive shock, unlike septic shock, maintains intact 
autoregulatory mechanisms that preserve vital organ perfusion and ensure that 
the depressed microcirculation can be adequately resuscitated with normalized 
systemic hemodynamics.25;26 However, compensatory autoregulatory mechanisms are 
severely disrupted during sepsis. This disruption, rather than systemic hemodynamic 
depression, results in impaired microvascular perfusion, characterized by endothelial 
dysfunction and heterogeneous flow patterns in otherwise homogeneously perfused 
microvascular beds.1;27;28 Preservation or loss of autoregulation explains why the 
different microvascular perfusion variables returned to normal in the obstructive model 
even when slightly resuscitated and why they could be restored only after supranormal 
resuscitation during endotoxemic shock.
Several experimental and clinical studies have demonstrated that early goal-directed 
cardiac output fluid resuscitation is associated with improved outcomes prior to high-risk 
surgery,29 directly after surgery,30 after trauma,31 and in sepsis.32 However, these studies 
did not take the microcirculation into account. This is important, because persistent 
microvascular perfusion abnormalities during sepsis are associated with increased 
organ failure and mortality independent of systemic hemodynamic variables.7;14;33 
Retrospective15 and prospective34 studies suggest that these abnormalities can be 
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Figure 3. Relative changes (plotted as proportional changes from baseline) of different microvascular 
perfusion variables visualized with the sidestream dark field imager in different vascular beds. 
This graph demonstrates the relative changes of the microvascular flow index (MFI) (A), perfused 
capillary density (PCD, n/mm2) (B), and the proportion of perfused vessels (PPV, %) (C) for the three 
vascular beds at each time point for the endotoxemic shock and obstructive model. Bars represent 
median ± interquartile range. *p value of less than 0.05 versus obstructive shock. All microvascular 
perfusion variables decreased simultaneously in a similar magnitude during shock in both models 
and only increased toward baseline levels in the obstructive model after initial resuscitation (T2) 
and remained in this range at T3. In the endotoxemic model however, microvascular perfusion 
variables only improved toward baseline levels after additional resuscitation of cardiac output. 
Dashed line = sublingual, continuous line = intestinal, dotted line = muscle.
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additionally resuscitated independent of cardiac output or blood pressure. Furthermore, 
a previous study showed that a surrogate of gut mucosal perfusion, the intramucosal-
arterial Pco2 gradient, is only corrected by supranormal increases of intestinal blood 
flow and not by its normalization.35 Our study complements these investigations by 
demonstrating that persistent microvascular perfusion abnormalities in different 
peripheral tissues during endotoxemic shock were only improved after additional 
systemic resuscitation compared with obstructive shock. 
Clearly, our data show that the early phase of sepsis is characterized by a generalized 
perfusion deficit: the impairment of the global circulation (i.e., cardiac output) has a 
major impact on microvascular perfusion. This is in agreement with observations in 
patients with acute sepsis15 and with the beneficial effect of early goal-directed therapy 
in patients.16 In the later phase of sepsis, the development of mitochondrial dysfunction 
and impaired cellular energy metabolism are most likely the predominant causes of organ 
dysfunction36;37 This is supported by our own observation that the lactate levels in the 
endotoxemic model remained elevated despite restoration of microvascular perfusion. 
This can very well explain the poor effect of “late” supranormal cardiac output therapy.38
As such, the relation between microvascular perfusion and organ dysfunction at this 
stage remains unclear. Although the landmark study by Sakr et al14 has associated the 
persistence of microvascular hypoperfusion in late-phase sepsis with poor outcome, 
the early intervention study by Boerma39 suggested that outcome was not related to 
differences in microvascular perfusion. Additionally, in an observational study in our 
own department we found no differences between survivors and non-survivors when 
comparing microvascular perfusion during the first week of admission.40
Of special interest is the comparison of the microvascular perfusion (SDF) and Sto2 
(NIRS) data. In obstructive shock, both microvascular perfusion and Sto2 were restored 
with the resuscitation of cardiac output, whereas during endotoxemic shock, a disparity 
occurred. At hyperdynamic cardiac output levels, microvascular perfusion was restored, 
but tissue hemoglobin saturation remained below baseline levels in all tissues. Because 
low Sto2 has been associated with decreased local blood flow,
4 it must be concluded 
that recovery of local microvascular perfusion was not sufficient to completely restore 
oxygen delivery during sepsis, resulting in increased local oxygen extraction. This is 
supported by the elevated lactate levels. Most likely this is due to a difference between 
SDF and NIRS in terms of catchment area: SDF provides an image of only the superficial 
microvascular bed, whereas the NIRS signal reaches a depth of 15–25 mm. It can be 
hypothesized that especially during sepsis, where increased heterogeneity of regional 
blood flow occurs, this difference in technical features becomes apparent.  
Based on our observations, it is difficult to identify the microvascular bed or 
monitoring technique that is most suitable as target during resuscitation. Especially 
in the obstructive shock model, all microvascular perfusion variables displayed a 
rather similar pattern, whereas in the endotoxemic group, patterns were a little more 
heterogeneous. As a result, no microvascular bed stood out as more sensitive to the 
changes during shock or resuscitation. This is in accordance with a previous study, 
showing that sublingual and gut microvascular perfusion were significantly related 
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during experimental sepsis.41 As such, the sublingual microvascular bed might be the 
most useful for monitoring under clinical conditions.
On the other hand, from a practical point of view, the lack of bedside, real-time 
information, and the dependency on experienced observer analysis do not favor the 
use of SDF imaging. Because changes in peripheral skin temperature difference and 
SDF were comparable in our study, it is easily hypothesized that real-time assessment 
of peripheral skin perfusion at the bedside could very well be a more valuable monitor 
of the effect of resuscitation in the clinical setting. If so, the underlying cause of shock 
might have to be taken into account: a correlation between microvascular perfusion and 
skin perfusion was observed in cardiogenic shock10 but not in septic shock patients.42
Although we found no significant difference in the cumulative fluid balance 
between the models after optimal resuscitation, the administered volume of fluids 
was almost 50% higher in the endotoxemic model compared with the obstructive 
model. This can be explained by the underlying pathophysiological mechanism of 
endotoxemic shock, that is, the decreased vasomotor tone and endothelial leakage, 
contributing to a hyperdynamic circulation. The beneficial effect of fluid resuscitation 
on the microvascular perfusion was recently demonstrated in patients with sepsis.43;44 
In addition, because excessive fluid administration may be harmful and can potentially 
cause pulmonary fluid overloading, we administered repeated fluid challenges based 
on cardiac fluid responsiveness so that fluid overloading was most likely avoided. 
Following the restoration of cardiac output to baseline levels in the endotoxemic 
animals, microcirculatory perfusion did not completely restore to baseline levels. The 
sharp increase in cardiac output from T2 to T3 (almost 70%), reaching the state of 
fluid unresponsiveness, is probably related to the normalization of the microcirculatory 
variables. The multiple insult of the endotoxemic/septic shock not only induces ischemia/ 
reperfusion injury like in the obstructive shocked animals but also induces tissue and 
endothelial injury, which might result in much higher global blood flow levels when 
the microcirculation is restored. So, the increased cardiac output could therefore very 
well present the severity of the damage and is not at much directly the consequence of 
fluid resuscitation. A causal relationship between the increase in cardiac output and the 
normalization of the microcirculation can however not be made from these experiments.
This study has some limitations that should be acknowledged. First, the 
endotoxemic shock and resuscitation model consisted of a continuous but relatively 
short-term endotoxin infusion. A more clinically oriented model of sepsis might 
have more adequately represented the inflammatory and metabolic derangements 
that occur during septic shock.45;46 However, profound hyperlactatemia (as a sign of 
anaerobic tissue metabolism or catecholamine-stimulated aerobic glycolysis) was 
present during shock in both models, and the lactate clearance was clearly altered 
in the endotoxemic model compared with the obstructive model. Therefore, we 
concluded that our models had sufficient analogy with clinical conditions.
Second, because we did not perform a time control, an adaptive effect of the 
animals to LPS infusion cannot be ruled out. However, we do not think this is an 
explanation for our observations. The severity of the shock state was not likely to 
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resolve spontaneously within the time frame of the experiment. Especially because 
we continued the LPS infusion, to mimic clinical conditions and prevent spontaneous 
recovery of a short lasting insult, we believe the increase in regional perfusion can be 
attributed to the increase in cardiac output. Nevertheless, the time frame of our model 
might have been too short for the development of profound tissue edema, which is 
a very common problem in patients and as such might hamper the translation of our 
results to clinical practice.   
Third, SDF imaging is a valuable technique, but it is based on semi-quantitative 
analyses. Therefore, data reliability may be affected by technical expertise and 
interobserver bias despite the use of standardized analysis software. Finally, we 
recognize that the sample size was limited for a multivariate analysis between the 
two groups. However, the sample size was adequate to address the specific aims of 
this study. Definitive determinations of the relationship between microcirculatory and 
systemic variables in sepsis require a more robust sample of longitudinal data.
Conclusions
Resuscitation of cardiac output to preshock levels produced a full recovery of the 
peripheral circulation in obstructive but not in endotoxemic shock. Apparently, the 
relationship between the systemic circulation and different microvascular and different 
peripheral perfusion variables is dependent on the underlying cause of circulatory 
shock. Our data show that different microvascular and peripheral perfusion variables 
can be used to assess the adequacy of hemodynamic resuscitation during different 
types of shock. Supranormal optimization of cardiac output is needed to restore 
these different variables in sepsis but might still not lead to full recovery of tissue 
oxygenation. Further research is required to assess the reproducibility of our findings in 
a clinical setting and further elucidate the relationship between systemic and different 
peripheral circulation and oxygenation variables as targets for systemic therapeutic 
interventions during the early phase of septic shock.
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to the Editor
Septic shock remains the most frequent cause of death in patients admitted to the 
intensive care unit (ICU).1 Careful titration of therapy is essential: undertreatment results 
in persistence of impaired tissue oxygenation, whereas overtreatment leads to a positive 
fluid balance which can result in pulmonary edema, prolonged mechanical ventilation 
and finally death.2-6 Although peripheral perfusion alterations are stronger predictors 
of outcome than systemic hemodynamic variables in septic shock patients, end points 
to guide volume resuscitation are still based on systemic parameters and little is known 
about resuscitation guided by endpoints of peripheral tissue perfusion.7-9 We therefore 
undertook a proof-of-concept randomized controlled study comparing early goal 
directed fluid resuscitation based on clinical assessment of peripheral perfusion with 
standard fluid therapy to investigate whether peripheral perfusion guided resuscitation 
is feasible and would lead to less fluid administration in septic shock patients. Some of 
the results of these studies have been previously reported in the form of an abstract.10
Materials and Methods
This trial was approved by the institutional review board and was registered at 
clinicaltrials.gov (NCT01397474). Deferred proxy consent was obtained from a relative 
authorized to consent on behalf of each patient.
In brief, we performed a prospective randomized controlled pilot study in 
septic shock patients admitted to the ICU, more details are listed in the electronic 
supplement. Directly after ICU admission patients were randomized into the control 
group or the intervention group (Peripheral Perfusion Targeted Fluid Management 
– PPTFM group) to determine the resuscitation strategy during the first 6 hours. 
In the PPTFM group, fluid management was based on peripheral tissue perfusion 
parameters: the capillary refill time (CRT), the peripheral perfusion index (PPI), 
the forearm-to-fingertip (Tskin-diff) body temperature gradient and thenar tissue 
oxygenation (StO2).
11 Only patients with “poor peripheral perfusion” (i.e. 3 out of 
4 parameters altered) were considered suitable for fluid repletion (Figure 1). In 
the control group, hemodynamic goals were based on the 2012 Surviving Sepsis 
guidelines12. We assessed protocol adherence at 2, 4, and 6 hours after study entry. 
Thereafter, data was collected daily until 72 hours after study entry (observation 
period). More details are provided in the electronic data supplement
We used linear mixed-model analyses to calculate differences between groups in 
systemic hemodynamics, peripheral perfusion parameters, laboratory variables, and 
fluid therapy over time (see electronic supplement).
Results
30 patients were included, of which 15 were allocated to each group. Baseline 
characteristics of all patients are shown in Table E1 . Both groups were well matched 
and there were no statistical differences between groups at baseline. During the 
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Figure 1. Study algorithm for the first 6 hours of ICU admission (control vs PPTFM group). 
In the control group fluid resuscitation was based on systemic hemodynamic parameters. In 
the intervention group, treatment was based on peripheral perfusion parameters: if 3 out of 
4 parameters were considered impaired a fluid challenge (250 ml colloids in 15 mins) was 
administered, aiming at an increase in peripheral perfusion. If peripheral perfusion parameters 
did not improve following 2 consecutive challenges, fluid administration was stopped.” PPTFM, 
Peripheral Perfusion Targeted Fluid Management;  CI, Cardiac Index; MAP, Mean arterial pressure; 
CVP, central venous pressure; UO, urine output; SaO2, arterial oxygenation; SV, stroke volume; 
HR, heart rate; CRT, capillary refill time; PPI, peripheral perfusion index; Tskin-diff, forearm-to-
fingertip skin temperature gradient; StO2, tissue oxygenation saturation.
study period we observed no significant difference between groups in systemic 
hemodynamic parameters and peripheral perfusion parameters. Importantly, the 
two groups had similar lactate concentrations and central venous oxygen saturation 
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values over time. PPTFM patients received less mean (SE) fluids during the treatment 
period, 4227 (1081 ml) vs. 6069 (1715 ml) (P= .39)  and almost 2.5 liters less during 
the observation period: 7565 (982 ml) vs. 10028 (941 ml) (P= .08)  in the control group 
(Table 1). Interestingly, patients in the control group stayed longer in the hospital 
compared to PPTFM patients with 43 (8) vs. 16 (3) days (P=.05) and had a higher organ 
failure scores (SOFA total scores and neurologic subscores). 
Discussion
This proof-of-concept study shows that early peripheral perfusion targeted fluid 
resuscitation leads to a trend towards less fluids when compared to a conventional 
regimen based on systemic hemodynamic parameters. 
Although the difference in fluid administration was not significant, PPTFM patients 
received almost 2 liters less in the first 6 hours already, leading up to 2.5 liters less 72 
hours after ICU admission. If performed on a larger scale, this could have important 
clinical implications as large volumes of fluids are associated with pulmonary – and 
table 1. Fluid therapy and outcome variables.
Variables Groups
Study period
0-6 h 7-72 h
Cumulative Fluids (ml) Control 6069 (1715) 10028 (941)
PPTFM 4227 (1081) 7565 (982)
Urine output (mL) Control 520 (160) 2469 (542)
PPTFM 332 (84) 1680 (527)
SOFA total Control 12.8 [10.0-16.8] 11.0 [5.3-15.3]
PPTFM 11.5* [8.0-13.0] 8.3 [5.5-13.1]
Outcome
Mechanical ventilation free days (days) Control 2 [2 – 6]
PPTFM 2 [1 – 5]
Intensive care unit mortality, n (%) Control 6 (40)
PPTFM 7 (47)
Intensive care unit stay (days) Control 8 [3 –8]
PPTFM 10 [2 –10]
Hospital stay (days) Control 43 [8 – 45]
PPTFM 16 [5 – 28]*
Data are presented as mean (SE) or mean [IQR], unless otherwise stated.
Dash (-) indicates the mean value between subsequent time points during the study periods; for 
the period from 0 hours to 6 hours and for the period from 7 to 72 hours.
Sum of crystalloid and colloid fluids over time
* P<0.05 between groups (Control vs PPTFM).
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renal failure and adverse outcomes.13 One can hypothesize that using our algorithm 
for targeting the peripheral circulation less fluids are administered because infusion 
is stopped earlier: as soon as peripheral perfusion is not impaired (anymore) or when 
perfusion remains impaired although maximum cardiac output is reached. Surprisingly, 
we observed that PPTFM patients have a significantly shorter hospital length of stay 
and significantly lower organ failure scores. It must however be noted that our study 
was not powered to for this purpose so these results should be interpreted with 
caution. A larger trial is needed to confirm and elaborate our findings.
Still, to our knowledge this is the first randomized controlled study that 
incorporates peripheral perfusion parameters as target for fluid resuscitation in septic 
shock patients. In our opinion this approach provides an important complement to 
currently targeted systemic hemodynamic parameters. From a physiological point of 
view, peripheral tissues are the first to reflect hypoperfusion during shock and are 
the last to reperfuse during resuscitation, as a result of compensatory sympathetic 
nervous system activation.14 If this response is adequate, restored peripheral perfusion 
indicates that enough fluid has been administered and a conservative strategy can be 
followed. It therefore makes sense to strive towards a more tissue perfusion based 
approach that allows the physician to titrate therapy in a way conventional targets 
such as blood pressure and urine production do not provide. These considerations, as 
well as the limitations of our study, are elaborated in the electronic supplement.
Further research is needed to confirm our findings and definitely demonstrate 
whether the use of peripheral perfusion parameters as resuscitation targets can benefit 
outcome in critically ill patients. 
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Material and methods
This trial was approved by the institutional review board, was conducted under the 
auspices of an independent Data Safety Monitoring Board (DSMB), and was registered 
at clinicaltrials.gov (NCT01397474). For all patients deferred proxy consent was 
obtained from a relative authorized to consent on behalf of such a patient.
Between October 2011 and November 2013 we performed a prospective 
randomized controlled pilot-study in septic shock patients that were admitted to the 
ICU who met two or more criteria for systemic inflammatory response syndrome1, with 
hypotension and/or a blood lactate level at or above 3.0 mEq/L on ICU admission. 
Exclusion criteria are listed in the electronic supplement.
Study protocol 
Fluid repletion was guided using fluid challenges in both groups (i.e. bolus of 250 
ml fluid[hydroxyl-ethyl starch 6% 130/0.4 [Fresenius Kabi, Germany] 130/0.4]), yet 
targeted by different endpoints. In the PPPTM group, after each fluid challenge, 
peripheral perfusion was re-evaluated to access further need of fluid challenges. To 
ensure normovolemia, fluid was also targeted at a minimum cardiac index of 2.5 L/
min/m2, irrespective of peripheral perfusion (Figure 1). When additional fluid infusion 
was no longer accompanied by a response in peripheral perfusion, fluid administration 
was cancelled to prevent fluid overloading.
Cardiac output index and its related variables were measured with transpulmonary 
thermodilution catheter (PiCCO; Pulsion Medical Systems AG, Munich, Germany) using 
a  femoral artery catheter and a central venous catheter (subclavian or internal jugular 
vein. Cardiac output measurements were performed with bolus injections of 20-mL 
saline (4°C) and were obtained in triplicate and averaged. We aimed for a minimum 
arterial blood pressure of 65 mmHg, according to the Surviving Sepsis Guidelines. In 
case of hypotension (i.e. MAP < 65 mmHg) at admission this was treated in both groups 
with the administration of noradrenaline, while immediate fluid resuscitation was 
started for the following 6 hours (intervention period) according to the study protocol
Inclusion criteria
All adult patients (≥ 18 years) with hemodynamic instability due to severe sepsis or 
septic shock on ICU admission were eligible for inclusion. Septic shock was defined 
as hypotension (mean arterial pressure <65 mm Hg) requiring the administration of 
a vasopressor (norepinephrine at any dose) or a blood lactate level at or above 3.0 
mEq/L on ICU admission in patients in whom infection was suspected.1 We excluded 
patients with preexisting conditions precluding peripheral perfusion assessment, such 
as hypothermia, Raynaud disease, or known severe peripheral vascular disease, acute 
coronary syndrome, acute pulmonary edema, burn or trauma, liver failure (prothrombin 
time > 15 seconds or international normalized ratio equal to or greater than 1.5 and 
any hepatic encephalopathy, after liver surgery, a contraindication for central venous 
catheterization, an evident aerobic cause of hyperlactatemia (at the discretion of the 
treating physician), any neurological insult (stroke, subarachnoid hemorrhage, brain 
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trauma, epileptic seizures prior to admission, a do-not-resuscitate status, pregnancy, 
or recent participation in another biomedical study. Patients were also excluded if they 
had an inability to start the study within 4 hours after ICU admission.
Systemic inflammatory response syndrome criteria according to Bone et al.1 Patients 
were required to have >2 of the following 4 criteria: 
i.) temperature >38° C or <36° C;
ii.) heart rate >90 beats per minute;
iii.) respiratory rate >20 breaths per minute, intubation or a PaCO2 <32Mm Hg; and,
iv.) white blood cell count >12,000/mm3, <4,000/mm3,
Randomization
The start of the study was defined as the opportunity to include a patient and start 
the study protocol within 4 hours after ICU admission. Randomization was done with 
the use of opaque sealed envelopes randomly shuffled by an investigator not involved 
in patient inclusion. The randomization was performed using block randomization 
containing 3 blocks with a block size of ten. The first two authors enrolled all patients 
and opened the envelopes. By immediately filling out name and date on the 
randomization-patient form, the connection between the patient and the outcome of 
the randomization was safeguarded. The random allocation sequence was generated 
with the use of the Random Allocation Software. The treating physicians were unaware 
of the randomization block size. To ensure that the treating physicians were following 
the protocol, complying with fluid procedures and data collection,  a researcher was 
present during the treatment period in patients randomized to the PPTFM group.
Data collection time points
Our protocol is based on different 6-hour early goal-directed landscape studies.2,3 We 
therefore assessed adherence to the PPTFM and control group protocol at 2, 4, and 6 
hours after study entry. We defined these first 6 hours as intervention period because 
during this time frame patients were actively resuscitated based on either protocol. 
We subsequently repeated these measurements daily until 72 hours after study entry 
and defined this as the observation period. For patients in the control group, the 
treating physicians directed all care based on protocolized clinical decision making.
Organ failure assessment
All components of the Sequential Organ Failure Assessment (SOFA) score were 
collected for each patient at each time point to assess the presence of organ 
failure. The total SOFA score was calculated by summing the scores for each of the 
components (i.e., cardiac, renal, nervous, respiratory, coagulation, and liver).  SOFA 
total and subscores were compared between groups.
Statistical analysis
Data are presented as mean ± SE unless otherwise specified. The results were analyzed 
according to an intention-to-treat principle, which was defined as all patients who had 
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undergone randomization except for those who did not provide consent for the use of 
their data. We used a Kolmogorov-Smirnov test and stratified distribution plots to verify the 
normality of distribution of continuous variables (P>.05). Differences between model means 
were compared using Student t test or Mann-Whitney U test if not normally distributed. 
Accordingly, we used a linear mixed-model analysis to assess differences between groups 
(controls vs. PPTFM) to calculate differences in fluid administration/balance during the first 
72 hours of ICU admission, Secondary we analyzed differences between groups in systemic 
hemodynamics, peripheral perfusion parameters, laboratory variables, fluid therapy, and 
SOFA scores over time; i.e. for the intervention period and the observation period (7-72 
hours), corrected for the following predefined covariables: age, Acute Physiology and 
Chronic Health Evaluation (APACHE) II score, and baseline SOFA score.
Statistical analysis was performed using SPSS (version 20.0; IBM, SPSS, Chicago, 
IL). A p value <.05 was considered statistically significant. No correction for multiple 
testing was performed due to planned comparisons 4
Results
table E1. Baseline characteristics at admission
Control group PPtFM group P-value
Age (years) 67 [55 - 74 ] 63 [58 -73] 0.78
Male sex, n (%) 9 (60) 9 (60) 0.94
Body mass index (kg/m2) 24.0 (1.3) 26.3 (1.9) 0.33
Median time from ICU admission to enrollment (minutes) 89 (21) 118 (35) 0.46
Acute Physiology and Chronic Health Evaluation II 24 (3) 26 (3) 0.59
Total Sequential Organ Failure Assessment at inclusion 13 (1) 11 (1) 0.89
Central temperature (°C) 36.5 (0.2) 36.8 (0.3) 0.45
Referring department, n
- Postoperative (acute)
- Postoperative (elective)
- Ward or emergency department
- Other ICU
1
8
5
1
3
4
6
2
Source of sepsis, n
- Abdomen
- Lungs 
- Vascular 
- Other
10
1
1
3
8
2
2
3
Noradrenaline use, n (%) 15 (100) 13 (87) 0.48
Noradrenaline dose  (µg/kg/min) 0.35 (0.08) 0.27 (0.09) 0.34
Unless otherwise specified values are expressed as mean (SE) or median [interquartile range]; 
n = 15 for each group.
There were no significant differences between groups in any of the variables.
Data presented is at study admission.
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Discussion
In combination with arbitrary minimum cardiac index values, early peripheral perfusion-
targeted resuscitation is easy to perform, feasible, and safe.
The current guidelines still suggest targeting a mean arterial blood pressure ≥ 
65 mmHg in septic shock patients. Recently, a large randomized trial however 
demonstrated that increasing mean arterial pressure (MAP) did not predict global 
tissue perfusion nor improved organ perfusion in septic shock patients.5 This arbitrary 
value can be debated since pressures around 45 -50 mmHg are adequate to maintain 
cardiac and cerebral blood.6
Urine output is conventionally used as a target for resuscitation. Understandably, 
when systemic blood flow fails and hypotension induced sympathetic nervous system 
activity leads to different compensatory mechanisms such as stimulation of the kidney 
to retain fluid, resulting in (prerenal) oliguria. Restoring systemic blood flow will result 
in decreased sympathetic activity and return of urine production. However, during 
septic shock restoring cardiac output will typically not lead to a decreased sympathetic 
outflow and renal fluid retention will persist. Depending on the course of the disease 
this might transform in acute kidney injury (AKI). It has been shown repeatedly that 
improving systemic hemodynamic parameters during severe sepsis does not result in 
recovery of urine production or kidney function, recently by Asfar et al.5 For this reason 
we decided not to incorporate urine production in the PPTFM algorithm. It should 
be noted however that a similar mechanism might be responsible for the changes 
in peripheral perfusion during severe sepsis. Persistent sympathetic activity despite 
recovery of systemic hemodynamic parameters might be responsible for impaired 
peripheral perfusion in severe sepsis. 
This proof-of-concept study shows that early peripheral perfusion targeted fluid 
resuscitation might lead towards less fluid administration. Although this effect did not 
reach significance, we hypothesized that fluid administration in the PPTFM group was 
limited in two ways. First, if peripheral perfusion was considered good, no more fluids 
were given irrespective of systemic hemodynamic parameters. Second, if peripheral 
perfusion was considered bad, fluid administration was continued only if peripheral 
perfusion improved as well as stroke volume. If one of these did not improve, no more 
fluids were administered. In this way, peripheral perfusion parameters worked as a safety 
limit rather than a resuscitation target. A secondary aim of our study was to test the 
feasibility of a peripheral perfusion targeted resuscitation protocol. For this purpose we 
designed a simple algorithm that was easy to interpret and left little room for mistakes.
Limitations
Naturally, our study has some limitations. First, we included patients that were admitted 
to the ICU with suspected sepsis. Septic shock occurs in a heterogeneous population, 
and care before randomization can be variable.  Because this is a single center study, 
this may limit the generalizability of our results. A future randomized trial should better 
monitor pre-inclusion resuscitation strategies. Secondary, this study is performed as 
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an open-label trial design.7,8 First, as blinding of the treatment team in a study like 
this is impossible, this imposes a great risk of bias. The study was however intended 
to mimic everyday bedside practice and such a design provides a closer reflection of 
everyday clinical practice compared to double-blind trials. Moreover, to minimize the 
risk of bias and protocol violation, all treating physicians were aware of the treatment 
protocol before the start of the study and were accompanied by a researcher, fully 
aware of the protocol, during the treatment period in patients randomized to the 
intervention group. Additionally, we chose to randomize patients after collection of 
baseline data, to minimize the likelihood of bias.9
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“Hemodynamic monitoring can be particularly helpful in the early stages of 
resuscitation, but is less useful when organ failure is established. Most importantly, 
one must never forget that it is not the monitoring itself that improves outcomes but 
the changes in therapy guided by the data obtained.” 1
Jean-Louis Vincent as part of a consensus regarding hemodynamic monitoring, 2011. Professor 
Vincent is Professor of Intensive Care, Université Libre de Bruxelles and the Department of Intensive 
Care, Erasme University Hospital (Belgium). He is a member of the editorial board of more than 30 
international journals, including the New England Journal of Medicine. 
Already in 1947 the noninvasive assessment of peripheral perfusion was advocated as a 
valuable parameter to grade circulatory shock in the early phase.2 Nowadays, physical 
examination has gained more skepticism: clinicians are more trained to evaluate 
scans and x-ray images even before they start talking to a patient or perform physical 
examination. This trend leads to an increased reliance on technology and consequently 
has reduced health carer’s confidence in traditional methods of physical examination. 
Consequently, when making clinical judgments there is a tendency to value numbers 
on a screen and an urge to perform further examination instead of relying on our own 
manual examination of a patient. Even when the latter might provide more useful 
information. For instance, a recent report by America’s national health insurance political 
advocacy regarding the use of diagnostic imaging claimed that 20- 50 % of all “high-
tech” imaging provided no useful information and could be considered unnecessary.3 
This suggests a widespread perception among many branches of medicine that today’s 
health care modalities are overused. This is surprising since there is an unsustainable 
rise in health care costs throughout the world.4 Surprisingly, increased health care costs 
per patient do not necessarily lead to better outcomes. To reduce the increase in health 
care costs and to warrant high-value, cost-conscious health care, the American College 
of Physicians convened a workgroup of physicians to identify, valuable screening and 
diagnostic tests in different clinical situations. It is therefore striking that examination of 
clinical skills is argued to be a poor value investment.5 Especially since warranting quality 
of  physical examination of different physicians might improve health care quality and 
could lead to a decrease in costs and strengthen the physician–patient relationship.6 
In this thesis we aim to demonstrate that a reliable assessment of the circulation 
of a patient can be obtained with physical examination. Using simple tests or non-
invasive techniques, the peripheral perfusion (i.e. perfusion of skin and muscle of hand 
or foot) can be evaluated at the bedside, is easy to interpret, and is able to identify 
critically ill patients. In Chapter 2A & 2B we discuss several subjective assessments 
and optical techniques that could be used to monitor the peripheral perfusion.
Validation of peripheral perfusion parameters
The peripheral perfusion index (PPI) is derived from the photoelectric plethysmographic 
signal of the pulse oximeter. This index is calculated as the ratio between the pulsatile 
component (arterial compartment) and the nonpulsatile component (venous and 
capillary blood and other tissues) of the light reaching the detector of the pulse 
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oximeter. Peripheral vasoconstriction reduces the pulsatile component and thus 
decreases the PPI. Because a pulse oximeter is universally available in the operating 
room, emergency room, and intensive care unit (ICU), it could potentially be useful 
for the early detection of peripheral vasoconstriction in response to reductions in 
central blood volume. In Chapter 3 we therefore investigated the ability of the PPI to 
reflect early peripheral vasoconstriction during controlled stepwise central progressive 
hypovolemia in twenty-five healthy male volunteers by applying lower body negative 
pressure (LBNP). During application of LBNP, the circulating volume is progressively 
redistributed from the upper to the lower body, inducing central hypovolemia, which 
triggers similar compensatory mechanisms as during acute hemorrhage and clinical 
hypovolemia, i.e. activation of the sympathetic nervous system. Already after the 
first LBNP step (−20 mm Hg), the mean PPI decreased substantially from baseline 
(41% ± 6.0%). During this step stroke volume significantly decreased, while heart rate 
remained unaltered. The magnitude of the PPI decrease was statistically different from 
the changes in stroke volume and heart rate. With progressive LBNP, SV decreased 
and HR increased progressively. The PPI was low throughout the remainder of the 
protocol and returned to baseline values when LBNP was released. Mean arterial 
blood pressure remained in the same range throughout the experiment. These results 
indicate that the pulse oximeter–derived PPI may be a valuable diagnostic tool for the 
early detection of hypovolemia, before the onset of cardiovascular decompensation. 
To further explore the effect of peripheral vasoconstriction on the different peripheral 
perfusion parameters, we performed a study in eight healthy volunteers in which we 
induced peripheral vasoconstriction by body surface cooling (Chapter 4). Cooling 
resulted in peripheral vasoconstriction in all volunteers with a significant decrease in the 
forearm-to-fingertip skin-temperature gradient (Tskin-diff) and the PPI. Subsequently we 
found that capillary refill time (CRT) changed similarly. CRT changed from 2.5 s (2.0–3.0) 
before cooling to 8.5 s (7.2–11.0) after 30 minutes of cooling and returned to normal after 
initiation of the rewarming process. Different systemic hemodynamic parameters, such 
as cardiac output, mean arterial pressure and heart rate did not change during cooling. 
We concluded that changes in the peripheral perfusion parameters reflect changes in 
peripheral vasomotor tone, independent of the systemic hemodynamic parameters. 
Monitoring and resuscitation of the peripheral 
perfusion in critically ill patients
Supported by the findings in Chapter 4, we were curious to find out whether central 
hypothermia-induced peripheral vasoconstriction would have a similar effect on 
the different peripheral perfusion parameters. We therefore performed in Chapter 
5 a prospective observational study in patients who were treated with therapeutic 
hypothermia after out-of-hospital cardiac arrest. In addition to the previously 
mentioned methods we also used a Sidestream dark-field imager to visualize the 
sublingual microcirculation. We found that the early post resuscitation hypothermia 
phase is characterized by vasoconstriction in both the sublingual microcirculation 
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and the peripheral circulation. The impaired perfusion is aggravated by induced 
hypothermia and not by impaired cardiac output. Persistence of these tissue perfusion 
alterations after hypothermia is independently associated with the development of 
organ failure and mortality in this group of patients.
As early identification of critical illness is widely acknowledged as a vital step 
towards improving survival,7-9 we aimed to determine whether repeated assessment 
of the peripheral circulation in the days following surgery could help to early identify 
patients that develop postoperative complications. In Chapter 6 we present the 
results of a prospective observational study in which we followed 111 consecutive 
patients who underwent elective major abdominal surgery. We found that peripheral 
perfusion alterations are associated with the development of severe complications, 
independently of systemic hemodynamics. Notably, peripheral perfusion alterations 
were already present in these patients immediately after surgery and became even 
more predictive over time.  These abnormalities were present approximately 2–12 
times more often in patients with severe complications. 
Although CRT has gained widespread acceptance as one of the strongest red flags 
to identify infection and tissue hypoperfusion in pediatric patients,10 its reproducibility 
and thus its reliability is still doubted in critically adult patients. For the first time in 
a postoperative population we studied CRT reproducibility and found a good overall 
agreement between different observers. It can thus be concluded that manual assessment 
of the peripheral perfusion is reliable, improves risk stratification independently of 
systemic hemodynamics, and can be used immediately after surgery to discriminate 
patients at high risk for developing severe complications. Early identification of patients 
at risk could help the surgeon to early adopt postoperative strategies tailored on 
individual basis and opens the perspective of new goal directed therapies. 
In view of goal directed therapies, the predictive value of the course of peripheral 
perfusion parameters over time has not been studied. For this purpose we evaluated 
the additional value of repeated assessment of the peripheral perfusion in septic shock 
patients (Chapter 7). We retrospectively analyzed thirty-five septic shock patients that 
were admitted to the ICU. In these patients, unfavorable evolution of the peripheral 
perfusion in the first days following initial resuscitation is strongly predictive of 
mortality in septic shock patients. Moreover serial assessment of peripheral perfusion, 
i.e. unfavorable evolution of both CRT and PPI, was more predictive for mortality when 
compared to a single assessment of peripheral perfusion.
The chapters above describe the potential additional value of peripheral perfusion 
assessment in critically ill patients. Its use in resuscitation is however still unknown. In 
light of this findings we conducted a prospective double-blinded study in postoperative 
esophagectomy patients admitted to the ICU (Chapter 8). These patients are known 
for their postoperative systemic “sepsis-like” inflammatory response and high 
morbidity and mortality rates. To observe microcirculatory peripheral perfusion, we 
visualized sublingual microvascular perfusion using SDF-imaging. We randomized 20 
postoperative esophagectomy patients in two groups: the intervention group (received 
a small dose of dobutamine: 2.5 μg/kg/min) directly postoperative and the placebo 
182
General discussion, summary, and future research perspectives
group (syringe with saline). At the first postoperative day, patients in the placebo 
group, showed altered sublingual microvascular perfusion, which could be prevented 
in the dobutamine group. These disturbances were not seen when we compared these 
findings with controls, patients after pancreaticoduodenectomy. 
This study was however limited in providing pathophysiological rationale as we 
could not establish whether dobutamine showed a true effect of recruitment itself, 
or whether this was the result of a complex of therapeutic interventions. Moreover, 
little was known about the use of regional tissue perfusion parameters as a direct 
target for resuscitation. We therefore designed an experimental study to examine 
the effect of cardiac output resuscitation on different microvascular perfusion and 
peripheral perfusion parameters during endotoxemic and obstructive shock states in 
pigs (Chapter 9). The main finding of this study was that the relationship between 
the systemic circulation and regional perfusion is dependent on the underlying cause 
of circulatory shock. The correction of cardiac output to normal levels is adequate 
for resuscitation of the regional perfusion parameters after obstructive shock but not 
after endotoxemic shock. In the latter model, only additional cardiac output-targeted 
fluid resuscitation to supranormal values could further improve the regional perfusion. 
These findings highlight that additional resuscitation at the regional (microcirculatory) 
perfusion level might be a complementary target if the conventional global resuscitation 
goals have been achieved during endotoxemic shock. It also raises the question whether 
we should aim at full recovery of microcirculatory disturbances in septic shock.11,12 
In the last part of my thesis, Chapter 10, we performed a prospective randomized 
controlled pilot-study in 30 septic shock patients admitted to the Intensive Care Unit 
between October 2011 and November 2013. In this study we investigated whether 
peripheral perfusion guided fluid resuscitation is feasible and would lead to less fluid 
administration compared to the currently used hemodynamic endpoints. Patients were 
randomized into two groups, i.e. the control group (standard fluid therapy) or the 
intervention group (Peripheral Perfusion Targeted Fluid Management – PPTFM group) in 
whom peripheral perfusion parameters were taken into consideration before each fluid 
challenge. We found that patients randomized to the PPTFM group received less mean 
fluids compared to the control group. Although the difference in fluid administration 
was not significant, PPTFM patients received almost 2 liters less in the first 6 hours 
after ICU admission, leading up to 2.5 liters less 72 hours after ICU admission. These 
findings support our hypothesis that peripheral perfusion parameters can both be used 
as diagnostic tool and as a target in the resuscitation of critically ill patients. 
Altogether, peripheral perfusion can be assessed at the bedside by physical examination 
and simple objective tools. It is reliable, and can be repeated as often as necessary.
Future research perspectives
Although this thesis demonstrated that evaluation of the peripheral perfusion provides 
an inexpensive good prognosticator for organ failure and outcome in different patient 
populations, several questions still remain unanswered. 
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We have demonstrated that, despite systemic hemodynamic optimization, tissue 
perfusion alterations can persist in different patient populations. Additionally it 
has been demonstrated that microcirculatory perfusion can be improved by some 
inotropes but not by others.13 It can be hypothesized that interventions directed at 
the regional tissue perfusion level may help bridging the gap between improved 
hemodynamics and patient outcome. In patients with septic shock, dose-dependent 
infusion of nitroglycerin reverted abnormal peripheral perfusion and poor tissue 
oxygenation in patients following circulatory shock resuscitation.14 Contrastingly 
Boerma and colleagues failed to show significant differences in the evolution of 
the sublingual microcirculation between septic shock patients treated without and 
those treated with nitroglycerin.15 Although this study precluded the effectiveness of 
nitroglycerin in the sublingual microvascular flow, the fixed dose of nitroglycerin used 
(2 mg/hour) was able to significantly increase skin blood flow as measured by central-
to-toe temperature gradient in the treatment group. In addition to that finding, the 
authors reported lower Sequential Organ Failure Assessment (SOFA) scores in patients 
who received nitroglycerin compared with the placebo group. Therefore it still needs 
to be proven whether these abnormalities in peripheral perfusion when incorporated 
in a diagnostic/treatment plan do improve patient outcome. 
A large powered randomized controlled multicenter trial is warranted to investigate 
whether peripheral perfusion assessment could help in a (postoperative) patient 
tailored treatment. Moreover recent publications give increasing awareness of the 
potential for harm due to the excessive fluid administration in patients with septic 
shock. This future randomized trial should be taken the previous into account and 
therefore should target (fluid) resuscitation in a goal-directed manner and targeted 
to physiologic needs of individual patient, to avoid the risk of over-resuscitation. 
We hypothesize that early goal-directed fluid resuscitation guided by endpoints of 
peripheral tissue perfusion might lead to less fluid administration and might result 
in improved outcome in different patient populations. Currently, protocols are being 
designed to conduct such a study. 
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Hemodynamic monitoring is a cornerstone in the care of the critically ill patient. 
Monitoring techniques have greatly improved over the last decade and technologies 
have evolved from invasive to non-invasive monitoring devices. The rationale of 
peripheral perfusion monitoring is based on the concept that peripheral tissues are 
the first to reflect a disturbance of the circulation that frequently characterizes shock*, 
independent of systemic hemodynamics. Peripheral perfusion monitoring not only 
provides a different point of reference for patient circulation, but is also non-invasive 
can be used directly at the bedside. 
In patients after out-of-hospital cardiac arrest, after major abdominal surgery, and 
in a heterogeneous intensive care unit population, persistence of these alterations is 
associated with organ failure and death, independent of systemic hemodynamics (i.e., 
heart rate, blood pressure, and cardiac output). Moreover, in septic shock patients, 
early peripheral perfusion targeted fluid resuscitation leads to a trend towards less 
fluids when compared to a conventional regimen based on systemic hemodynamic 
parameters. These findings demonstrate that assessment of the peripheral perfusion 
could be used to early identify specifically those patients in need of additional therapy 
and open the perspective of peripheral perfusion targeted resuscitation.
It can thus be concluded that assessment of the peripheral perfusion can be easily 
performed at the bedside, can be rapidly instituted throughout the hospital, and could 
be a potential target to optimize the circulation. Still, its role as an efficient target for 
resuscitation warrants further investigation.
*Circulatory shock is a life-threatening syndrome resulting in multiorgan failure and a high 
mortality rate. 
Cecconi M, De Backer D, Antonelli M, et al.: Consensus on circulatory shock and hemodynamic 
monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med. 
2014;40:1795-815.
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Monitoring van de perifere circulatie is gebaseerd op het concept dat perifere weefsels 
de eerste zijn die hypoperfusie laten zien tijdens circulatoire shock en de laatste 
die herstellen tijdens de behandeling. De beoordeling van de perifere circulatie is 
daarmee niet alleen een referentiepunt voor de beoordeling van de circulatie, maar 
kan met eenvoudige klinische beoordelingen en monitoringstechnieken op een non-
invasieve wijze aan het bed van de patiënt worden uitgevoerd. Bovendien is het klinisch 
beoordelen van de perifere perfusie eenvoudig, snel, goedkoop en uitvoerbaar in 
vrijwel iedere patiënt. Bij patiënten na reanimatie, na grote chirurgische buikoperatie en 
bij ernstig zieke patiënten opgenomen op de Intensive Care is een blijvend afwijkende 
perifere perfusie gerelateerd aan een verhoogd risico op orgaanfalen en overlijden, 
ook als de waarden van conventionele hemodynamische parameters, zoals bloeddruk 
en hartfrequentie, na behandeling normaliseren. Bij patiënten met ernstige septische 
shock (een aandoening die wordt veroorzaakt door een infectie in de bloedbaan, waarbij 
de bloeddruk gevaarlijk daalt en tot orgaanfalen kan leiden), leidt een op de perifere 
circulatie getitreerd vochtbeleid tot toediening van minder vocht wanneer deze wordt 
vergeleken met een vochtbeleid dat alleen gebaseerd is op verschillende conventionele 
hemodynamische parameters. Mogelijk kunnen interventies die de perifere circulatie 
verbeteren het klinisch herstel bespoedigen bij ernstig zieke patiënten. 
De perifere circulatie kan met de huidige non-invasieve methoden eenvoudig 
aan het bed van elke ernstig zieke patiënt, waar ook in het ziekenhuis, worden 
beoordeeld. Interventies die de perifere circulatie gebruiken als doel van therapie 
zouden het klinisch herstel van ernstig zieke patiënten kunnen bespoedigen. Alhoewel 
we positieve effecten hebben gezien van een dergelijke aanpak moet een definitieve 
gerandomiseerde studie dit nog bevestigen. 
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2010
2010
2011 
2011
2011-2012
2011-2012
2012
2012
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0.25
0.25
0.25 
0.25
1
0.5
1.5
0.5
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